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Abstract 
A major challenge of drug development is maximising specificity and efficacy at the lowest 
possible dose to minimise toxic side effects (Basile et al., 2012). Not only are the pharmaceutical 
windows small for both drug candidates and approved drugs alike, but they can also vary between 
individuals, making a dose level safe for one individual potentially harmful for another. One 
strategy for overcoming this problem is to develop new drug delivery methods where the drug is 
preferentially concentrated at the site of disease (Basile et al., 2012). In this respect, liposomal drug 
delivery systems have been used with success in topical applications in skin cancer treatment, and 
there is significant research interest in engineering similar systems for intravenous administration 
(Al-Jamal & Kostarelos, 2011; Fan & Zhang, 2013). Incorporating nanovalves into liposomes with 
controllable gating properties would further enhance the usefulness of liposomal drug delivery 
systems, providing a method to further regulate the release of liposome-encapsulated drugs from 
liposomes at the target site (Martinac et al., 2014). 
The mechanosensitive channel of large conductance (MscL) has been identified as a major 
candidate for the development of a protein-based nanovalve (Martinac et al., 2014). More generally, 
MscL is a prototype for the class of ion channels primarily gated by membrane tension, which 
includes medically significant proteins such as Piezo channels and TRP-type sodium channels 
(Martinac, 2011). As a well-expressing protein from Escherichia coli, MscL has been extensively 
studied both structurally and biophysically (Martinac, 2011). However, the channel gating 
mechanism of MscL, and by extension of mechanosensitive channels in general, remains poorly 
understood at the molecular level. 
This thesis aims to investigate the relationship between E. coli MscL and phospholipids both in the 
context of its structure and its behaviour in a lipid bilayer environment. While much has been 
studied on the channel gating properties of MscL in various phospholipid environments (Anishkin 
et al., 2005; Iscla et al., 2004; Iscla et al., 2011; Levin & Blount, 2004; Powl et al., 2008b; Tsai et 
al., 2005; Yoshimura et al., 2004), there remains a limited understanding of the behaviour and 
distribution of MscL in the bilayer. These are not only important from academic perspective as well 
as in the context of nanovalve development, but also for example, to identify factors which may 
limit the functional studies on MscL. More specifically, this thesis has focused on the identification 
of phospholipids closely associating with MscL, the distribution of MscL in phospholipid bilayers, 
and the incorporation of MscL into liposomes with heterogeneous phospholipids. 
The first research chapter (Chapter 2) outlines the optimisation of MscL expression and purification 
system for biophysical and structural studies. The original MscL construct had problems of 
ii 
 
heterogeneous expression and being not well-suited to reliable quantification by routine methods. 
New constructs were successfully designed to overcome these issues, and the results have been 
published in European Biophysical Journal. 
Chapter 3 investigates the interaction between MscL and phospholipids at the biophysical level. At 
the start of the project, it was hypothesised that there were functionally relevant native 
phospholipids associating with E. coli MscL. Thin layer chromatography of purified MscL showed 
a different lipid profile from native E. coli lipid and confirmed the presence of tightly-associating 
lipids. The same technique was then employed to purify these phospholipids for identification by 
lipid mass spectrometry. MscL was also reconstituted back into heterogeneous phospholipid 
liposome samples in order to identify any preference of its incorporation as well as any effects of 
these factors on its channel gating function and distribution within liposomes. Lastly, MscL was 
reconstituted into liposomes prepared from pure phospholipids and studied with electron 
microscopy in order to further identify the lipid effects on MscL function. 
Chapter 4 outlines the efforts to experimentally determine a high-resolution structure of E. coli 
MscL. A wide range of techniques were employed, including 2D crystallisation, 3D crystallisation, 
and single particle electron microscopy. For 2D crystallisation experiments, both the traditional 
crystallisation experiments based on the successful attempt by (Saint et al., 1998) and monolayer-
assisted method described by (Landsberg et al., 2010) have been employed and described in this 
thesis. In parallel, 3D crystallisation of detergent-solubilised E. coli MscL has been attempted, with 
some promising initial outcome. 
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1. Introduction 
1.1. Drug Delivery Methods 
Globally the pharmaceutical industry is focused on developing highly effective and specific drugs 
with minimal side effects. However, most drug candidates act on non-targeted tissues through either 
specific or nonspecific interactions, causing side effects. The levels at which many drugs are both 
safe enough for administration and effective for the intended use, called pharmaceutical window, 
are often too narrow or too variable between individuals to be used. Lack of efficacy at the safe 
level of dose has led to the failure of a third of Phase II clinical trials in 2004-2010 (Ledford, 2011), 
with another quarter of drug candidates in Phase III trials not approved for this reason (Fig. 1.1) 
(Hay et al., 2014; Ledford, 2011). In response to this, pharmaceutical companies often raise the 
price of new drugs to recoup the loss, and ultimately develop new agents or techniques which limit 
the side effects of active compounds. Such methods add financial burden and uncertainty to both the 
companies and the patients, contributing to the rise in health care costs. 
One of the reasons for drugs affecting non-target tissues is the fact that both oral and intravenous 
administration typically results in an even distribution of the drug throughout the body via the 
circulatory system (Egusquiaguirre et al., 2012). Non-target tissues are therefore exposed to similar 
drug concentrations as target tissues, resulting in unpredictable and potentially undesirable 
 
Figure 1.1. Causes of Product Failures in Phase II and Phase III Clinical Trials. Figure courtesy of 
(Ledford, 2011) 
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consequences. This is of particular concern for anti-cancer and hormonal drugs (Kubek et al., 2009; 
Montemurro et al., 2012; Nicolas et al., 2013), in which target proteins are often expressed in both 
target and non-target tissues. These classes of drugs account for a large portion of both existing 
drugs and those in development (Hay et al., 2014; Ledford, 2011), so there have been significant 
efforts to address this simple but serious issue. 
A solution to this problem is to increase localisation of drugs to the target tissue, thereby 
minimising side effects on the healthy tissue (Basile et al., 2012) (Fig. 1.2). In the case that excess 
drug is administered at the target tissue, the concentration will become diluted to levels below the 
toxic threshold once the excess or non-adsorbed molecules are in circulation. An added advantage 
of this approach is that the overall required dose to be administered to the patient becomes much 
lower as a result of more efficient delivery. This is beneficial not only for drugs with high toxicity 
but also for expensive ones such as biologics where cost is often a major factor limiting patient 
access (Kubek et al., 2009). Consequently, targeted drug delivery systems can reduce cost while 
increasing safety and efficacy of drugs. 
There are two main approaches to develop targeted drug delivery systems. The first method is to 
directly apply drugs at the target tissue. Examples of this strategy include the treatment of 
superficial infections with topical drugs which are poorly absorbed through the skin, hence 
remaining at the intended site of action without reaching the circulatory system (Tomalik-Scharte et 
al., 2005). Physically immobilised drugs are also commonly used in bone fracture repair and 
surgery of atherosclerotic blood vessels, where implants are often coated with drugs to prevent 
infection, induce repair and reduce inflammation without affecting the whole body (Hussain, 2012; 
Trajkovski et al., 2012; Weinberg et al., 2008). Currently related strategies such as carmustine  
Figure 1.2. Schematic Diagram of Targeted Drug Delivery system. A) In a standard drug administration, 
drug (green) will be evenly distributed across the body and affect both target and non-target tissues. B) In a 
targeted drug delivery system, drug will localise to the target tissue, and non-target tissues will be less 
affected. 
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implants for brain tumours are undergoing clinical trials on cancer chemotherapies with positive 
results (Allhenn et al., 2012), opening up new avenues for advanced healthcare. 
In the second approach, drugs or drug delivery vehicles, which either are coated with, encapsulate, 
or otherwise internalise the drugs, are designed to be bioavailable only at the target site (Fig. 1.3) 
(Hu & Zhang, 2012). They can be injected into the bloodstream, and are designed to accumulate at 
the intended site of drug release using various mechanisms. This method has an advantage over 
physical implants in that surgical operation is not needed, as well as that cessation or modification 
of the therapy is more flexible. Several established systems, such as liposomal doxorubicin and 
cisplatin (Slingerland et al., 2012), rely on nanoparticles for delivery to target sites with reduced 
off-target effects on healthy tissues. More advanced forms of nanoparticles for improved drug 
localisation need to overcome several problems before deployment. A major condition for clinically 
safe nanoparticles is that they must be hypoimmunogenic, biodegradable, and without toxicity 
(Nicolas et al., 2013). This excludes a number of organic polymers and inorganic particles such as 
fullerene derivatives, gold particles and silica nanobeads, although the last of the three is still under 
consideration due to their high drug absorptivity (Dreaden et al., 2012; Hu & Zhang, 2012). 
Remaining candidates include biopolymers such as polysaccharides and lipid-based nanoparticles 
such as niosomes and liposomes. The choice of drug carriers between them is likely to be both 
disease and drug-specific: drugs that require slow release will be more compatible with biopolymer 
systems while those requiring rapid release will be more suited to liposome encapsulation; and 
 
Figure 1.3. Schematic figures of various nanoparticle drug carriers. Yellow particles represent hydrophilic 
drug molecules, and pink particles represent hydrophobic drug molecules. A) liposome; B) polymeric 
micelle; C) polymer-drug conjugate; D) dendromer; E) oil nanoemulsion; F) mesoporous silica 
nanoparticle; G) iron oxide nanoparticle. Courtesy of (Hu & Zhang, 2012) 
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lipid-based systems will be preferred for hydrophobic drugs. 
1.2. Nanovalve-based Liposomal Drug Delivery System 
1.2.1. Liposomal drug delivery system 
A liposome is an approximately spherical nanoparticle with its interior separated from the outside 
by a lipid bilayer similar to a cell membrane. Liposomal drug delivery systems have advantages 
over other drug delivery methods in three areas. First, they can carry a range of cargo molecules (H. 
I. Chang & Yeh, 2012). Both small molecules and much larger ones such as proteins can be 
contained in liposomes, and hydrophobic molecules can be dissolved and carried in the lipid bilayer 
(Hu & Zhang, 2012). In addition, liposomes are capable of carrying polynucleotides, allowing their 
potential use in gene therapy (Caracciolo & Amenitsch, 2012). Second, liposomes are easily 
modifiable to accommodate various properties/function (Levchenko et al., 2012; Slingerland et al., 
2012). For example, antibodies and polyethylene glycols can be added to improve their target 
specificity as well as reduced immunogenicity (Garnier et al., 2012; Wolff et al., 2010), and lipid 
composition has also been varied for improved solubility of specific drugs (Slingerland et al., 
2012). Third, liposomes can be easily adsorbed by tissues, as evidenced by topical liposomes 
commonly used by the cosmetic industry (Betz et al., 2005; Posner, 2002) as well as for topical 
nystatin formulations (Torchilin, 2005). 
Liposomal drug delivery systems have already found use as a drug administration strategy, 
particularly in cancer chemotherapy (H. I. Chang & Yeh, 2012; Fan & Zhang, 2013; Slingerland et 
al., 2012). For example, doxorubicin is commonly encapsulated in liposomes, often coated with 
polyethylene glycol prior to intravenous delivery which achieves a minor targeting effect in 
treatment of skin cancers (H. I. Chang & Yeh, 2012). This strategy not only reduces doxorubicin’s 
cardiotoxic effect, but also keeps concentration at the target site more consistent over time due to 
slower clearance from circulation. Such benefits make possible combined use with trastuzumab 
(Theodoulou & Hudis, 2004), another cardiotoxic anticancer agent, which has recently been use in 
chemotherapy (Gavila et al., 2015; Tahover et al., 2015; Uriarte-Pinto et al., 2016), and several 
variations of the formulations are currently in clinical trials as well (Pircher et al., 2015; Tuxen et 
al., 2014). Successful uses of liposomes in drug formulations are expanding to other agents such as 
cisplatin, whose cytotoxicity and hydrophobicity have limited its use until now (Fan & Zhang, 
2013). 
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1.2.2. Delivery Strategies for Liposomal Drug Delivery Systems 
Despite these successes, there are also limitations to be overcome in order for this technology to 
become more widely applicable. Major disadvantages of liposomes are their relative instability 
compared to other nanoparticles, the large size which restricts their access to certain tissues 
(Heneweer et al., 2012), and inefficient release of the drug molecules from the liposomes at the 
target site. With the first problem, there is active research to improve liposomes’ stability through 
the use of synthetic lipids as well as establishing a scaffold within the liposomes and coating them 
with stabilising molecules (Al-Jamal & Kostarelos, 2011; H. I. Chang & Yeh, 2012; Egusquiaguirre 
et al., 2012). With the second, it is possible to produce stable modifiable liposomes smaller than 
100 nm, which is small enough to cross the blood-brain barrier. With the third challenge, liposomes 
which directly release drugs at the target site via nanovalves and those which undergo receptor-
mediated fusion to the target cells are currently under development (Garnier et al., 2012; Nakayama 
et al., 2015). 
1.2.2.1. Passive Targeting 
There are three main ways for liposomes to accumulate in diseased tissues. Current successes rely 
heavily on passive targeting methods, where adsorption of liposomes relies largely on leaky 
vasculature (Fig. 1.4B) (Sawant & Torchilin, 2012). Liposomes usually have diameters of 100 - 300 
nm, which are too large to pass through the walls of blood vessels (Fig. 1.4A) (Lammers et al., 
2012). In diseased tissues like tumours, however, inflammation and active angiogenesis make the 
vessel walls more permeable, allowing liposomes to pass through (Lammers et al., 2012). Diseased 
tissues consequently become far more accessible to liposomes than healthy tissues, and are as a 
result subject to much higher concentrations of drugs released from them. However, this method has 
weaknesses in that A) a significant portion of drug release in the bloodstream could still affect 
healthy cells, B) inflamed non-target tissues or those undergoing active angiogenesis for other 
reasons (e.g. regeneration of uterus lining) will be exposed to similar levels of drugs, C) this 
strategy will be ineffective if the target tissue does not have liposome-permeable vasculature, and 
D) a slow and inconsistent rate of accumulation make the dosage at the target difficult to control 
(Lammers et al., 2012; Sawant & Torchilin, 2012). Hence, other methods for targeting are desirable 
if liposomes are to find a broader use as a drug delivery system. 
1.2.2.2. Active Targeting 
More recent developments have seen successes in concentrating liposomes at targeted sites by 
embedding molecules with specific affinity to target cells on the liposomal membrane (Fig. 1.4C) 
(Basile et al., 2012; Garnier et al., 2012; Lammers et al., 2012; Sawant & Torchilin, 2012). The  
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specificity of these affinity tags can range from fairly low (e.g. polyethylene glycol and ionic tags) 
to highly specific (e.g. ligands) (Basile et al., 2012; Fan & Zhang, 2013; Levchenko et al., 2012). 
They can also facilitate fusion of liposomes with cell surface membranes depending on the tags 
used, releasing the cargo directly into the cell. This has the potential to effectively deliver drugs at 
effective doses even at a very low level of overall dose, and has also opened up the possibility of 
exploiting liposomes as potential delivery systems for gene therapy (Heneweer et al., 2012; 
Levchenko et al., 2012). Moreover, in the case of metastatic cancer, active targeting allows 
  
Figure 1.4. Schematic diagram of delivery strategies for liposomal drug delivery system. A) in healthy 
tissues, liposomes are too large to pass through the blood vessels (red); B) in diseased tissues, blood vessel 
walls are often more porous, allowing liposomes to deliver their cargo by passive diffusion; C) ligands 
such as antibodies on liposomes actively target diseased cells, and potentially release drugs directly into 
them; D) nanovalves on liposomes are induced to open by external triggers, releasing drugs at the target 
tissue. 
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liposomes to target cancer cells which have metastasised to other tissues. A basic form of active 
targeting strategy is already used for a chemotherapy formulation, where DoxilTM has polyethylene 
glycol on the liposomal surface to facilitate not only immune surveillance avoidance but also its 
accumulation in skin tissues in Kaposi’s sarcoma (Northfelt et al., 1996). A few cationic lipid-based 
liposomes are in clinical trials and ligand-based systems, particularly those using antibodies, are 
also subjects of intense research efforts, making the active targeting method a highly promising 
strategy for liposomal drug delivery and imaging systems (Heneweer et al., 2012; Lammers et al., 
2012). 
Active targeting strategies have a few significant disadvantages (Lammers et al., 2012). Most 
affinity tags cannot be truly specific to the diseased tissue, as in most cases surface antigens and 
ligand receptors expressed by diseased cells are also expressed by at least some healthy cells, 
making them vulnerable to exposure of highly damaging concentrations of drugs (Lammers et al., 
2012). Ionic lipids will also be attracted to any surface with an opposing charge. Hence, while 
active targeting can be expected to contribute to greatly reduced side effects, those which remain 
may become exacerbated due to higher dosage to the affected cells. For example, Doxil has lower 
maximum tolerated dose than free doxorubicin injection (Gabizon, 2001), and it has greatly 
increased skin toxicity due to accumulation in healthy skin cells (Torchilin, 2006). This safety 
concern may therefore require additional clinical trials on each tagged liposome; i.e. since the safety 
and efficacy of actively targeting liposomes is additionally dependent on the affinity tag used, 
another clinical trial to assess them will be required in addition to trials establishing the safety and 
efficacy of the cargo drug. Moreover, different affinity tags would usually be required for different, 
significantly influencing the current versatility of generalised liposomal and likely increasing the 
number of clinical trials. Considering the time and cost of clinical trials, such active targeting 
methods may result in the rise of potentially effective drugs that either fail to enter or are 
permanently pulled from clinical trials for strategic reasons, which already accounted for a fifth of 
“failed” stage II trials in the 2008-2010 period. In addition, for highly mutagenic diseases such as 
cancer, there is a risk of the cells developing mutations which reduce affinity to the tags, which will 
make the targeting less effective (Ledford, 2011). 
1.2.2.3. External Targeting Through Localised Release 
An alternative strategy for liposomal targeting involves the use of external forces to trigger the 
release of cargo from liposomes specifically at the target tissue (Fig. 1.4D) (Egusquiaguirre et al., 
2012; Lammers et al., 2012; Preiss & Bothun, 2011). In this system, liposomes are embedded with 
nanovalves or nanoparticles responsive to external stimuli such as magnetic field (Hughes et al., 
2008; Preiss & Bothun, 2011). When liposomes reach the site of an applied stimulus, drugs are 
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released, through the opening of nanovalves or by destruction of the liposomes with vibrating 
nanoparticles for example. This method is unique in that it is not dependent on the accumulation of 
liposomes at the target tissue. Additionally, it has the advantage of not necessarily having to have 
liposomes pass physical barriers, as drugs (which are generally small enough to pass through such 
barriers) can still be released at the targeted site for adsorption to the targeted tissues. Therefore, it 
can be used either independent of passive or active targeting strategies, or in conjunction with them 
to achieve a synergistic effect (Egusquiaguirre et al., 2012; Lammers et al., 2012). 
This strategy, while still in early development, has found success in proof-of-concept experiments 
that have demonstrated its viability (Pradhan et al., 2010). One of the approaches, the use of 
nanoparticles to disrupt liposomal architecture, has shown particular promise in part due to the 
simplicity of operation. For example, photothermal release of doxorubicin from nanoparticle-
embedded liposomes has successfully been demonstrated in vivo in a mouse study (Preiss & 
Bothun, 2011). There are still a number of areas in need of further research, such as the practicality 
of applying magnetic pulses to patients for extended periods, but these experiments do show that 
external targeting is a possible strategy. 
Another focus of external targeting systems is the use of nanovalves to release cargo from 
liposomes without destroying them. An ideal nanovalve system might possess the ability to be 
opened in response to e.g. an externally applied magnetic field (Hughes et al., 2008). This would 
allow controlled release of drugs over time by restricting both the size of the valve pore and the 
duration of its opening. In addition, nanovalves which are biodegradable organic compounds would 
be highly favoured over, for example, those that incorporate gold nanoparticles (potentially 
nephrotoxic). In this regard, the use of gated transmembrane protein channels as liposomal 
nanovalves has been investigated. Hughes et al. (2008) successfully attached magnetic particles to 
an engineered potassium channel and opened the channel by applying magnetic force to it. 
Recently, the mechanosensitive channel of large conductance from Escherichia coli, has been 
studied as a potential nanovalve (Kocer, 2010; Kocer et al., 2005; Nakayama et al., 2015). 
Mutational studies have demonstrated the ability to control its pore size as well as the activation 
energy required for the conformational change between open and closed states (Blount et al., 1996; 
Iscla et al., 2013; Kocer et al., 2005; L. M. Yang & Blount, 2011). Being a protein, MscL is less 
likely to cause toxicity issues than inorganic nanoparticles such as silica nanoparticles (Duan et al., 
2013). Proof-of-concept studies have also demonstrated release of reporter molecules and small 
peptides in response to various stimuli, including a light-activated chromophore attached to the 
channel gate, ferromagnetic nanoparticle also attached to the channel gate, and the use of 
lysophosphatidylcholine to induce channel opening (A. Foo et al., 2015; Kocer-Sagiroglu et al., 
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2005; Nakayama et al., 2015; Perozo, Kloda, et al., 2002). The first two examples, which are mixed 
nanoparticle-nanovalve approaches, have successfully been demonstrated in vitro so far. 
1.3. Mechanosensitive Channels 
Mechanosensitive channels are integral membrane channel proteins whose primary opening trigger 
is membrane tension (Martinac, 2011; Pivetti et al., 2003). When the membrane bilayer is stretched 
or curved, it imparts a negative pressure on the mechanosensitive channels, which forces open the 
channels via a conformation change. For this reason, mechanosensitive channels are commonly 
present in unicellular organisms, where they serve as a protective mechanism against hyposmotic 
shock (Fig. 1.5) (Haswell et al., 2011). When the organism swells due to the hyposmotic 
environment, the cell surface membrane becomes stretched, triggering channel opening (Haswell et 
al., 2011). As a result, intracellular contents escape the cell through the channels and the turgor 
pressure is relieved. Due to their importance, a number of organisms have redundant 
mechanosensitive channels opening at different tension thresholds to provide some level of 
regulation of the hyposmotic shock response (Haswell et al., 2011; Kung et al., 2010). This 
phenomenon is well characterised in E. coli where only mechanosensitive channels of small 
conductance (MscS) open to control osmotic pressure releasing intracellular ions in mild 
hyposmotic environments, whereas in severe hyposmotic environments, mechanosensitive channels 
of large conductance (MscL) additionally open to rapidly balance the osmotic gradient across the 
cell surface membrane at the cost of a wide range of intracellular molecules such as adenosine 
triphosphate (ATP) and peptides being released into the extracellular milieu (Haswell et al., 2011; 
Kung et al., 2010; Martinac, 2011). Biophysics of MscS and MscL have been extensively studied, 
as they serve as prototypes not only for their own structural families, but also for mechanosensitive 
 
Figure 1.5. Schematic diagram of MscS (blue heptamers) and MscL (brown pentamers) channel 
activation with osmotic pressure. In a weakly hyposmotic environment, stretched membrane induces MscS 
to open to relieve the osmotic stress. In a major hyposmotic shock, MscL opens in addition to MscS to 
more quickly release intracellular contents through its larger channel pore. Courtesy of (Martinac et al., 
2014) 
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channels and mechanosensitive membrane proteins in general. 
Mechanosensitive channels are also found in higher-order organisms, where they have a variety of 
roles (Martinac, 2011; Martinac et al., 2014). Members of the MscS-family of proteins are found in 
plants in addition to unicellular organisms, with the mechanosensitive function retained in some, 
but not all, members. Different families of mechanosensitive channels are also found in animals, 
with the most notable examples being Piezo, transient receptor potential (Trp) channels, and the 
two-domain potassium channel (K2P) families of proteins (Brohawn, 2015; Corey, 2003; Gottlieb 
& Sachs, 2012). They have recently attracted significant research interest due to their medical 
significance, such as Piezo1 channels implicated in hereditary xerocytosis (Bae et al., 2013), TrpV4 
and TREK2 channels in cancer (K. S. Park et al., 2013; Thoppil et al., 2015), and TrpV4 and TrpA1 
in inflammatory pain. Owing to this and the technological advancement in methods for studying the 
structure of eukaryotic membrane proteins, particularly cryo-electron microscopy, the structures of 
their members Piezo1, TRAAK, TREK1, TREK2, TrpA1, TrpV1, and TrpV4 channels, have been 
determined (Brohawn et al., 2012; Cao et al., 2013; Dong et al., 2015; Ge et al., 2015; Liao et al., 
2013; Paulsen et al., 2015; Pike, 2014). In addition, membrane tension acts as a secondary trigger 
for a number of protein channels primarily gated by other triggers, such as the CFTR (Cystic 
Fibrosis Transmembrane Conductance Regulator), mutations in which are commonly responsible 
for cystic fibrosis (Vitzthum et al., 2015). All families except MscL and Piezo channels include 
both mechanosensitive channels and non-mechanosensitive channels as members, and they are 
highly divergent in structure, suggesting multiple evolutionary origins for mechanosensation as well 
as diverse mechanisms of action. 
1.3.1. Mechanosensitive Channels of Small Conductance 
1.3.1.1. Overview of MscS-Family of Proteins 
The mechanosensitive channel of small conductance is the defining member of a membrane protein 
family with unique membrane and carboxy-terminal domains (Pivetti et al., 2003). This protein 
family is highly divergent in both structure and function. Examples have been found in all three 
domains of life, although their existence in animals has yet to be established (Fig. 1.6) (Pivetti et al., 
2003). It is also common for multiple MscS-family proteins to be present in a species, with good 
examples being E. coli where there are at least four channels (MscS, MscM, MscK, and YnaI), and 
Arabidopsis thaliana which has ten (MSC1-10) (Hamilton et al., 2015; Martinac, 2011; Zou et al., 
2015). Although MscS is a non-specific channel, other members of this family are ligand-specific  
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and some of them are hypothesised not to be channel proteins at all, which explains the plurality of 
MscS-like proteins in a species (Gibson et al., 2015; Wilson et al., 2013). 
1.3.1.2. MscS Structure and Function 
Structures of E. coli MscS, the prototypical member of its family, in closed and nonconducting 
states as well as its functional homologs from other organisms have been determined by protein 
crystallography (Fig. 1.7) (Bass et al., 2002; Bottcher et al., 2015; Vasquez et al., 2008; W. Wang 
et al., 2008), and these, combined with simulation and biophysical studies, have provided structural 
and functional insights into the mechanism of MscS channel gating. MscS is a homoheptameric 
membrane channel of 211 kDa in size, and has a complex three-domain structure consisting of: a 
transmembrane domain comprised of three α-helices per subunit (TM domain); an intermediate 
cytoplasmic domain composed of β-strands (C1 domain); and a C-terminal cytoplasmic domain 
with a mix of helices and strands (C2 domain). 
The N-terminus of the protein is located in the TM domain approximately 50 Å long across the 
membrane and has a diameter of 80 Å (Bass et al., 2002). While its exterior surface is largely 
hydrophobic, it has arginine residues forming a positively charged ring via which MscS is thought 
to interact with the phospholipid head groups of the lipid bilayer. A recent mass spectrometry study  
 
Figure 1.6. Phylogenetic tree of MscS family of mechanosensitive channels. Species with the Roman 
numeral I belong to bacteria, II to archaea, IIIa to yeasts, and IIIb and IIIB are different members of MscS 
family proteins in plant cells. Courtesy of (Martinac et al., 2014) 
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on phospholipids identified phosphatidylglycerols, whose head group has net negative change, as 
the main phospholipid species interacting with MscS (Pliotas et al., 2015). Molecular dynamics 
simulation showed them to be interacting with the arginine residues, confirming their significance 
in the protein-lipid interaction.  
The central channel pore remains closed in the inactive state, but when there is membrane tension, 
equivalent to -10 mmHg pressure in patch clamp experiments, it opens in an optical diaphragm-like 
motion (Haswell et al., 2011; Martinac, 2001). The size of the channel pore in a fully open state is 
somewhat debated, with early experiments observing a pore diameter of up to 16 Å, but the current 
consensus favouring 10 Å, as concluded from later patch clamp experiments and molecular 
dynamics simulations (Bass et al., 2002). While the primary molecules which pass through the 
channel pore are thought to be water and potassium ions - the latter has sometimes led to the 
mislabelling of MscS as an ion channel (A. R. Battle et al., 2009; Koprowski & Kubalski, 2003) - 
small organic molecules such as glutamate have also been observed to diffuse across the pore 
(Gamini et al., 2011). A major factor for the lack of substrate specificity is the absence of highly 
selective structural elements such as those present in sodium channels.  
 
Figure 1.7. Structure of E. coli MscS determined by protein crystallography. The structure on the left is in 
closed conformation, and the one on the right is in expanded nonconducting state. Courtesy of (Martinac 
et al., 2014) 
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The channel pore then leads to a spheroid internal chamber of approximately 60 Å long and 40 Å 
across formed by the C1 and C2 domains (Bass et al., 2002). There are a total of eight pores 
connecting to the cytoplasmic exterior: seven pores of 7 Å at the C1 and C2 domain interface at the 
widest section of the chamber; and an 8 Å pore at the elongated end of the chamber, opposite the 
channel pore. These pores form simple sieve-like filters with mild enthalpy barrier, presumably to 
prevent clogging the pores while selecting for small molecules (Gamini et al., 2011). The chamber 
reportedly expands and distorts to a more spherical shape during channel opening, with the role of 
this conformational change yet to be studied in detail. The cytoplasmic domain forming the 
chamber also has other functions such as mediating interactions with co-factors in both MscS and 
its structural homologues (Becker & Kramer, 2015; Koprowski et al., 2015; Rowe et al., 2013), 
which are currently subjects of further research as well. 
1.3.2. Mechanosensitive Channels of Large Conductance 
1.3.2.1. Overview of MscL Family of Proteins 
The mechanosensitive channel of large conductance (MscL) belongs to another family of 
mechanosensitive channels which are structurally distinct from MscS family proteins. MscL-family 
proteins are characterised by a two-domain alpha-helical barrel-on-barrel structure with a relatively 
large retractable pore compared to the protein size (Fig. 1.9.) (G. Chang et al., 1998; Steinbacher et 
 
Figure 1.8. Phylogenetic tree of MscL family of mechanosensitive channels. Species with the Roman 
numeral I belong to bacteria, II to archaea, and IIIa to eukaryotes. Courtesy of (Martinac et al., 2014) 
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al., 2007). They are more structurally homogenous than members of the MscS family, and all 
proteins identified so far are nonspecific channels, the gating of which are triggered by intense 
membrane tension. This lack of functional and structural diversity may account for there being only 
one copy of the protein in each species (Martinac, 2011). Contrary to their low diversity, this 
protein family is actually phylogenetically ancient, with representatives in all three domains of life 
(Fig. 1.8) (Martinac, 2011; Pivetti et al., 2003; C. X. Wang et al., 2007). 
Like MscS, MscL proteins used in studies are often sourced from a range of species. While the 
majority of biochemical characterisation has been carried out using E. coli MscL, determined MscL 
structures are from Mycobacterium tuberculosis, Staphylococcus aureus, and archaeal 
Methanosarcina acetivorans (G. Chang et al., 1998; J. Li et al., 2015; Liu et al., 2009). The 
structure and function was initially perceived to be conserved between species, leading to 
extrapolation of biochemical and biophysical characteristics of MscL from one species to similar 
proteins in other species. In addition, nearly all species expressing MscL are microorganisms (fungi 
being the only multicellular organisms). This has made MscL an attractive target for antibiotic 
development, with at least one compound targeting MscL in active development (Iscla et al., 2015), 
and has also further encouraged characterisation of MscL across multiple species in order to 
facilitate design and identification of effective ligands or agonists. However, one of the drawbacks 
of different MscL homologues being studied is that in some aspects, there is insufficient 
overlapping data between channels from different organisms to enable accurate comparison. This is 
especially pronounced between M. tuberculosis and E. coli MscL: there are experimentally 
determined structures and lipid mass spectrometry data for M. tuberculosis MscL (Steinbacher et 
al., 2007; Zhong & Blount, 2013), but comparatively little residue-specific data (e.g. EPR, FRET, 
and mutation studies) is available. For E. coli MscL the situation is the opposite. However, recent 
data (see section 1.3.2.2. and 1.3.2.3.) indicates that there is significant biophysical difference 
between the two species, leading to at least one paper cautioning against the extrapolation of data 
between them (Rui et al., 2011). Hence, further experimental data will be needed to ensure that 
MscL provides a comprehensive model for mechanosensitive channel gating more generally. 
1.3.2.2. MscL Structure and Function 
Despite the challenge of being a membrane protein with a small soluble domain (less than 25 kDa 
in total), there has been intense research interest in the structure of MscL, with crystallographic 
structures now available for a number of species. The structure of M. tuberculosis MscL was 
initially determined in its closed state by Chang et al. in 1998, but with a major error in the model 
identified leading to the publication of a revised structure by the same laboratory in 2007 
(Steinbacher et al., 2007). Subsequently, the structure of S. aureus MscL in an unusual tetrameric  
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nonconducting state was also determined by the same group (Liu et al., 2009), with the change in 
quaternary structure concluded to be induced by the detergent environment forcing its transition  
away from the natural pentameric state (Dorwart et al., 2010). During the course of this project, a 
truncated structure of the cytoplasmic domain of E. coli MscL became available (Walton & Rees, 
2013), and another MscL structure from M. acetivorans was also determined (J. Li et al., 2015). 
Notably, however, a full structure of E. coli MscL is not available despite decades of effort, with an 
attempt at two-dimensional crystallography resulting in an incorrect low-resolution structure with 
pseudohexameric symmetry (Saint et al., 1998). Therefore, the descriptions of MscL structure in 
literature, in this thesis and elsewhere, needs to be viewed with a degree of caution. 
E. coli MscL is a homopentameric membrane channel protein complex with a molecular weight of 
80 kDa (Martinac et al., 2014). MscL consists of two N-terminal transmembrane helices TM1 and 
TM2 forming the transmembrane domain, and a C-terminal S1 helix forming the cytoplasmic 
domain. Both N- and C-termini are at the cytoplasmic side while the flexible loop linking TM1 and 
TM2 is at the periplasmic side. Together, the larger transmembrane domain and smaller 
 
Figure 1.9. Structure of MscL. The structure on the left is M. tuberculosis MscL in closed state 
determined by protein crystallography. The structure on the right is E. coli MscL in open state generated 
by molecular dynamics simulation. Courtesy of (Martinac et al., 2014) 
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cytoplasmic domain form a structure resembling a stack of two cylinders (Fig. 1.9).  
The transmembrane domain of MscL consists of TM1 and TM2 from each subunit oriented against 
the bilayer plane forming an optical diaphragm-like pore similar to MscS (Fig. 1.6 and 1.7) 
(Martinac et al., 2014). In the closed state, the pore is constricted on the cytoplasmic side and 
exposed on the periplasmic side with a conically shaped cavity. The pore interface is dominated by 
the TM1 helix, which is highly conserved across species, with a minor contribution from the N-
terminal region of the TM2 helix, which is less conserved. At the cytoplasmic end of the pore, L17, 
V21, and T25 in M. tuberculosis MscL (L19, V23, and A27 in E. coli) line the main pore 
constriction (G. Chang et al., 1998). While there are no strong specific interactions such as 
hydrogen bonds between the subunits to form strong energy barriers against channel opening, the 
hydrophobicity of this region stabilises MscL in the closed conformation in the absence of an 
external trigger (Birkner et al., 2012; G. Chang et al., 1998; S. Sukharev et al., 2001; Yoshimura et 
al., 2001). Substitution of these residues for hydrophilic ones such as aspartate results in an 
enhanced sensitivity to membrane tension (gain-of-function mutation) (Anishkin et al., 2005; 
Yoshimura et al., 1999), probably due to a reduced energy requirement for conformational change. 
In particular, an E. coli mutant with G22C substitution is frequently employed in MscL studies 
because 2-(trimethylammonium) ethyl methanethiosulphonate (MTSET) can induce opening of the 
pore through the introduction of a positive charge around the constriction when it reacts with the 
introduced cysteine residue (Yoshimura et al., 2001). On the other hand, the periplasmic side of the 
MscL pore lacks distinctly charged or hydrophobic regions (G. Chang et al., 1998; Iscla et al., 
2013; Yoshimura et al., 2001; Yoshimura et al., 1999), hence the absence of any associated ion 
selectivity function within the channel. 
Although the structure of MscL in the fully open state has not been determined by X-ray diffraction 
analysis of protein crystals, EPR and FRET spectroscopic studies as well as computational 
modelling have led to a general consensus on the structural dynamics of its transmembrane domains 
(Fig. 1.9). According to open-state models, the interaction between TM1 and TM2 does not 
significantly change from the closed to the open state. However the tilt angle of the subunits with 
respect to the membrane plane is increased by around 20° between the two channel conformations 
(Perozo, Cortes, et al., 2002; S. Sukharev et al., 2001; Yilmaz et al., 2015). In addition, the partially 
open structure of M. acetivorans MscL indicates that the L-shaped TM1 helix undergoes a minor 
pivot-like motion, with the angle of the bend increasing from 93° to over 140° (J. Li et al., 2015). 
All open channel models have a similar pore diameter of ~30 Å corresponding to ~20 nm2 in-plane 
protein expansion (Bavi et al., 2014; Deplazes et al., 2012; Gullingsrud et al., 2001; Konijnenberg 
et al., 2014; Sawada et al., 2012). This is also supported by the structures of M. acetivorans and S.  
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aureus MscL (J. Li et al., 2015; Liu et al., 2009). This conformational change also decreases the 
length of the transmembrane domain by at least 13 Å (J. Li et al., 2015; Liu et al., 2009), likely 
more given the larger tilt of TM helices in the fully open state proposed by simulation studies. 
The cytoplasmic domain consists of five TM2-S1 interhelical loops and S1 helices contributed by 
each subunit (Steinbacher et al., 2007). Like TM1 and TM2, the S1 helices are also oriented against 
the bilayer plane. Between TM2 and S1 is a RKKEE motif, which is thought to be critical for the 
stability of MscL structure, sensitivity to pH, and synchronised conformational change of subunits 
during the opening of the channel (Anishkin et al., 2003; Hase, Le Dain, et al., 1997; Kloda et al., 
2006). Unlike TM1 and TM2, the function of the S1 helices is not very well understood. This is in 
part because it is not as well conserved across species. Its length alone is highly variable and ranges 
from being absent (M. acetivorans) to over 80 residues (Mycoplasma gallisepticum). Moreover, 
  
Figure 1.10. Sequence alignment of MscL family of mechanosensitive channels. Residue numbering and 
location of secondary structures (in cyan) are based on E. coli MscL. Green highlight denotes high level of 
sequence conservation across members. Yellow highlights denote moderate level of sequence 
conservation. The RKKEE motif (104 – 108) is underlined in dark blue. Proline and alanine-rich loop 
region is marked with a red box. Sequence data courtesy of Protein database (NIH, USA). Sequence 
alignment was performed with Clustal Omega (Sievers et al., 2011). 
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there is often little sequence similarity between species, with negatively charged residues 
dominating the surface of M. tuberculosis MscL whereas E. coli MscL is rich in proline and alanine 
on the N-terminal end (Fig. 1.10) (G. Chang et al., 1998). Given that proline’s rigid structure is 
often used for structural and functional significance (Williamson, 1994), it is possible for this region 
to contribute to the functional difference between the two proteins. This is further complicated by 
the finding that a significant truncation of this domain does not critically compromise the function 
of the channel (Anishkin et al., 2003), making its relationship with the transmembrane domain and 
functional significance unclear. 
The structure of the cytoplasmic domain in the open state is also contentious with two prevalent 
competing models. Electron microscopy studies, together with the observed ability of MscL to 
allow molecules as large as insulin to pass through the pore, suggests that the C-terminal domain 
might dissociate and incorporate into the transmembrane domain during channel opening (Sawada 
et al., 2012; S. Sukharev et al., 2001; van den Bogaart et al., 2007; Yoshimura et al., 2008). At odds 
with this however, are molecular dynamics simulations (Corry et al., 2010; Deplazes et al., 2012; 
Zhu et al., 2016), mass spectrometry (Konijnenberg et al., 2014), and mutational analyses (L. M. 
Yang & Blount, 2011), which suggest that the C-terminal domain remains intact and undergoes 
only partial dissociation proximal to the TM2 helix. Complicating this issue further is that neither of 
the two structures of MscL in non-conducting states feature the C1 helix (J. Li et al., 2015; Liu et 
al., 2009), either by design or by nature. Moreover, many simulation experiments either fix the 
conformation of the cytoplasmic domain or even truncate it (Colombo et al., 2003; Gullingsrud & 
Schulten, 2003; Y. Li et al., 2009; Meyer et al., 2006), probably due to the lack of experimental 
data. Considering that the cytoplasmic domain has the potential to restrict the pore size, this 
information will be important not only to understand the mechanism of mechanosensitive channel 
gating but also for the development of MscL as a protein-based nanovalve. 
1.3.2.3. Mechanism of MscL Mechanosensation 
As a protein channel primarily gated by membrane tension, MscL’s interaction with phospholipids 
is a subject of intense research interest. There are two main areas of interest with regard to their 
relationship: role of phospholipids in channel activation, and the phospholipids preferentially 
interacting with MscL. 
MscL channel opening is largely facilitated by destabilisation of the hydrophobic region of the 
membrane (Martinac et al., 2014). This is evidenced by a large number of residues critical to 
channel function located at the interface with the fatty acyl chains of phospholipids (Levin & 
Blount, 2004; Ou et al., 1998). Modifying the width of the phospholipid bilayer also affects the  
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sensitivity of MscL to membrane tension (Powl et al., 2007), suggesting that this is mediated by the 
interaction with the hydrophobic region. On the other hand, residues interacting with phospholipid 
head groups, especially those on the periplasmic side, are not critical for MscL channel function, 
even tolerating truncation (Blount et al., 1996). 
Less well understood is the type of stress on the membrane required to trigger channel opening. In 
the first hypothesis, MscL mainly senses curvature-induced stress on the membrane, defined by the 
discrepancy between the cross-sectional areas of the phospholipid head groups and fatty acyl chains 
(Fig. 1.11C) (Bavi, Cox, et al., 2016; Meyer et al., 2006; Powl et al., 2008b). This is supported by 
the lowered pressure threshold for MscL opening in liposomes containing “cone-shaped” 
phospholipids, which have larger head groups than the tail ends and consequently favour curvature 
formation (Powl et al., 2003). In addition, introducing lysophospholipids (LPC), which have only 
one fatty acyl chain (thence much smaller cross-sectional hydrophobic area), results in spontaneous 
“flickering” (quick opening and closing) of MscL channel, giving further credence to this 
 
Figure 1.11. Schematic diagram of the models of MscL channel gating mechanism. A) MscL in closed 
state; B) In the stretch-activation hypothesis, near-even stretch on both sides of the bilayer provides energy 
for conformation change; C) In the curvature-activation hypothesis, MscL channel gating is facilitated by 
uneven shear force across the bilayer. 
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hypothesis (Perozo, Cortes, et al., 2002; Perozo, Kloda, et al., 2002). 
In an alternative hypothesis, membrane tension simply decreases the thickness of the bilayer, with 
the resulting hydrophobic mismatch driving MscL’s conformational change (Fig. 1.11B) 
(Yoshimura & Sokabe, 2010). There are several studies supporting this, such as: 1) experiments 
showing MscL’s increased mechanosensitivity in membranes comprised of phospholipids with 
shorter chain length (Powl et al., 2003, 2007); 2) analyses on the phospholipid head groups which 
indicate they have no impact on MscL channel function (P. Moe & Blount, 2005; Powl et al., 
2005); 3) and a patch clamp experiment testing the two hypotheses (P. Moe & Blount, 2005). This 
is a simpler model than the curvature-based one, and as a result has been adopted as the primary 
channel trigger in many simulation experiments. 
1.3.2.4. Phospholipids Associating with MscL and Their Functional Significance 
MscL in its native environment is speculated to preferentially interact with certain types of 
phospholipids, a property which will likely affect its channel gating function (Zhong & Blount, 
2013). The clearest evidence of this so far has been MscL clustering in native E. coli membranes 
observed by confocal microscopy (Grage et al., 2011). In addition, MscL channel gating properties 
are dependent on the phospholipid environment, namely those comprised of with 
phosphatidylglycerol (PG), phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidic 
acid (PA) and cardiolipin (CL) head groups (Andrew R. Battle et al., 2011; Grage et al., 2011; P. 
Moe & Blount, 2005; Powl et al., 2008a, 2008b). CL and PG are also known to localise to certain 
areas of E. coli membrane (Andrew R. Battle et al., 2011; Oliver et al., 2014; Romantsov et al., 
2010), suggesting that E. coli MscL may have differing levels of affinity for these lipids. In a 
separate but related experiment, the pressure threshold of M. tuberculosis MscL differs between 
synthetic membranes using PG and phosphatidylinositols (PI; M. tuberculosis membrane contains 
 
Figure 1.12. Atomic force microscopy of E. coli MscL cluster on DOPC membrane. a) Overview of 
MscL cluster; b) magnified view of the cluster which reportedly shows individual MscL particles; c) a 
further magnified view showing what could be individual particles. Image courtesy of (Grage et al., 2011) 
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PI instead of PG) (Zhong & Blount, 2013), supporting the importance of phospholipids on the 
function of MscL.  
MscL’s relationship with phospholipids is also characterised by its distribution within the 
membrane. MscL clustering in both native E. coli membrane and DOPC has been observed in at 
least two separate experiments using a range of techniques such as fluorescence microscopy, small-
angle neutron scattering (SANS), and atomic force microscopy (Fig. 1.12) (Grage et al., 2011; 
Nomura et al., 2012). This clustering of MscL appears to have a functional significance, as the 
proportion of active channels significantly decreases in this environment. Unfortunately, however, 
the clustering behaviour was not further studied with a wide range of phospholipids, limiting the 
level of information available to establish functional significance. 
1.3.2.5. MscL’s Potential as Nanovalve Candidate 
MscL is a major protein-based nanovalve candidate due to a number of its favourable properties: it 
opens relatively large and non-selective pore, the trigger is purely mechanical and not ligand-
dependent, it is relatively small in size, and it is stable across a range of temperature and detergent 
conditions (Iscla et al., 2013; Martinac et al., 2014). A current proposed biotechnological 
application for this nanovalve is for the release of cargo molecules from liposomes in a new drug 
delivery system. An alternative, more radical proposal might involve the direct incorporation of 
MscL into target cells in order to increase their permeabilisation and drug uptake (Doerner et al., 
2012). 
Such practical applications require MscL gating to be controlled by triggers other than membrane 
stress, and this is an area of active development. In order to facilitate this, MscL needs to be 
engineered with either the addition of molecules activated by external stimuli, or by substitution of 
its residues to be responsive to the environment specific to the target site. Of these, there have been 
considerable progress on the former strategy. Two external stimuli, light and electromagnetic force, 
have been proposed as inducible triggers for MscL channel gating (Kocer et al., 2005; Nakayama et 
al., 2015). The system based on light was pioneered by a group at the University of Groningen, and 
uses E. coli MscLG22C with a molecule containing a spiropyran group, which can be reversibly 
charged by 366 nm ultraviolet light to induce channel opening with the repulsive force between the 
charged regions (Kocer et al., 2007; Kocer et al., 2005; Yilmaz et al., 2015). The electromagnetic 
field-based approach was first performed on TREK1, another mechanosensitive channel, with 250 
nm Fe3O4 particles attached (Hughes et al., 2008). While inducible opening of the channel as a 
result of repulsive forces between the magnetic particles was achieved, this was considered 
impractical for medical application due to the large size of the particles used. However, a similar 
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result was recently achieved using MscL instead, this time with 5 nm CoFe2O4, which is not only 
small enough to be incorporated within liposomes without impacting their permeability to physical 
barriers but also non-cytotoxic (Nakayama et al., 2015). While the experiment was carried out at 
sub-threshold membrane tension created by patch clamp, applying this strategy on an MscL 
construct with a lowered gating threshold may produce a nanovalve primarily activated by 
electromagnetic force. 
A second aspect in the development of MscL as a nanovalve is controlling the specificity of the 
channel pore. MscL has a large pore lacking a selective mechanism for substrates. While this is an 
advantageous property for the nanovalve’s use in liposomal drug delivery system, for other 
applications such as the use of MscL for increasing the permeabilisation of target cells (Doerner et 
al., 2012), the option of being able to add a size or charge-based filter may be necessary and/or 
advantageous. One potential strategy is to add molecules with inducible charges to the pore 
constriction. The light-induced channel opening system previously described, for example, 
introduced charges to the channel pore, which would select against certain like-charged molecules 
as demonstrated in a separate experiment (Kocer et al., 2005). An alternative approach is to use the 
cytoplasmic domain as a molecular size-based sieve, based on the observation that the dissociation 
of the domain is at least not necessary (if it happens at all) (L. M. Yang & Blount, 2011; L. M. 
Yang et al., 2012). In this method, cysteine disulphide bridges would be added to the loop region 
linking the TM2 helix to the cytoplasmic helix, reducing the size of the gaps between the subunits. 
A combination of these two strategies is also a possibility, allowing the conversion of MscL into a 
more selective channel where desirable. 
1.3.2.6. MscL as a Drug Target 
MscL is widely found in microorganisms but absent in higher order organisms such as humans, 
making it a potential drug target. The two lead compounds are: parabens, which lower the tension 
threshold for mechanosensitive channels by destabilising the cell membrane, leading to the loss of 
ions even in mild osmotic stress (Nguyen et al., 2005); and 1,3,5-tris[(1E)-2′-(4″-benzoic 
acid)vinyl]benzene, which is thought to bind to MscL at the channel pore, locking it in an open 
conformation (Iscla et al., 2015). Of these, the latter has been tested successfully in vivo with 
Caenorhabditis elegans infected with methicillin-resistant S. aureus. Interestingly, this compound 
was not effective on M. tuberculosis, whose MscL served as the basis for the in silico docking 
experiment used for the drug design. 
 
23 
 
1.3.3. Mechanosensitive Channels in Higher-order Organisms 
While mechanosensitive channels in prokaryotes remain best-studied, they play significant roles in 
higher organisms as well. Starting with the identification of TRAAK in rat atrial cells in 1992 (Kim, 
1992, 1993), new eukaryotic mechanosensitive channels have steadily been identified, a trend 
which continues. Apart from MscL and MscS, which had already been discussed, three families 
have been identified as having eukaryotic mechanosensitive channels as members: K2P, Trp, and 
Piezo channels. 
K2P channels, which include TRAAK, TREK1 and TREK2 as members gated primarily by 
membrane tension, are potassium channels found in various tissues in multicellular complex 
organisms (Fig. 1.13) (Brohawn, 2015). Whereas TRAAK is mainly found in neuronal cells, 
TREK1 and TREK2 are expressed in smooth muscle tissues and nociceptors, and have been 
implicated in pain sensation, as well as cancer, and side effects to fluoxetine, also known as 
Prozac©  (Acosta et al., 2014; Brohawn, 2015; Dong et al., 2015; K. S. Park et al., 2013). The 
structures of all three proteins have been determined by protein x-ray crystallography (Brohawn et 
al., 2013; Brohawn et al., 2012; Pike, 2014), and show a compact homodimeric structure with a 
potassium-selective pore in the centre. Unlike MscL and MscS, K2P channels have broad 
membrane tension ranges for channel activation, constantly flickering between closed and open 
states, but favouring the open state at higher tension (Brohawn, 2015). This is speculated to be due 
to a suggested relatively small conformational change required for channel activation, and probably  
 
Figure 1.13. Crystal structure of human TREK2 in closed state (PDB ID: 4XDJ). A) Side view with the 
transmembrane domain at the bottom. B) Top view seen from the transmembrane domain. One of the two 
subunits has been coloured blue. 
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has a physiological role of allowing quantitative response to the stimulus. Interestingly, the TRAAK 
channel also activates in the presence of polyunsaturated fatty acids and arachidonic acid (Fink et 
al., 1998; Kim, 1992), suggesting a close relationship between channel activity and phospholipids. 
Trp channels are another family of ion channels with a diverse range of stimuli including 
mechanical stress. Of its members, TrpV1 and TrpV4 have been recognised as mechanosensitive 
channels (Huynh et al., 2014), with TrpA1, TrpC1, and TrpC2 also reported to be mechanically 
activated (El Karim et al., 2015; Kloda et al., 2006). The closed-state structures of TrpV1 and 
TrpA1 have been determined by cryo-transmission electron microscopy using single particle 
analysis (Fig. 1.14) (Liao et al., 2013; Paulsen et al., 2015).  
  
Figure 1.14. Crystal structures of human TrpA1 (PDB ID: 3J9P) and rat TrpV1 (PDB ID: 3J5R), both in 
closed state. A) Side view of TrpA1 with transmembrane domain at the bottom; B) Top view of TrpA1 
seen from the transmembrane domain; C) Side view of TrpV1 with transmembrane domain at the bottom; 
D) Top view of TrpV1 seen from the transmembrane domain. One subunit from each structure has been 
coloured blue. Two antiparallel helices from each subunit form the channel pore in both proteins. 
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TrpV1 features a selectivity filter structure well-conserved in potassium channels, which is 
surrounded by a connected structure thought to be involved in mechanosensation. Mechanosensitive 
Trp channels are found in various cells such as skeletal muscle, blood vessels, sensory neurones, 
lens epithelial cells, and odontoblasts (Baratchi et al., 2016; Corey, 2003; El Karim et al., 2015; T. 
C. Ho et al., 2012; Shahidullah et al., 2015; Sharif-Naeini et al., 2008), and are involved in kinase 
pathways while also having mechanosensitive ion channel function (El Karim et al., 2015; 
Shahidullah et al., 2015). Trp channel activity is influenced by the presence of 
phosphatidylinositols, which can be either stimulatory or inhibitory depending on the molecules, 
and this is due to both the direct interaction between them (i.e. mechanosensation) and mediated by 
external factors such as phosphatases (Rohacs, 2014). 
Piezo channels are nonselective cation channels also found in a wide range of cells. They are 
characterised by a large structure comprised of three 300+ kDa subunits forming a triangular 
channel, which then forms 2MDa dimer structure (Coste et al., 2012; Ge et al., 2015). A medium-
resolution structure of Piezo1 has been determined by electron microscopy, and reveals a long and 
narrow selectivity filter in the middle resembling P2X channels (Fig. 1.15) (Ge et al., 2015). 
Uniquely for a mechanosensitive channel, a blade-like structure in the soluble domain has been 
proposed as the mechanosensor rather than the surface of the transmembrane domain (Ge et al., 
2015). However, this hypothesis has not been validated with biophysical experiments, and there is 
speculation that they might not be traditional mechanosensitive channels at all, activated by a  
 
 
  
Figure 1.15. Crystal structure of mouse Piezo1 channel in the closed state (PDB ID: 3JAC). A) Side view 
with the transmembrane domain at the bottom; B) Top view seen from the transmembrane domain. One 
subunit has been coloured blue. 
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cytoskeletal structure instead (Soattin et al., 2016). Despite their broad medical significance (Coste 
et al., 2012; Gottlieb & Sachs, 2012; Soattin et al., 2016), their biophysical and physiological 
properties are poorly understood and remain to be studied. 
1.4. Project Overview 
The first aim of this thesis was to characterise the relationship between MscL and the phospholipid 
membrane. MscL is primarily gated by membrane tension exerted by phospholipids, but their 
relationship remains poorly understood (Yoshimura & Sokabe, 2010). This problem is especially 
pronounced in a broader context than molecular-level interaction, as most studies have focused on 
the relationship between phospholipids and single MscL molecules (Bavi, Vossoughi, et al., 2016; 
Deplazes et al., 2012; Pliotas et al., 2015; Yoshimura et al., 2008). Therefore, this project has 
sought to address this gap in knowledge by studying the effect of various membrane-related 
variables such as curvature and phospholipid composition on MscL function. In particular, their 
influence on MscL aggregation was investigated, with implications on its channel gating threshold. 
The findings from this objective would not only help with understanding MscL function on its own 
right, but also aid with future biophysical experiment designs. 
The second aim of this thesis was to structurally characterise E. coli MscL. While there are 
crystallographic structures of its homologues in M. tuberculosis, S. aureus, and M. acetivorans (G. 
 
Figure 1.16. The Outline of the project “Biophysical and Structural Characterisation of Escherichia coli 
MscL in Lipid Bilayers” 
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Chang et al., 1998; Liu et al., 2009; Zhu et al., 2016), the one for E. coli MscL, which remains 
biophysically the best characterised protein of this family, has still not been determined. Moreover, 
MscL structure was found to be sensitive to detergents, which are the environments where all MscL 
structures were determined, resulting in S. aureus MscL taking an unusual tetramer conformation 
(Dorwart et al., 2010; Liu et al., 2009). Therefore, both 2D and 3D crystallisations were attempted 
with E. coli MscL to determine its structure. In particular, MscL structure in 2D crystals would have 
provided unique insight into MscL’s relationship with phospholipids, which was the first aim of this 
thesis. Ultimately, findings from these two objectives would help not only with understanding the 
function of mechanosensitive channels but also with the development of a new liposomal drug 
delivery system with MscL as the nanovalve.  
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2. MscL Construct Design 
2.1. Introduction 
One of the challenges of this project was the quality of the starting contruct of E. coli MscL. In 
particular, the MscL plasmid construct resulted in heterogeneously expressed products, producing 
two species of MscL monomers. Second, due to the lack of tryptophan and tyrosine in MscL, the 
expressed protein poorly absorbed ultraviolet light at 280 nm wavelength, which in turn made the 
quantification both inaccurate and imprecise. Works focused on solving these issues are detailed in 
this chapter, part of which have been published in an academic journal with myself as the first 
author. 
Contributions to the publication are as described in the following: 
MscL construct design, construct production, protein expression, protein purification, 
concentration measurements with UV/Vis spectrometer and infrared spectrometer, and SDS-
PAGE were performed by Gamma Chi (me). 
Mass spectrometry experiment was performed by Dr. Michael Landsberg. 
Sample preparation for patch clamp experiment was performed by Paul Rohde. Patch clamp 
experiment was performed by Pietro Ridone. The analysis was performed by Pietro Ridone 
and Prof. Boris Martinac. 
First draft for the publication was written by Gamma Chi (me), and was reviewed by 
Gamma Chi (me), Dr. Michael Landsberg, Prof. Ben Hankamer, and Prof. Boris Martinac. 
Supporting funding was provided by the NHMRC via grant 635513. Mechanosensitive 
channels: Antimicrobials, channelopathies and nanovalves for drug delivery. CI Hankamer 
& Martinac 
There are also experiments which are not discussed or detailed in the publication relevant to this 
chapter, which will be explained in the following section. The most significant of these are 
techniques used for site-directed mutagenesis, and experiments to troubleshoot one of the produced 
constructs, MscLTEVc.   
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2.2. Publication: Functional similarities between heterogeneously and 
homogenously expressed MscL constructs 
Gamma Chi1, Paul R. Rohde2, Pietro Ridone2, Ben Hankamer1, Boris Martinac2,3, Michael J. 
Landsberg1,4 
1 Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD 4072, Australia 
2 Molecular Cardiology and Biophysics Division, Victor Chang Cardiac Research Institute, 
Darlinghurst, NSW 2010, Australia 
3 St Vincent’s Clinical School, University of New South Wales, Darlinghurst, NSW 2010, Australia 
4 School of chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 
4072, Australia 
2.2.1. Abstract 
The mechanosensitive channel of large conductance MscL is a well-characterized mechanically 
gated non-selective ion channel, which often serves as a prototype mechanosensitive channel for 
mechanotransduction studies. However, there are some discrepancies between MscL constructs 
used in these studies, most notably unintended heterogeneous expression from some MscL 
expression constructs. In this study we investigate the possible cause of this expression pattern, and 
compare the original non-homogeneously expressing one to confirm that there is little functional 
difference between them. In addition, a new MscL construct has been developed with an improved 
molar extinction coefficient at 280 nm, enabling more accurate protein quantification. 
2.2.2. Keywords 
MscL, Mechanosensitive channel, Construct design, Protein quantification, Heterogeneous 
expression, Patch clamp 
2.2.3. Introduction 
Mechanosensitive channels are non- or weakly selective ion channels that are primarily gated by 
membrane tension, which exerts a mechanical force that opens the channel and in turn allows the 
passage of ion currents. The MS channels of large (MscL) and small conductance (MscS) were first 
identified in Escherichia coli as emergency valves that protect against hypoosmotic stress (Blount 
et al., 1997; Levina et al., 1999; S. I. Sukharev et al., 1993). Further MS channels with various 
functions have been discovered since then, including medically significant mechanosensitive 
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channels in mammals and other higher eukaryotes, such as Piezo and transient receptor potential 
(TRP) channels (Coste et al., 2012; Sharif-Naeini et al., 2008). More recent discoveries 
notwithstanding, MscL and MscS remain the most extensively studied and are thus prototypes for 
the mechanosensitive class of ion channels, due largely to their ease of expression, purification and 
reconstitution into artificial membrane systems (Martinac, 2011). These characteristics have also 
led to particularly MscL often being used as a reference protein for the development of new 
experimental approaches to study other membrane proteins (Konijnenberg et al., 2014; Lee & Liu, 
2015; Qi et al., 2014). Finally, interest in MscL has increased in recent years because of its 
demonstrated potential to be modified and implemented as a stimulus-triggered nanovalve in 
liposomal drug delivery systems (A. Foo et al., 2015; Kocer et al., 2007; L. M. Yang et al., 2012) 
and for introducing cell-impermeable biomarkers and bioactive molecules into mammalian cells 
(Doerner et al., 2012). 
Since its molecular identification in 1994 (S. I. Sukharev et al., 1994), the biophysical and structural 
properties of MscL have been the focus of intense study. The structure of MscL from 
Mycobacterium tuberculosis in the closed stated has been determined by X-ray crystallography (G. 
Chang et al., 1998; Steinbacher et al., 2007) revealing a homopentameric assembly comprised of an 
N-terminal transmembrane and C-terminal cytoplasmic domain. More recently, the structure of the 
C-terminal cytoplasmic domain of the E. coli channel was also solved by X-ray diffraction (Walton 
& Rees, 2013), showing little difference to the equivalent region of the M. tuberculosis homologue. 
Mutation studies and functional characterization, predominantly using patch clamp experiments, 
have revealed residues distributed throughout the transmembrane domain that are critical for protein 
channel gating (Ajouz et al., 2000; Balleza & Gomez-Lagunas, 2009; Blount et al., 1996; Hase, Le 
Dain, et al., 1997; Kloda et al., 2006; Maurer & Dougherty, 2001; Perozo et al., 2001; Yoshimura 
et al., 1999). In combination with these, low-resolution structures of MscL in the open state 
determined using spectroscopic methods such as EPR and FRET (Corry et al., 2010; Corry et al., 
2005; Perozo, Cortes, et al., 2002; Y. Wang et al., 2014) have helped with building plausible 
models for the channel gating process, subsequently evaluated by molecular dynamics-driven 
simulation (Corry et al., 2010; Deplazes et al., 2012; Meyer et al., 2006; Sawada et al., 2012). 
One potentially confounding factor in extrapolating these results is that many of the above studies 
have been conducted in different laboratories using MscL constructs that differ to varying extents. 
The earliest studies of MscL utilized a construct that, when expressed recombinantly, contained 
nine non-native amino acids plus the N-terminal methionine (Hase et al., 1995), which is removed 
from wild-type protein in vivo. Extensive evidence shows that this original MscL expression 
construct yields two distinct species when the purified expression products are analyzed by SDS-
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PAGE, indicating that it is a heterogeneously expressing construct (Hase, Le Dain, et al., 1997; 
Kloda et al., 2006; S. I. Sukharev et al., 1994). Many research groups have since developed their 
own MscL expression constructs with differences tailored to their specific experimental needs 
(Arkin et al., 1998; Kocer et al., 2007). However, this original MscL expression construct is still 
widely used (Doerner et al., 2012; Grage et al., 2011; Yoshimura et al., 2001), possibly due to 
inadvertent ignorance (depending on the conditions of SDS-PAGE, the two products may not be 
resolved), or due to the apparent lack of detectable interference with MscL expression or function. 
In this paper we investigate the cause of this heterogeneous expression of MscL and directly 
compare the functional activity of this construct with a homogeneously expressing one derived from 
it. In the course of this work, we have also produced an MscL construct with improved accuracy for 
quantification with the standard 280 nm ultraviolet light absorption technique, with positive 
implications for future reproducibility of biophysical and structural observations. 
2.2.4. Methods 
2.2.4.1. Site-directed mutagenesis 
All constructs used in this study were derived from MscL 2.1 in pQE-31 plasmid, itself derived 
from the MscL pGEX1.1 plasmid described in Häse et al. (Hase et al., 1995). Numbering 
throughout the manuscript is relative to the wild-type sequence starting with methionine-1, which is 
post-translationally cleaved from the mature protein. Overlap extension PCR as described by Ho et 
al. (S. N. Ho et al., 1989) was used to generate a construct with the methionine-1 substituted for 
alanine (MscLM1A). A modified inverse PCR protocol was subsequently used to create a construct 
with a further substitution of the leucine at position (-7) to tyrosine (MscLL-7Y) introduced into the 
MscLM1A construct (i.e., MscLL-7Y is strictly a MscLM1A/L-7Y double mutant; for simplicity we retain 
the MscLL-7Y nomenclature throughout). Introduction of point mutations was confirmed by gene 
sequencing at the Brisbane branch of the Australian Genome Research Facility (AGRF). 
2.2.4.2. Protein expression and purification 
All MscL expression constructs were purified using a modified version of the protocol described by 
Häse et al. (Hase et al., 1995). Expression was in the E. coli AW737-KO strain (S. I. Sukharev et 
al., 1994). The presence and purity of MscL was checked at each step by 16 or 18 % SDS-PAGE. 
2.2.4.3. N-terminal sequencing and mass spectrometry 
Purified MscL constructs were separated by 12 or 18 % Tris-glycine SDS-PAGE. Individual gel 
bands were excised, the proteins eluted overnight, washed with 0.1 % TFA and then subjected to 20 
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cycles of Edman N-terminal sequencing using an Applied Biosystems 494 Procise Protein 
Sequencing System (ABSCIEX, Concord, Canada). 
LC-MS/MS was performed on a Shimadzu Nano HPLC (Kyoto, Japan) coupled to a QStar Elite 
mass spectrometer (ABSCIEX). Sample preparation was identical, with the exception that excised 
gel bands were destained, dehydrated, and then rehydrated in 40 mM ammonium bicarbonate buffer 
containing 10 % acetonitrile and 1 µg sequencing grade porcine trypsin (Promega). Peptides were 
de-salted on a 50 mm x 300 µm trap and then separated on a 150 mm 300 µm C18 column using a 
two-step linear gradient of 0-36 % (1.3 % min-1) then 36-72 % (7.2 % min-1) acetonitrile in the 
presence of 0.1 % formic acid at a flow rate of 3 µl min-1. Samples were introduced to the 
spectrometer via a nano electrospray ion source (3000 V, curtain gas flow 16, nebulizer gas 1 (GS1) 
25 and interface heater 120 °C). Full-scan TOF-MS data were acquired (m/z 350-1800), followed 
by full-scan ion data (m/z 100-1800) in an information-dependent acquisition mode. A threshold of 
12 counts and a charge state of +2 to +5 was set to trigger collection of MS/MS data for the three 
most intense ions. Data were processed using Analyse QS 2.0 software (ABSCIEX). 
2.2.4.4. Patch clamp experiments 
Proteoliposomes were prepared following the dehydration/rehydration (D/R) method as previously 
described (Delcour et al., 1989; Hase et al., 1995). Briefly, 2 mg of soybean azolectin (Sigma) was 
dissolved in chloroform and then air-dried under a stream of N2 gas. The dried lipid film was 
resuspended in 200 µl D/R Buffer (200 mM KCl, 5 mM HEPES, pH 7.5) by brief vortexing then 
sonication for 10 min. Purified MscL was added to a 1:500 final protein to lipid ratio (w/w) and the 
volume increased to 3 ml with D/R buffer. The mixture was incubated on a rotary shaker for 1 h and 
then further incubated for 3 h following addition of approximately 10 mg of Biobeads (SM-2; Bio- 
Rad). The liquid phase was collected and centrifuged at 40,000 rpm for 30 min. The resulting pellet 
was resuspended in 40 µl D/R buffer, spotted onto a microscope slide and dehydrated under 
vacuum overnight at room temperature and stored at 4 °C. 
Dried lipid spots were rehydrated for patch-clamp recording with a 50 µl drop of D/R solution and 
kept at 4 °C for at least 3 h. MscL currents were measured in the inside-out patch configuration 
using an AxoPatch 1D amplifier (Axon Instruments). Data were collected at a 5-kHz sampling rate 
with 2-kHz filtration. Borosilicate glass pipettes (Drummond Scientific, Broomall, PA) were pulled 
using a Narishige puller (PP-83; Narishige) to achieve a bubble number of approximately 6.0. All 
recordings were collected in symmetrical bath and pipette solutions containing 200 mM KCl, 40 
mM MgCl2, 5 mM HEPES (pH 7.2). Suction was applied to the patch membrane using a computer-
controlled High-Speed Pressure Clamp-1 apparatus (HSPC-1; ALA Scientific Instruments). All 
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patch clamp experiments were repeated a minimum of three times and data shown were 
representative. Dwell time analyses were conducted on traces containing only single channel events 
(e.g., no more than one MscL firing at any time during the recording). Suction was applied to the 
patch gradually until single channel events could be detected, and then kept constant near the MscL 
opening threshold until multiple channel openings could be detected, at which point the experiment 
was terminated. The automated analysis tool on pClamp was used to measure the open probability 
(P0) and the average dwell time of a recorded trace with minimum 500 single channel events. Each 
data point was plotted according to its dwell time and P0 value, grouped with similar data points 
and the distribution trends were compared between each experimental sample. 
2.2.4.5. Protein quantification using ultraviolet and infrared light absorption 
UV absorption at 280 nm was measured in triplicate using a Nanodrop UV/Vis spectrometer 
(Thermo Scientific). Following estimation of the protein concentration based on theoretical molar 
extinction coefficients (ε0), solutions were adjusted to a theoretical concentration of 1 mg/ml and 
the absorbance re-measured. Absolute protein concentrations were obtained by infrared 
measurement using a Direct Detect spectrometer (EMD Millipore). Samples were analyzed in 
triplicate in a buffer free of infrared absorbance at 1650 cm-1 (amide bond absorbance maxima). 
AM2 background and NIST analysis settings were used to account for the presence of β-DDM in 
the solution. 
2.2.5. Results and discussion 
Prior to this study, repeated experiments in our hands have reproducibly shown that the original 
MscL expression construct (Hase et al., 1995) yields two stable and distinct bands that both migrate 
close to a 15 kDa marker following cleavage of the recombinantly expressed fusion tag (Fig. 2.1b). 
This phenomenon is also observed in several publications where SDS-PAGE data of MscL are 
available (Hase et al., 1995; Hase, Le Dain, et al., 1997; Hase, Minchin, et al., 1997; Kloda et al., 
2006; Saint et al., 1998; S. I. Sukharev et al., 1994). Notably, the electrophoretic mobility of the 
lower molecular weight band on SDS-PAGE appears unchanged, regardless of whether the N-
terminal fusion tag is cleaved or not, suggesting that this lower molecular weight species may be 
degraded or otherwise differs at its N-terminus in a way that either removes the N-terminal fusion 
tag or renders it resistant to cleavage. To clarify this, we performed N-terminal sequencing. Twenty 
cycles of Edman degradation revealed that the N-terminal sequence of the lower molecular weight 
construct was Ser-Ile-Ile-Lys-Glu-Phe-Arg-Glu-Phe-Ala-Met-Arg-Gly-Asn-Val-Val-Asp-Leu-Ala-
Val. This sequence matches exactly the native MscL N-terminal sequence commencing from  
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serine-2 (i.e. minus the initial methionine residue) (Fig. 2.2). 
LC-MS/MS analyses of the higher and lower molecular bands following extraction from SDS-
PAGE, destaining and trypsin hydrolysis supported the observations from N-terminal sequence 
analysis. A peptide with m/z 446.8 (z = 2) was identified in the MALDI spectrum of the lower 
molecular weight band and MS/MS fragmentation of this ion yielded the sequence Ser-Ile-Ile-Lys-
Glu-Phe-Arg (Fig. 2.2a), an exact match for the N-terminal sequence detected by Edman 
degradation. For the high molecular weight band, a peptide with m/z 543.6 (z = 3) was observed 
and fragmentation of this ion yielded the sequence Gly-Ser-Leu-Glu-His-Arg-Glu-Asn-Asn-Met-
Ser-Ile-Ile-Lys (Fig. 2.2b) with deamidation of the Asn residue at position 8 observed. This was an 
exact match for the expected amino acid sequence deduced from the plasmid DNA. 
Since N-terminal methionine cleavage is a common post-translational modification in bacteria 
(Frottin et al., 2006; Hirel et al., 1989), these analyses suggested that the lower molecular weight 
band arises from expression of the native MscL sequence. Furthermore, since the AS737-KO cell 
line used in these studies (and many preceding studies) has the endogenous MscL sequence 
replaced with a chloramphenicol resistance gene, it would appear that this native sequence is 
plasmid-encoded with translation initiated at the native methionine-1 residue, a non-unprecedented 
phenomenon (Bazykin & Kochetov, 2011). 
2.2.5.1. Engineering of a homogeneously expression MscL construct 
Since transcription initiation in bacteria typically requires a promoter sequence located 10-30 base 
pairs upstream of a start codon, we hypothesized that the linker region of the MscL expression 
plasmid might contain a secondary promoter sequence. Furthermore, the DNA sequence of the five  
  
Figure 2.1. a) Schematic illustration of the original MscL2.1-pQE-31 expression construct indicates the 
expected expression product (intended product) as well as a secondary, unintended product which arises 
from translation initiation at the wild-type methionine. These constructs correspond to the upper and lower 
bands, respectively, as shown in Fig. 2.2. b) A typical SDS-PAGE showing purified MscL expressed from 
the widely used MscL2.1-pQE-31 plasmid, following protease cleavage to remove the plasmid-encoded 
fusion tag. Similar results have been observed for the parent plasmid MscL-pGEX1.1 described in Häse et 
al. (Hase et al., 1995) 
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amino acid immediately preceding MscL Met-1 is derived from the original genomic cloning of 
MscL, and thus may contain unknown contextual translation start information. We proposed that 
silent mutation of either of these elements might prevent the lower molecular weight species from 
being expressed, however, no recognizable promoter or translation initiation sequences could be 
identified using either sequence analysis tools (Stano & Klucar, 2011) or by manually searching for  
 
Figure 2.2. Nanospray LC-MS/MS of tryptic peptides generated from gel-purified upper and lower 
molecular weight band proteins shown in Fig. 2.1b. The spectra shown correspond to the N-terminal 
peptides of the lower band (a) and upper band (b). The double and triple charged parent ions are labelled 
([M+2H]2+ and [M+3H]3+) along with b-series and y-series ions that give rise to the amino acid sequences 
shown in the top of each panel. Sequence coverage by the b-series and y-series ions is indicated by dashed 
arrows above and below the amino acid sequences. The parent ion and fragmentation series indicate 
deamidation of Asn-8 
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known promoter sequences (Harley & Reynolds, 1987; Ma et al., 2002). We therefore focused our 
initial efforts on engineering a modified MscL expression construct that introduced a TEV cleavage 
sequence in a manner that would produce cleaved, recombinant protein indistinguishable in 
sequence from the native protein. While this construct was successfully expressed and purified, it 
proved highly resistant to cleavage by both thrombin and TEV protease. Similarly, the introduction 
of the native Met-1 along with the preceding four residues to generate a thrombin cleavage site. In 
summary, all efforts to introduce a protease cleavage site at or near the N-terminus of the native 
MscL sequence resulted in a construct that could not be cleaved. We suggest that this may be due to 
the hydrophobic nature of the flanking sequences and/or the proximity to regions of the folded 
protein predicted to be membrane- or micelle-embedded. 
Subsequently, we adopted a strategy that involved replacing the native start codon of the MscL-
encoding region with an alanine codon. This new construct (MscLM1A) also expressed well, could 
be cleaved (to remove the N-terminal fusion tag) and importantly, migrated as a single species on 
SDS-PAGE (Fig. 2.3) at a position coincident with the higher molecular weight species seen in 
previous analyses. The absence of the lower molecular weight band from these gels appeared to 
confirm that in the original construct, expression of the lower molecular weight species resulted 
from a secondary translation start site. The propensity for this to occur appears to be quite strong, 
since in our hands mutation of the native ATG to TTG does not ablate lower band expression (P. 
Rohde, unpublished data). Interestingly though, translation initiation at the native ATG has not been 
observed in cell free expression systems based on E. coli extracts (P. Rohde, unpublished data) and 
 
Figure 2.3. SDS-PAGE of the three purified MscL constructs described in this study. The double band 
resulting from heterogeneous expression can be clearly seen in the purification product of the original 
MscL construct (WT-MscL), while both MscLM1A and MscLL-7Y express as single species, coincident with 
the upper of the two bands observed for the original expression construct 
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so the mechanism of heterogeneous expression appears to require more than just the existence of a 
downstream ATG.  
2.2.5.2. MscL construct with improved UV absorbance at 280 nm 
An additional problem we have encountered in our studies of MscL is a difficulty with obtaining 
accurate, reproducible measurements of protein concentration. The capability to rapidly and 
accurately quantify purified MscL is desirable in many experimental situation, such as for 
quantitative patch clamp, functional assays which rely on accurate lipid-to-protein ratio 
determination, and for reproducibility of, e.g. 2D and 3D crystal screening experiments. Native 
MscL contains only one tyrosine and to tryptophan, which gives a hypothetical molar extinction 
coefficient (ε0) of 1490 cm-1M-1 at 280 nm, approximately a tenth of its molecular mass. As a result, 
MscL absorbs ultraviolet light relatively poorly at this wavelength, meaning protein quantification 
by this technique is unreliable. Colorimetric assays are often sensitive to detergents, required to 
maintain solubility of MscL, and while the bicinchoninic acid (BCA) is relatively insensitive to 
detergents, this assay significantly underestimates MscL concentration due to its dependence on 
 
Figure 2.4. Representative patch clamp data for the original, heterogeneously expressing MscL construct 
(original MscL) and the new MscLM1A and MscLL-7Y construct. Both channels were activated at ~-60 
mmHg, and have similar current amplitudes when open 
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tryptophan, tyrosine and cysteine residues (the latter is also absent from the native MscL sequence). 
Recently, techniques based on the absorption of infrared light at 1650 cm-1 by amide bonds have 
gained popularity for absolute protein quantitation, but organic molecules such as HEPES and 
ethylenediaminetetraacetic acid (EDTA) have significant overlap with the amide bond IR spectrum. 
Especially in the case of MscL, HEPES and TRIS are commonly used buffers in some purification 
steps and in biophysical experiments (K. H. Park et al., 2004; Price et al., 2011; Yoshimura et al., 
2008), and so the technique is not without its limitations. 
To address this problem, we proposed introducing an extra tyrosine or tryptophan into the MscL 
expression construct, resulting in better absorption of UV light at 280 nm, and by extension an 
increased molar extinction coefficient and improved reliability of protein concentration 
measurement by UV absorption. We calculated that addition of one extra tyrosine would increase ε0 
of MscL to 2989 cm-1M-1, whereas an extra tryptophan would increase ε0 to 6990 cm-1M-1.  
Rather than modifying the MscL-encoding region, we decided to introduce either tyrosine or 
tryptophan within the residual N-terminal linker region, which remains after thrombin cleavage of 
the fusion tag. Since tyrosine is less hydrophobic than tryptophan and has a similar hydrophobicity 
to leucine, we chose to substitute tyrosine for a leucine located seven residues in front of the native 
methionine-1 residue to reduce the impact this might have on the purification process (as was seen 
with earlier efforts to substitute sequences close to the native N-terminus). 
The new construct (MscLL-7Y) carries both the methionine-to-alanine substitution at position 1 of 
the native sequence, as well as the leucine-to-tyrosine substitution and like MscLM1A, expressed 
well and yielded a single band on SDS-PAGE (Fig. 2.3). The expected increase in molar extinction 
coefficient at 280 nm was clearly apparent when we compared the new construct to both the 
original MscL construct and the MscLM1A construct (Table 2.1). Solution concentrations for all 
three proteins were estimated based on absorbance at 280 nm and the same samples then had their 
protein concentrations analyzed by infrared spectroscopy using the amide I band at 1650 cm-1.  
Table 2.1 Comparative quantitation of the original MscL expression construct, MscLM1A and 
MscLL-7Y via Nanodrop (UV at 280 nm) and direct detect (IR at 1650 cm-1) 
 
UV Absorbance at 280 nm IR absorbance at 
1650 cm-1 
mg/ml 
Disparity 
(A280/IR) 
ε0 (cm-1M-1) A280 mg/ml 
Original 
construct 
1490 0.092 0.99 0.53 1.9 
MscLM1A 1490 0.089 0.96 0.54 1.8 
MscLL-7Y 2980 0.179 0.96 0.99 1.0 
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While a significant discrepancy was observed in the protein concentration estimates obtained by the 
two techniques for both the original MscL construct and MscLM1A, both techniques gave nearly 
identical measurements for the modified MscLL-7Y construct (Table 2.1.) indicating that MscL 
concentration can be more accurately measured by either technique with the MscLL-7Y construct. 
 
Figure 2.5. Biophysical analysis of original MscL (filled circle), MscLM1A (filled diamond) and MscLL-7Y 
(filled triangle) constructs via patch clamp analysis. a 3 individual samples were probed at 13 different 
voltages and a strong linear correlation independent of voltage, was established. Voltage-dependency plots 
of current observed through the MscL channel pore were effectively superimposed and yielded identical 
conductances of 3.3 nS for each construct, suggesting no detectable differences in the channel pore 
diameter. b Histogram of the opening and closing mid points of the wild-type and mutant MscL (pipette 
voltage Vp = + 30 mV) shows no significant difference between the wild-type and mutant channels based 
on the Student’s t test (mean ± SD, n = 3). c A plot of the single channel dwell time against the channel 
open probability. The dwell time for MscL M1A suggests apparently longer openings compared to the 
wild-type and MscLL-7Y mutant. However, the difference was not significant based on the t test 
(comparison to wild-type MscL) 
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2.2.5.3. Functional comparison of heterogeneous and homogeneous MscL constructs 
Since the N-terminal region of MscL is known to be important to its function (Corry et al., 2010; 
Iscla et al., 2008), we investigated whether the homogeneously expressing MscLM1A and MscLL-7Y 
constructs exhibited any measurable differences in function to the original MscL construct, the 
latter containing a mixture of two species that vary in the length of their N-terminus. Biophysical 
analyses were performed on both the original MscL construct and the new MscLM1A and MscLL-7Y 
constructs. When reconstituted into soybean azolectin using the dehydration/rehydration 
reconstitution technique (Ajouz et al., 2000; Delcour et al., 1989; Hase et al., 1995), both channels 
exhibited pore-forming activity, with channel activation thresholds of ~-60 mmHg (Fig. 2.4). 
Conductivity readings were also identical at 3.3 nS, indicating a similar channel pore size (Fig. 
2.5a). This indicates that there is little if any distinguishable difference in MscL function and 
activity between the homogeneously and heterogeneously expressing constructs. In addition, no 
significant difference for midpoints of activation and deactivation thresholds was measured between 
the mutants compared to the wild-type MscL (Fig. 2.5b). We also performed dwell time analysis of 
single channel activity (Fig. 2.5c). Plotted against their respective open probability, dwell times for 
the MscLM1A mutant showed a trend towards longer openings compared to the wild-type and 
MscLL-7Y mutants, although the difference was not statistically significant. 
2.2.6. Summary 
The use of a heterogeneously expressing construct in some studies and homogeneously expressing 
constructs in others represents a potentially confounding factor in studies of MscL. Here we have 
identified the cause of heterogeneous expression in the original MscL expression construct 
developed in 1994 (Hase et al., 1995; S. I. Sukharev et al., 1994) and still widely used today. 
Despite recent studies showing that the N-terminal sequence of MscL influences the functional 
properties of the channel (Corry et al., 2010; Iscla et al., 2008), we show that this heterogeneously 
expressing construct is functionally indistinguishable from a newly engineered, homogeneously 
expressing channel, in agreement with an earlier study showing that extending the length of the N-
terminal domain has no effect on the functional properties of MscL (Hase, Le Dain, et al., 1997). 
Since the use of a homogeneously expressing construct is highly desirable (for studies of MscL 
structure, in particular), our work removes any uncertainty concerning the extrapolation of findings 
from previous studies utilizing the heterogeneously expressing construct, and recent and future 
studies utilizing homogeneously expressing constructs. Furthermore, we have shown that by 
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introducing a single residue substitution within the residual linker region of the recombinant MscL 
construct, protein concentration measurements can be much more reliably obtained. This represents 
an important variable, since accurate protein concentration measurements are essential to reliably 
interpret biophysical data and aid reproducibility in biophysical and structural studies. 
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Supplementary Information 
2.3. Methods 
In this section, supplementary methods not detailed in the published are provided. 
2.3.1. Site-directed Mutagenesis 
Site-directed mutagenesis alters nucleotide sequences in a gene in a predictable and reproducible 
way, making it a useful tool in protein studies. Three methods were used in this study to create new 
plasmid constructs with altered DNA sequences. 
2.3.1.1. Cassette mutagenesis 
Cassette mutagenesis involves insertion of a DNA fragment containing the desired genetic sequence 
to an existing construct, allowing multiple base mutations to be introduced (Fig. 2.6) (Wells et al., 
1985). This protocol was used in the first attempt at producing MscLTEVc (in pQE-31 plasmid) 
construct.  
The sequence of a native plasmid was analysed using Vector NTI (Invitrogen, U.S.A.), and 
mutation sequences were designed. Two unique restriction enzyme cutting sites were identified on 
 
Figure 2.6. Schematic outline of cassette mutagenesis protocol. Red denotes the mutant sequence 
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either side of the target sequence, allowing cleavage of the site of interest. An insertion fragment 
was designed to include the recognition sites (NruI and XmaI) as well as the mutation sequence. 
The insertion fragment was ordered as two single-stranded primers, one direct and one 
complementary, with an overlapping region. They were annealed and extended by one PCR cycle (1 
min denaturation at 95°C; 2 min annealing at 50°C; 5 min extension at 72°C). 
A quantity of 500 ng each of the fragment (Fr1) and the native plasmid were then separately 
incubated with the restriction enzymes in 30 μL of solution at 37°C for 1 h. One unit of shrimp 
alkaline phosphatase (New England BioLabs, U.S.A.) was added to the plasmid solution, and both 
fragment and plasmid solutions were further incubated at 16 °C for 30 min. The linearised plasmid 
was purified by agarose gel electrophoresis (100 mL 0.8 % agarose gel; 130 V, 30 min), while the 
fragment was purified by polyacrylamide gel electrophoresis (PAGE) using 12% acrylamide 1 x 
Tris-borate-EDTA (TBE) gel with 1 mm x 85 mm x 85 mm  dimension (80 V, 1 hr). 
A quantity of 300 ng of the fragment and 100 ng of the linearised plasmid were combined into one 
tube, together with two units of T4 DNA ligase (New England Biolabs, U.S.A.) and 4 μL T4 DNA 
ligase buffer, with the final volume adjusted to 40 μL with sterile water. The solution was incubated 
at 16°C for 4 – 6 h, after which the reaction was stopped by incubation on ice. Transformation-
competent E. coli DH5α cells (50 µl) were transformed with 2 μL of the ligated plasmid following 
the methods in Section 2.3.3. Plasmids were extracted from the cultures according to Section 2.3.2., 
and were sequenced at the Australian Genomic Research Facility (University of Queensland, 
Brisbane) for confirmation. 
2.3.1.2. Overlap Extension PCR 
Overlap extension PCR is another method used to introduce specific genetic mutations to an 
existing construct. While this technique is more complicated than cassette mutagenesis, it produces 
larger DNA fragments which allow easier detection of problems in the case of failure. Here, the 
protocol described by Ho et al. (S. N. Ho et al., 1989) was followed with research-specific 
modifications, and was successfully used to produce MscLTEVc (in pQE-31 plasmid), MscLThrombin 
(in pQE-31 plasmid), and MscLM1A (in pQE-31 plasmid) constructs.  
The original plasmid sequence was analysed with Vector NTI (Invitrogen, U.S.A.), and mutation 
sequences were designed. A forward (F2) and a reverse (R1) primer were designed, with the 
mutation sequences flanking them on the 5’ end (Fig. 2.7). Two unique restriction sites on either 
end of the mutation sequences were identified. A second set of primers (forward (F1) and reverse  
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 (R2)) encompassing each restriction site (NheI and SalI) was designed.  Primers were supplied by 
Integrated DNA Technologies (U.S.A.) and dissolved in DNase-free sterile water for a final 
concentration of 20 μM. 
Original plasmid (20 ng), 10 μL of 5 x iProof-HF buffer, 1.5 μL of 10 mM dNTP, and 1 μL of 
iProof-HF DNA polymerase (Bio-rad, U.S.A.) were added to each of two PCR tubes. 1 µL each of 
F1 and R1 primers was added to one tube, and F2 and R2 primers to another tube. The final volume 
of each PCR reaction mix was adjusted to 50 μL with water. The two samples were amplified by 
PCR (30 cycles; conditions listed in Table 2.2). Fragments corresponding to the expected base pair 
(bp) size were separated by agarose gel electrophoresis (100 mL 1.2 % agarose gel; 130 V, 40 min) 
and extracted. The two fragments (Fr2 and Fr3) were combined in a tube, and ligated by PCR (20 
 
Figure 2.7. Schematic outline of overlap extension PCR protocol. Green indicates wild-type sequence 
targeted for mutation, and Red denotes the mutant sequence 
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cycles) as per the same protocol and conditions described above, but with F1 and R2 primers 
(F1/R2). The ligated fragment (Fr4) was subsequently purified with agarose gel electrophoresis 
(100 mL 1.0 % agarose gel; 130 V, 30 min). 
The original plasmid (300 ng) and the fragment were separately incubated with the restriction 
enzymes in 30 μL solution at 37°C for 1 hr to create complementary ends. Both samples were run  
on 1.0 % agarose gel, and all unique bands were extracted. The fragment with longer base length 
from the plasmid sample (plasmid backbone) and the insertional fragment were combined. DNA 
ligation was carried out as described in Section 2.3.1.1., but using ExpressLinkTM T2 DNA Ligase 
(ThermoFisher Scientific, U.S.A.) instead of T4 DNA ligase. Competent Escherichia coli DH5α 
cells (50 μL) were transformed with 2 μL of the ligated plasmid. Plasmids were extracted from the 
cell culture, and were sequenced by the Australian Genomic Research Facility (AGRF) for 
confirmation of the correct fragment insertion. 
2.3.1.3. Site-directed mutagenesis by Inverse PCR 
Site-directed mutagenesis using an Inverse PCR method is a faster method of creating new 
constructs with specific mutations than the overlap extension PCR protocol, which can take up to 
three weeks. While this method is based on the publication by Dominy et al. (Dominy & Andrews, 
2003), the protocol has been significantly changed to simplify the process. It was used to 
successfully produce the MscLL-7Y (in pQE-31 plasmid) construct, and unsuccessfully for MscLL-7W 
(in pQE-31 plasmid), and MscLG22C (in pGEX 1.1 plasmid) constructs.  
The original plasmid sequence was analysed with Vector NTI (Invitrogen), and mutation sequences 
were designed to include not only the targeted mutation but also a set of silent mutations to  
Table 2.2. List of PCR parameters used for each sample in overlap extension PCR 
PCR Condition 
Initial 
Denaturation 
Denaturation Annealing Extension Final Extension 
MscLTEVc 
F1/R1 98 °C; 3 min 98 °C; 30 s 52 °C; 15 s 72 °C; 15 s 72 °C; 5 min 
F2/R2 98 °C; 3 min 98 °C; 30 s 56 °C; 15 s 72 °C; 15 s 72 °C; 5 min 
MscLThrombin 
F1/R1 98 °C; 3 min 98 °C; 30 s 55 °C; 15 s 72 °C; 15 s 72 °C; 5 min 
F2/R2 98 °C; 3 min 98 °C; 30 s 56 °C; 15 s 72 °C; 15 s 72 °C; 5 min 
MscLM1A 
F1/R1 98 °C; 3 min 98 °C; 30 s 55 °C; 15 s 72 °C; 15 s 72 °C; 5 min 
F2/R2 98 °C; 3 min 98 °C; 30 s 56 °C; 15 s 72 °C; 15 s 72 °C; 5 min 
F1/R2 (All Constructs) 98 °C; 3 min 98 °C; 30 s 49 °C; 15 s 72 °C; 25 s 72 °C; 5 min 
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introduce a sticky-end restriction site (S1) (Fig. 2.8). The forward (Fi) primer consisted of 
sequences containing the desired mutation, and the reverse (Ri) primer consisted of sequences 
complementary to the native sequence starting from the loci represented by the 5’ end of the Fi 
primer. Primers were supplied by Integrated DNA Technologies (U.S.A.) and dissolved in DNase-
free sterile water for a final concentration of 20 μM. 
Original plasmid (20 ng), 1 µL each of Fi and Ri primers, 10 μL of 5 x iProof-HF buffer, 1.5 μL of 
10 mM dNTP, and 1 μL of iProof-HF DNA polymerase (Bio-rad, U.S.A.) were added to a PCR 
tube. The final volume of each PCR reaction mix was adjusted to 50 μL with water, and the sample 
was amplified by PCR (30 cycles; conditions listed in table 2.3). An agarose gel electrophoresis 
(100 mL 0.8 % agarose gel; 130 V, 30 min) was performed with the sample to separate linear DNA 
from circular DNA, and the linear DNA component (Fr5) was extracted. 
12 µL of the DNA solution, 2 µL T4 PNK buffer, 1 µL 20 mM ATP, 4 µL water, and 1 µL T4 
polynucleotide kinase were added to a tube, which was then incubated at 37 °C for 30 min to 
 
Figure 2.8. Schematic outline of inverse PCR protocol. Green indicates wild-type sequence targeted for 
mutation, and Red denotes the mutant sequence 
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catalyse phosphate addition to the 5’ terminus of the DNA fragment. The reaction was terminated 
by the addition of 2 µL of 0.5 M EDTA, and the DNA fragment was purified by the same ethanol 
precipitation method as above. 
12 µL of the DNA solution, 4 µL of ligase buffer, 3.5 µL water, and 0.5 µL of ExpressLinkTM T2 
DNA Ligase were added to a PCR tube, and was incubated at room temperature for 15 min. 
Competent DH5α E. coli cells (50 µL) was then transformed with 2 µL of the ligated plasmid as 
described in section 2.3.1.1. Plasmids were extracted from the culture as described in section 2.3.2. 
500 ng of original plasmid, 3 µL of restriction enzyme buffer, and 1 µL of restriction enzyme for S1 
site were added to a PCR tube, and water was added to a final volume of 30 µL. The restriction 
enzyme digestion was carried out at 37 °C for 1 hr, and was analysed with agarose gel 
electrophoresis (50 mL 0.9 % agarose gel; 130 V, 30 min), where successful digestion indicated 
successful mutation. The plasmid was sequenced by the Australian Genomic Research Facility 
(AGRF) for confirmation of the correct fragment insertion. 
2.3.2. Plasmid Extraction from E. coli DH5α 
Where the purity of the sample was a concern such as for DNA sequencing, plasmids were 
extracted using a Miniprep®  plasmid extraction kit (Bio-Rad). In most cases, however, the 
following method was used. 
The transformed E. coli culture broth was incubated on a shaker at 37°C for 12 hr. A quantity of 5 
mL of culture was centrifuged at 2000 g for 10 min. The cell pellet was resuspended in 100 μL PBS 
and gently mixed with 500 μL of alkaline lysis buffer (1 % SDS; 0.2 M NaOH). The lysis was 
terminated within 5 min by adding 350 μL of 5 M potassium acetate. The solution was centrifuged 
at 13,000 g for 3 min, and the supernatant was transferred to another tube. Ethanol was added to the 
solution for a final concentration of 80% (v/v), and the mixture was incubated at room temperature 
for 5 min to precipitate the plasmid. The solution was centrifuged at 13,000 g for 3 min, and the 
supernatant was discarded. The pellet was dissolved in 200 μL water, and was re-precipitated by 
Table 2.2.  List of PCR parameters used for each sample in inverse PCR 
PCR Condition Initial 
Denaturation 
Denaturation Annealing Extension Final Extension 
MscLL-7W 98 °C; 3 min 98 °C; 30 s 53 °C; 20 s 72 °C; 100 s 72 °C; 5 min 
MscLL-7Y 98 °C; 3 min 98 °C; 30 s 52 °C; 20 s 72 °C; 100 s 72 °C; 5 min 
MscLG22C 98 °C; 3 min 98 °C; 30 s 53 °C; 20 s 72 °C; 100 s 72 °C; 5 min 
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adding 800 μL ethanol for cleaning. The solution was centrifuged at 13,000 g for 3 min, and the 
supernatant was discarded. The pellet was dissolved in water for a final DNA concentration of 
approximately 100 μg/mL. 
2.3.3. Transformation of Competent E. coli cells with Plasmid 
Plasmid solution (1 µL unless otherwise stated) was added to a tube containing 50 µL of chemically 
competent E. coli cells, and was incubated on ice for 15 min. The tube was incubated on a 42 °C 
heat block for 40 s, and then was immediately placed on ice. 500 µL of LB media was added to the 
tube, which was then incubated on a shaker at 37 °C for 1 h. 
Two LB agar plates with antibiotics which the plasmid (and the competent cells’ genomic DNA 
where relevant) have resistance genes for were prepared. LB agar with 50 mg/mL ampicillin was 
used for cultures intended for plasmid extraction, and LB agar with 50 mg/mL and 25 mg/mL 
chloramphenicol was used for cultures intended for protein expression. 200 µL of the incubated 
culture was evenly spread over one plate with sterile L-spreader. 20 µL of the culture was mixed 
with 180 µL of LB media, and was then spread over another plate with sterile L-spreader. Both 
plates were then incubated at 37 °C for a minimum of 12 h. 
Colonies visible with naked eye were picked with each 200 µL pipette tip, and each of 25 mL LB 
media containing the antibiotics was inoculated with it. The pre-cultures were then incubated at 
37 °C for 6-8 h or overnight. 
2.3.4. Protein Expression and Purification 
2.3.4.1. Protein Expression 
E. coli AW737-KO strain, which has the native MscL gene substituted with chloramphenicol 
resistance gene, was transformed with the plasmid containing MscL gene as in section 2.3.3. Each 
of 500 mL LB media, 250 µL of 100 mg/mL ampicillin, and 5 mL of the pre-culture were added to 
a 2 L flask. In later experiments, 10 mL of a nutrient-rich solution (1 mM glucose, 100 g/L tryptone, 
100 g/L yeast extract, 30% (v/v) glycerol, 100 mM Na2HPO4, pH 7.0) was added to each flask to 
reduce background expression and to increase both cell and protein yields. 
The flasks were then incubated on a shaker (180 rpm) at 37 °C until the OD600 absorbance reading 
reached 0.7-0.8 (path length 1 cm). 400 µL of 1 M IPTG was added to each flask, and the culture 
was further incubated on a shaker (180 rpm) at 37 °C for 5 h. Cells were harvested by centrifugation 
with Avanti J-30i (Beckman Coulter, U.S.A.) at 7,000 g for 15 min. Supernatant was discarded, and 
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the cell pellet was used either immediately for purification or collected and stored at -20 °C. 
2.3.4.2. Protein Purification 
Prior to the start of the experiment, the following solutions were prepared. 
Phosphate buffered saline (PBS; 10 mM Na2HPO4, 1.8 mM KH2PO4, 2.7 mM KCl, 137 mM NaCl, 
adjusted to pH 7.5 with HCl) internally prepared by Queensland Biosciences Precinct (QBP) store 
was used as the main buffer in the experiments. 
PD8 (PBS pH 7.5, 8 mM β-DDM) buffer was prepared with the volume corresponding to 15 mL 
per gram of cell pellet. PD1 (PBS pH 7.4, 1 mM β-DDM) buffer was prepared with PD8 buffer and 
PBS with the volume corresponding to 30 mL per gram of cell pellet. 50 mL of PDI1-15 (PBS pH 
7.5, 1 mM β-DDM, 15 mM imidazole) and 50 mL of PDI1-300 (PBS pH 7.5, 1 mM β-DDM, 300 
mM imidazole) buffer solutions were prepared with PD8 buffer, PBS, and 2 M imidazole solution. 
If size exclusion chromatography were to be performed, further 200 mL of PD1 buffer was 
prepared. For the purification of MscLG22C, all solutions also contained 1 mM β-mercaptoethanol. 
PBS was added to the cell pellet at a ratio of 9 mL per g cell, and the cell was thoroughly 
resuspended by vortexing for 2 min or more. The resuspended cells were then lysed with Constant 
Cell Disruption Systems (Thermo Scientific, U.S.A.) set to 23 kpsi pressure and passed twice. The 
lysate was then centrifuged at 13,000 g for 20 min at 4 °C. The supernatant was collected and 
centrifuged with Optima L-100XP ultracentrifuge (Beckman-Coulter, U.S.A.) at 184,000 g (Rav) for 
1:40 h at 4 °C. The supernatant was discarded, and the membrane pellet was either used for further 
purification or stored at -20 °C. 
The membrane pellet was resuspended in PD8 buffer at a ratio of 1 g per 40 mL buffer, and was 
incubated for solubilisation on a rocker at 4 °C overnight, or 8-10 h. The solution was centrifuged 
with ultracentrifuge at 75,000 g for 30 min at 4 °C. The supernatant was collected. 
Approximately 1 mL of TalonTM resin per g membrane was prepared by repeatedly washing with 
water and then with PD1 buffer. The resin was then added to the supernatant and incubated on a 
rocker for 2 h at 4 °C. 
The combined samples were then poured into a gravity fed column. The resin was washed with 10 
column volumes (CV) of PD1 buffer, followed by 50 mL of PDI1-15 (PBS, 1 mM β-DDM, 15 mM 
Imidazole) buffer to remove nonspecifically bound proteins and then with 10 CV PD1 buffer again 
to wash out residual imidazole. 
To collect the His-tagged MscL, 0.5 CV of PDI1-300 buffer was added to the column and the eluent 
collected. 2 CV of PDI1-300 buffer was then added again and the eluent was collected again a 
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second time. 
Alternatively to cleave the linker region with His-tag from the MscL construct, the resin was 
resuspended in 2 CV of PD1 buffer and transferred to a 50 mL Falcon tube instead of eluting with 
PDI1-500 buffer. 20 U thrombin per g membrane was added to the sample, which was incubated on 
a rocker at room temperature for 4 h followed by overnight incubation on a rocker at 4 °C. The 
resin was transferred to the gravity flow column, and the eluent was collected. 2 CV of PD1 buffer 
was then added to the column and the eluent was collected a second time. 
The eluent fractions were combined and concentrated with a 100,000 molecular weight cut-off 
(MWCO) concentrator either to a final volume of 1 mL, or to a concentration of 10 mg/mL. In the 
case of His-tagged MscL, the buffer condition was exchanged from PDI1-300 to PD1 by repeated 
dilution with PD1 followed by concentration. Alternatively, a PD10 desalting column (GE Life 
Sciences, U.S.A.) was used for the buffer exchange. The sample was either used for experiments or 
further purified. 
For structural studies (Chapter 4), thin-layer chromatography (Chapter 3) and for experiments in the 
publication (section 2.2.), MscL samples with higher purity were obtained by size exchange 
chromatography. Superdex 200 10/300 GL column (GE Life Sciences) was connected to AKTA 
Purifier (GE Life Sciences), and was equilibrated in PD1 buffer. 500 µL of sample was injected 
onto the column, and the chromatography experiment was carried out with 0.5 mL/min flow rate at 
4 °C. All fractions were collected, and of these, the peak fractions presumed to contain MscL were 
combined and concentrated to 5 mg/mL protein concentration with 100,000 MWCO concentrator. 
15 µL of sample was collected at each purification step detailed above, and they were run on SDS-
PAGE (15 % acrylamide gel; 80 V, 1 h) to check expression level and purity of MscL sample in the 
experiment. 
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2.4. Results and Discussion 
As most of the results from this chapter are already detailed in the publication (section 2.2.), this 
section will focus on the site-directed mutagenesis experiments, and MscL expression and 
purification protocol optimisation. 
2.4.1. Site-Directed Mutagenesis 
The first proposed solution to address the problem of heterogeneous expression of MscL was to 
substitute methionine-1 and the preceding linker region with TEV protease recognition site. The 
rationale for this was that 1) substituting methionine-1 would remove the second initiation site 
where the unintended MscL species was translated, and 2) cleavage with TEV protease would 
produce MscL with no linker region overhang, which was the case with the initial construct. 
2.4.1.1. Cassette Mutagenesis 
The first few attempts at producing this MscLTEVc construct used cassette mutagenesis method. This 
involved ligating two long primers to create a fragment containing mutation sequences (Fr1), which 
was then used to replace the original sequence with restriction enzymes and ligase (Fig. 2.6). The 
primer ligation step was successful (Fig. 2.9A) as well as the restriction digest of the main plasmid 
with NruI and XmaI which yielded the plasmid backbone with sticky-end restriction site on either 
end (Fig. 2.9B). However, the restriction digest of the Fr1 fragment could not be confirmed due to 
the small change in base pair size. The ligation of the Fr1 fragment to the plasmid backbone did not 
appear to work, as the same number colonies (4) grew on LB agar with ampicillin (LB/Amp) for 
both E. coli transformed with the plasmid and the untransformed cells (as negative control). When 
the plasmids from the cells were extracted and sequenced, they were found to match the original 
  
Figure 2.9. A) Polyacrylamide gel electrophoresis of starting primers (1 and 2), Fr1 fragment (3), and Fr1 
cut with restriction enzymes (4). B) Agarose gel electrophoresis of original MscL2.1-pQE-31 plasmid (5), 
plasmid cut with NruI (6), plasmid cut with XmaI (7), and plasmid cut with both enzymes (8) 
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plasmid rather than the one with mutated sequence, confirming that the experiment was not 
successful. 
2.4.1.2. Overlap-Extension PCR 
The next attempt at producing the MscLTEVc construct used a different strategy called overlap-
extension PCR. In this method, the first round of PCR produced two fragments containing mutated 
sequences (Fr2 and Fr3), which were then joined by a second round of PCR to produce a larger 
fragment (Fr4). Then this fragment replaced the original sequence using restriction enzymes and 
ligase (Fig. 2.7). The first round of PCR was successful, producing Fr2 fragment of 230 bp in size, 
and 600 bp Fr3 fragment (Fig. 2.10A). The second round of PCR was also successful, producing 
Fr4 fragment larger than Fr3 in agarose gel electrophoresis (Fig. 2.10B). Restriction enzyme 
digestion of F4 fragment with NheI and SalI was also successful. 
However, similarly to the cassette mutagenesis, ligation of Fr4 fragment to the plasmid backbone 
did not appear to work in the first few attempts, as E. coli cells transformed with the ligated plasmid 
did not grow on LB/Amp agar plate. A different set of restriction enzymes (NruI and SalI) was also 
tried, as were longer ligation times (24 h instead of 4-6 h), however the ligation still did not appear 
to work. 
In the third attempt, the same protocol for the first attempt (described in the first paragraph of this 
section) was used, except that the ligase used was changed from T4 DNA ligase to ExpressLinkTM 
T2 DNA Ligase. The latter, while more expensive, had higher ligation efficiency and so is often 
used in the ligation of blunt end fragments. This experiment was successful, with 10 colonies 
growing on the LB/Amp agar plate with E. coli transformed with the ligated plasmid, whereas none 
grew on the plate with untransformed E. coli. All 10 colonies were picked for plasmid extraction, 
and 4 of them were sent to AGRF for sequencing. All four sequences matched the designed mutant 
sequence. 
  
Figure 2.10. A) Agarose gel electrophoresis of original MscL plasmid (1), and pBlunt with mutant 
sequence insertion (2). B) Agarose gel electrophoresis of Fr2 (3), Fr3 (4), Fr4 fragment produced with 
Platinum Taq polymerase (5), and Fr4 fragment produced with iProof DNA polymerase (6). 
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This strategy was later repeated to produce MscLThrombin construct, which contained the thrombin 
cleavage site instead of the TEV protease recognition site, as well as MscLM1A construct, which 
substituted methionine-1 with alanine. These experiments were also successful. 
2.4.1.3. Site-directed Mutagenesis Using Inverse PCR 
Inverse PCR method was used to produce MscLL-7W, MscLL-7Y, and MscLG22C constructs for two 
reasons: first, this strategy took as little as three days, making it considerable shorter than overlap-
extension PCR; and second, this experiment was not critical to the thesis at the time, so a quick 
approach which would not take too much time and resources was preferred. 
A major disadvantage of Inverse PCR was that, unless there was a native restriction site close to the 
sequence targeted for mutation, a new restriction site overhang would have to be produced in the 
PCR step, which would then have to be removed in additional steps. Therefore, a simpler approach 
was developed, wherein the whole plasmid would be amplified with PCR with one of the primers 
containing mutated sequences, followed by blunt-end ligation of the Fr5 fragment. 
The fragment amplification with PCR was successful on the second attempt, but only for MscLL-7Y 
and not for MscLL-7W and MscLG22C (Fig. 2.11). While the reason for this is unclear, it might have 
been due to the inherent problems with amplifying a whole plasmid with PCR. The fragment was 
 
Figure 2.11. Agarose gel electrophoresis of Fr5 fragments of MscLG22C (1), MscLL-7W (2), and MscLL-7Y 
(3) 
Table 2.4. The number of DH-5α E. coli colonies transformed with the ligated plasmid (for 
MscLL-7Y) grown on LB/Amp agar 
Plasmid used 
No plasmid used 
(negative control) 
Untreated MscLL-7Y 
MscLL-7Y treated with 
PNK 
Number of colonies 0 47 130 
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split into two, and one was treated with T4 polynucleotide kinase (PNK). 
Both fragments were ligated and then used to transform E. coli cells, where the sample treated with 
PNK produced significantly more colonies on the LB/Amp agar plate than untreated one, but it was 
shown not to be a critical step (Table 2.4). Plasmids were extracted from the colonies and sent to 
AGRF for sequencing, where all of their sequences matched the mutated sequence. 
2.4.2. MscL Expression and Purification Protocol Optimisation 
The MscL expression and purification protocol based on Häse et al. (Hase et al., 1995) and 
modified by Dr. Michael Landsberg (unpublished) was mostly followed. A more nutrient-rich 
culture was used instead of LB media, which improved the cell yield from 4 g/L culture to over 6 
g/L, as well as MscL yield from 0.5 mg/L culture to 1 mg/L. In addition, MscL at the end of 
purification was kept in PD1 buffer instead of exchanging it to 20 mM Tris (pH7.5), 1 mM β-DDM 
buffer. Tris buffer’s relatively large pH sensitivity to temperature change (0.028 per °C) was 
speculated to affect MscL stability, as it could be concentrated to over 10 mg/mL in PD1 buffer but 
only up to approximately 1 mg/mL in Tris/β-DDM buffer. 
 
 
  
Figure 2.12. A) SDS-PAGE of various MscL samples treated with proteases. 1 – Original MscL eluent 
after thrombin treatment of Talon resin; 2 – Talon resin after thrombin treatment; 3 – Original MscL 
eluent after TEV protease treatment of Talon resin; 4 – Talon resin after TEV protease treatment; 5 – 
MscLTEVc eluent after thrombin treatment of Talon resin; 6 – Talon resin after thrombin treatment; 7 – 
MscLTEVc eluent after TEV protease treatment of Talon resin; 8 – Talon resin after TEV protease 
treatment. B) SDS-PAGE of Talon resin-bound MscLTEVc treated with heat and proteases. 9 – Thrombin 
with no heat treatment; 10 – TEV protease with no heat treatment; 11 – Thrombin after 70 °C incubation; 
12 – TEV protease after 70 °C incubation; 13 – Thrombin after 95 °C incubation; 14 – TEV protease after 
95 °C incubation  
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2.4.2.1. Affinity tag cleavage of MscLTEVc with TEV protease and Thrombin 
MscLTEVc construct has two protease recognition sites in the C-terminal linker region: TEV protease 
site at the C-terminal end of the MscL region, and thrombin site at 8 residues upstream of the MscL 
region. While this construct could be homogeneously expressed and purified, it was resistant to 
cleavage by both proteases (Fig. 2.12). As it was thought at the time that the linker region could 
interfere with protein crystallisation, and because His-tag is known to affect channel gating, 
attempts were made to find a condition for the protease cleavage to be successful. 
In the first approach, a much larger amount of protease (100 U per g membrane instead of 20 U) 
was added for tag cleavage, which was not successful (Fig. 2.12A). In the second attempt, MscL 
sample was split into three aliquots and they were incubated at room temperature (22 °C), 75 °C, 
and 90 °C respectively for 5 min. It was hypothesised that the linker region but not MscL would 
denature at 75 °C, hence improving the proteases’ access to the recognition site, and 90 °C 
incubation was used as a positive control where MscL as a whole would become denatured. This 
approach was not successful either, as neither thrombin nor TEV protease could cleave the linker 
region of the construct in any of the samples (Fig. 2.12B).  
The exact cause of this problem is not known, and has not been investigated beyond these two 
attempts. However, it is reasonable to speculate that the result may be due to the hydrophobic nature 
of the thrombin and TEV protease recognition sites (Fig. 2.13). The substituted region in the 
original construct was largely hydrophilic, and by replacing this with the more hydrophobic TEV 
protease recognition sequence, the linker region becomes more hydrophobic. As a result, the N-
terminal linker region may have formed its own hydrophobic core with a propensity to bury itself 
  
Figure 2.13. Schematic representation of the hypothesis on the resistance of MscLTEVc to protease 
cleavage. Hydrophilic residues are highlighted with blue; neutral residues are in light green, and 
hydrophobic residues are highlighted with grey. A) The linker region of original MscL construct is largely 
hydrophilic with the exception of thrombin recognition site, so it is stable in solution. B) Both thrombin 
and TEV protease recognitions sites of MscLTEVc are buried in the detergent micelle core due to the 
hydrophobicity. This prevents access by the proteases. 
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within the detergent micelles, hindering access by proteases. In order to address this problem, 
another construct (MscLM1A) was designed so that there would be little change to the linker region, 
whose product could be cleaved by thrombin like the original construct. 
2.5. Conclusion 
I have detailed in this chapter the site-directed mutation experiments to produce new MscL 
constructs which express homogeneously and which is also reliably quantified. Clearly a 
homogeneous protein preparation is highly desirable for crystallisation experiments, and accurate 
and precise quantification allows these experiments to be carried out with the protein using 
concentration as a controllable variable. The new constructs, especially MscLM1A and MscLL-7Y, 
were used in the experiments in the third and fourth chapters. 
Patch clamp experiments (by Pietro Ridone and Dr. Yoshimura Nakayama at Victor Chang Cardiac 
Research Institute, Sydney) have also demonstrated that the mutations did not significantly change 
the channel gating properties, which makes it possible to extrapolate data between commonly used 
MscL constructs. For example, a heterogeneous MscL complex containing both wild-type and 
recombinant species having similar channel gating properties to homogeneous constructs show that 
the C-terminal linker region has little influence on the protein function (Chi et al., 2015). 
In addition, to simplify the site-directed mutagenesis protocol, a modified method based on Inverse 
PCR was developed and successfully used to produce a new MscL construct. 
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2.6. Supplementary Figures 
  
Figure 2.S1. Size exclusion chromatography of 0.5 mg of original MscL construct (blue), MscLM1A (red), and 
MscLL-7Y (green). 
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3. Biophysical Characterisation of Interaction Between MscL and 
Phospholipid 
3.1. Introduction 
Membrane protein function is dependent on the membrane environment, and there is a growing 
research interest into their relationship. As protein channels primarily gated by membrane tension, 
this is especially significant for mechanosensitive channels. For example, MscS localises to the 
poles of bacterial cells where relatively high concentrations of negative phospholipids 
phosphatidylglycerols (PG) and cardiolipins alter both its aggregation and channel function 
(Andrew R. Battle et al., 2011; Nomura et al., 2012; Romantsov et al., 2010). The cleft between 
TM domain and C1 domain is thought to be a binding site for certain phospholipids (Pliotas et al., 
2015). Some non-mechanosensitive TRP channels are regulated by phosphoinositides in membrane, 
providing indirect evidence for phospholipid interaction with mechanosensitive TRP channels 
(Rohacs, 2014). Therefore, it is important that the function of mechanosensitive channels be 
understood in the context of the membrane environment they are studied with. 
There is growing evidence that the membrane environment is a factor in MscL function, but their 
relationship remains poorly understood and is not taken into account in many experimental designs. 
This has led to several misinterpretation of data in the past: the channel gating threshold of M. 
tuberculosis MscL was initially thought to be significantly higher than E. coli MscL (P. C. Moe et 
al., 2000). This later turned out to be due to M. tuberculosis MscL in membrane containing 
phosphatidylinositol, which is found in native M. tuberculosis membrane but not in E. coli (Zhong 
& Blount, 2013). Such lack of information on the relationship between MscL and phospholipids 
continues to be a confounding factor. The majority of research on MscL is conducted with 
membranes dominated by phosphatidylcholines (PC) (Corry et al., 2010; Grage et al., 2011; Iscla et 
al., 2013; Kocer, 2015; Meyer et al., 2006; Rui et al., 2011; Sawada et al., 2012; Yoshimura et al., 
2008) despite PC not being a native component of E. coli’s inner membrane. However, E. coli 
MscL’s gating threshold is significantly lower in pure PC membrane than in one with the addition 
of phosphatidylethanolamine (PE) (Kamaraju & Sukharev, 2008; P. Moe & Blount, 2005), calling 
into question the validity of a number of studies. Other membrane environment factors are often not 
given serious consideration in experimental design or data analysis either: global curvature’s 
influence on MscL function has not been explored beyond simulations (Bavi, Cox, et al., 2016; 
Meyer et al., 2006); the distribution pattern of MscL within membranes remains poorly understood 
apart from the observed clustering in DOPC (Grage et al., 2011; Nomura et al., 2012); and there 
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have been few studies investigating protein-to-protein interaction, focusing on MscS (Andrew R. 
Battle et al., 2011; Nomura et al., 2012). However, there is increasing evidence that these have 
significant impact on MscL function as observed in both past publications (Grage et al., 2011; 
Nomura et al., 2012) and in this thesis (sections 3.3.2. and 3.3.3.). 
The information on the relationship between MscL and the membrane is relevant not only from an 
academic perspective but also for the development of MscL as nanovalve in a liposomal drug 
delivery system. Smaller liposomes are generally favoured for drug delivery because they tend to be 
more permeable to physiological barriers such as blood vessels (Garnier et al., 2012). There are 
conflicting hypotheses, both based on molecular dynamics studies, on the influence of global 
curvature in small liposomes on MscL function (Bavi, Cox, et al., 2016; Meyer et al., 2006), 
making an experimental confirmation of whether MscL is to be engineered for gating threshold 
(Iscla et al., 2013; Nakayama et al., 2015). Likewise, the relationship between MscL and lipids 
(including but not limited to phospholipids) needs to be better understood, since phospholipids used 
for liposome formulation can be dependent on the type of target tissues or objectives (H. I. Chang & 
Yeh, 2012; Fan & Zhang, 2013; van den Hoven et al., 2011). 
In this chapter, I have investigated three aspects of the MscL/phospholipid relationship. First 
phospholipids’ association with E. coli MscL in the native environment, mainly employing thin 
layer chromatography. It was hypothesised that MscL may interact strongly with certain lipids in 
the native environment, and that the interaction would be relevant to MscL function. Hence, this 
information had the potential to help explain the observed behaviour of MscL in various liposomal 
environments. 
Second, MscL function in liposomes consisting of different phospholipids was studied to determine 
whether they were influenced by certain liposomal environments such as phospholipid composition 
and the liposome size. Using heterogeneous phospholipid mixtures allowed multiple variables such 
as liposome size, phospholipid types and the method of liposome preparation, to be studied at once 
and at a much lower cost than would be possible if homogeneous phospholipids were used. Electron 
microscopy of the liposomes was carried for structural analysis and to observe the aggregation 
pattern. Dynamic light scattering was used for quantitative measurement of the liposome size. 
Lastly, the arrangement of MscL within lipid bilayers was investigated as a function of membrane 
lipid composition. Mainly employing electron microscopy, the tendency of MscL to aggregate or 
cluster within liposomes was investigated in the presence of multiple different lipid species. The 
results are later used to help with the optimisation of 2D crystallisation experiments performed and 
detailed in Chapter 4.  
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3.2. Methods 
3.2.1. Phospholipid Preparation for Liposome Production 
Phospholipids purchased as lyophilised powders from either Avanti Polar Lipids (U.S.A.) or Sigma 
Aldrich (U.S.A.) were dissolved in chloroform at a final concentration of 10 mg/mL. Aliquots were 
either used immediately or stored at -80 °C for subsequent use. The list of phospholipids used is 
detailed in Table 3.1. 
500 µL of the phospholipid solution was added to a 5 mL glass tube pre-cleaned with chloroform, 
and chloroform was evaporated under a nitrogen gas stream while rotating the tube along the tube 
axis to produce a thin layer of phospholipid on its wall. 1 mL of water (section 3.2.3.1.) or buffer 
(section 3.2.2.1.) was added to the tube. The tube was vortexed for 1 min, followed by 5 min 
sonication in a bath sonicator to produce a dispersion of vesicles. The solution was either aliquoted 
in 1.5 mL microtubes and stored at -20 °C or used immediately in the following steps. 
3.2.2. Size Fractionation of MscL Proteoliposome 
The method for preparing and size fractionating MscL proteoliposomes is based on a method 
developed by Dr. Alexander Foo and described in (Alexander Foo, 2014). 
3.2.2.1. MscL Proteoliposome Preparation by Extrusion 
2 mL of 5 mg/mL liposome solution in carboxyfluorescein buffer (5 mM HEPES pH 7.2, 100 mM 
Table 3.1. List of phospholipids used in Chapter 3 
Phospholipid Head Group Tail Group Product Source 
E. coli Lipid Mixed (58 % PE; 15 % PG) Mixed Avanti Polar Lipids 
Soy Azolectin Mixed (30 – 40 % PC) Mixed Sigma-Aldrich 
DOPC Zwitterionic 18:1/18:1 Avanti Polar Lipids 
POPC Zwitterionic 16:0/18:1 Avanti Polar Lipids 
DPPC Zwitterionic 16:0/16:0 Avanti Polar Lipids 
DMPC Zwitterionic 14:0/14:0 Avanti Polar Lipids 
DOPE Zwitterionic 18:1/18:1 Avanti Polar Lipids 
Cardiolipin Negative 18:1/18:1,18:1/18:1 Avanti Polar Lipids 
DOPS Negative 18:1/18:1 Avanti Polar Lipids 
POPG Negative 16:0/18:1 Avanti Polar Lipids 
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KCl, 50 mM 5,6-carboxyfluorescein) was extruded using a LiposoFast-Basic System (Avestin, 
Canada) by passing it through a 400 nm membrane (Whatman, U.S.A.) eleven times. The solution 
was then re-extruded using a 100 nm membrane (Whatman). Approximately half of the 
phospholipid by mass is lost during the extrusion step due to factors including less than 100 % 
solution recovery and adherence of lipid to the membrane; this loss is taken into account in 
calculations in the following steps. 
1 mg/mL MscL solution in PD1 buffer (PBS pH 7.4, 1 mM β-DDM) was added to the liposome 
solution to obtain a desired protein-to-lipid ratio (w/w; 1:10, 1:20, and 1:100 were used in this 
thesis), and incubated on a rocker at room temperature for 30 min. 100 mg of Bio-BeadsTM SM-2 
(Bio-Rad) prepared by sequential wash with methanol and water was added to the solution, and 
further incubated on a rocker at room temperature for 4 – 6 h. This solution was either directly used 
in the following steps, or was used after dialysis with 3,500 MWCO SnakeSkinTM (ThermoFisher 
Scientific, U.S.A.) dialysis membrane in 100 mL PD1 buffer overnight to remove free 
carboxyfluorescein. 
3.2.2.2. Size Fractionation of Proteoliposome by Continuous Sucrose Gradient 
12 mL of sucrose gradient solution (10 mM HEPES pH 7.4, 300 mM sucrose, 100 mM KCl) was 
prepared in a thin-wall UltraClearTM ultracentrifuge tube (Beckman-Coulter, U.S.A.). The tube was 
frozen at -80 °C and then thawed for 3-5 h at 4 °C before use. 200 µL of the proteoliposome 
solution was gently added to the top of the tube so as not to disturb the gradient. The sample was 
centrifuged at 114,000 g (Rav) at 4 °C for 14 – 16 h. 200 – 500 µL fractions from the sucrose 
gradient were collected by puncturing the tube wall on the side with a syringe fitted with a needle. 
Liposome fractions were characterised by dynamic light scattering using a Zetasizer Nano ZS 
(Malvern, United Kingdom). The peak liposome diameter, mean liposome diameter, and the 
polydispersity index (PdI), a measure of the size distribution were recorded for each fraction. 
3.2.2.3. Lipid Mass Spectrometry 
Phospholipid analysis by mass spectrometry was performed in collaboration with Prof. Stephen 
Blanksby (Queensland University of Technology, Australia). The samples were directly injected to 
a LC-ESI-MS/MS system with precursor ion scan followed by collision energy scans for individual 
phospholipids (phosphatidylcholine, phosphatidylethanolamine and phosphatidylinositol). 
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3.2.3. Electron Microscopy of MscL Proteoliposomes 
3.2.3.1. Pure Phospholipid Proteoliposome Preparation 
6 µL of a 5 mg/mL liposome solution, 0.5 µL 200 mM MgSO4, and either 6 µL or 0.6 µL of 5 
mg/mL MscL were combined in a tube resulting in a protein-to-lipid ratio (w/w) of 1:1 or 1:10 
respectively. PD1 buffer was added to a final volume of 30 µL. The solution was incubated on a 
rocker at room temperature for 30 min. The solution was then transferred to another tube containing 
2.0 – 2.5 mg of Biobeads, and further incubated on a rocker at room temperature for 4 – 6 h. During 
the optimisation of this protocol, solutions which did not contain MgSO4 as well as those which 
contained MgCl2 instead were also tried. 
3.2.3.2. Negative Staining of MscL Proteoliposome on EM Grid 
Electron microscopy (EM) grids used in this study were prepared in the laboratory. 400-mesh 
copper grids (Electron Microscopy Sciences, U.S.A.) were coated with a thin layer of Formvar resin 
(ProSciTech, Australia). A thin carbon film was then evaporated onto the Formvar layer using 
graphite threads in a Q150T E carbon evaporator (Quorum Technologies, United Kingdom). Grids 
were glow-discharged immediately prior to use. 
5 µL of proteoliposome solution was applied to the grid, incubated for 2 min, and subsequently 
blotted with filter paper. The grid was washed twice with water, and was stained with 1 % uranyl 
acetate solution by incubation on the drop for 1 min, followed by blotting with filter paper. 
Alternatively to tag MscL with 5 nm Ni-NTA-Nanogold (Nanoprobes, U.S.A.), 5 µL of 
proteoliposome solution was incubated on the grid for 5 min followed by blotting with filter paper. 
A 6 µL drop of Nanogold solution was then applied to the grid for 30 min, following which the grid 
was washed with 20 µL of PBS pH 7.4 solution containing 10 mM imidazole for 1 min. The grid 
was twice washed with water, and was stained with 1 % uranyl acetate solution by incubation for 1 
min followed by blotting with filter paper. 
Grids were imaged using a JEOL 1011 transmission electron microscope (JEOL, Japan) coupled to 
a Morada charge-coupled device (CCD) imaging system (Olympus Soft Imaging Solutions, 
Germany). The microscope was operated at a high-tension voltage of 100 keV and images were 
recorded at nominal magnifications of 5,000x, 25,000x, 50,000x, and 100,000x. 
3.2.3.3. Quantitative Analysis Based on Gaussian Distribution and Cluster Size Distribution 
Clustering of Nanogold particles in electron micrographs was modelled in Matlab®  (Mathworks, 
U.S.A.) using a protocol developed together with Dr. Jennifer Yarnold (Institute for Molecular  
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Bioscience, Australia). Clustering was modelled using a multi-component Gaussian mixture model, 
based on approaches described in the Matlab tutorials published on the Mathworks website 
(Mathworks, 2016). 
Electron micrographs recorded at 100,000x magnification (Fig. 3.1A) were first processed (only) 
for improved contrast with Photoshop®  CS6 (Adobe, U.S.A.). After initial processing, Nanogold 
particles were the darkest pixels in the image and could be readily detected (Fig. 3.1B). Where 
overstaining of liposomes was a problem, parts of the liposomes were masked so that only 
Nanogold-tagged MscL could be identified as black pixels on Matlab. 
A multi-component Gaussian mixture model was applied to the imported electron micrographs and 
the cluster groups analysed. Initially, two protocols were run with the number of components set to 
 
Figure 3.1. The schematic diagram of the protocol for semi-quantitative MscL cluster analysis. A) Raw 
micrograph. B) Image with contrast enhanced with Photoshop. C) Calculation of the area of each cluster 
with Matlab. D) Data processing with Excel. E) Data conversion into chart with Excel. 
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two (much fewer than the actual number of clusters) and seven (usually more than the actual 
number of clusters) respectively to gauge the number of clusters recognised by the program. The 
number of defined components in the protocol was then changed to be one more than the number of 
suspected clusters (the extra component accounting for non-clustered Nanogold particles). The 
protocol was run iteratively and checked for convergence. If the iterations failed to reach 
convergence, the number of components was increased by one, and the protocol was rerun. If there 
was convergence, triplicate analyses were performed as a control to check whether non-clustered 
particles were consistently grouped into a single component as they should. The proportion of this 
component in the scatter was recorded and compared across micrographs. 
Additionally, the size of each cluster/particle was measured to estimate the number of particles in 
the cluster. Electron micrographs with improved contrast were again analysed with Matlab, this 
time using a protocol that returned the area of each Nanogold (black pixel) cluster (Fig. 3.1C). The 
dataset was then transferred to Excel 2013 (Microsoft, U.S.A.) (Fig. 3.1D), where noise was filtered 
out by removing areas smaller than 10 pixels, the average size of a single Nanogold particle at 
100,000x magnification. The number of particles in each area was also estimated from this, and a 
histogram of the number of clustering particles was produced for each liposomal condition (Fig. 
3.1E). The Matlab script for one of the processed images and the chain of Excel commands are 
listed in the supplementary information (section 3.6.). 
3.2.4. Thin Layer Chromatography 
Purified MscL at a concentration of more than 2 mg/mL concentration was transferred into a glass 
tube, and acetone was added to give a final concentration of 80 % (v/v). The tube was vortexed for 
30 s several times, and was then incubated at room temperature for 5 min, followed by 
centrifugation at 1,000 g for 5 min. The supernatant was transferred to another glass tube. 
120 mL of mobile phase solution for thin layer chromatography was prepared by mixing the 
components together. Early experiments used toluene, acetone and water mixed at ratios of 4:12:1 
and 7:9:1 (v/v) respectively. In later experiments, the mobile phase consisted of chloroform, 
methanol, and water at 13:5:1 (v/v) ratio respectively. 
The mobile phase solution was shaken well, and 60 mL was poured into a TLC chamber. 0.2 m x 
0.2 m plain drawing paper and 0.2 m x 0.2 m glass-backed silica gel matrix plate (Sigma-Aldrich, 
U.S.A.) were placed in the chamber. The wash step was run until the mobile phase had migrated to 
the top of the silica plate. The chamber was emptied, and the plate was dried in an incubator at 
50 °C for at least 15 min. 
65 
 
60 mL of fresh mobile phase solution and 0.2 m x 0.2 m of drawing paper were added to the TLC 
chamber, and left to equilibrate. MscL and phospholipid samples were loaded onto the silica plate 
with a minimum of a 2 cm gap between them. The plate was then placed in the equilibrated TLC 
chamber, and the chromatography was run until the mobile phase approached the top of the plate. 
The plate was dried in an incubator at 50°C. Lipids were visualised using one of three different 
approaches. In early experiments, 45 % H2SO4 was sprayed on the plate, which was then charred in 
an incubator at 70 °C until the stains developed, usually for 15 min. Alternatively, the TLC plate 
and approximately 1 g of iodine granules were placed in a cleaned TLC chamber until lipid spots 
were visible. In later experiments, 0.05 % primuline solution was sprayed on the plate, and was 
visualised under UV light with a Gel Imaging System (Bio-rad, U.S.A.). The two latter methods 
have the advantages of staining non-destructively, hence allowing further analyses of the lipids such 
as mass spectrometry. 
3.2.5. Extraction of Compounds from Silica Gel for Subsequent Analysis 
The first extraction method used the main components of the mobile phase (chloroform and 
methanol) and the original solvent (acetone) used to extract the compounds from MscL. Locations 
and sizes of bands on a TLC plate with non-destructive stains (iodine or primuline) were clearly 
marked with pencil. Silica gel in each marked area was gently scraped from the plate with a clean 
spatula, and was transferred to a glass tube. The gel was mixed with 1 mL chloroform by vortexing, 
and was incubated on a shaker at room temperature for 10 min. The tube was centrifuged at 100 g 
for 5 min to pellet silica gel, and the chloroform was transferred to another glass tube. 
The gel was then resuspended in 1 mL acetone by vortexing and incubated on a shaker at room 
temperature for 10 min. The tube was centrifuged at 100 g, and acetone was transferred to the glass 
tube containing the chloroform extract. Both the washed silica gel and extract solution were then 
stored at 80 °C. 
In an alternative method, a protocol by Bligh and Dyer (Bligh & Dyer, 1959) was followed. 1 mL 
water, 2.5 mL methanol, and 1.25 mL chloroform were mixed with the silica gel scraped from TLC 
plates by vortexing for 10 min. 1.5 mL chloroform was added to the sample, and was further 
vortexed for 1 min. 1.5 mL water was then added to the sample, and was vortexed for 1 min. The 
sample was centrifuged at 500 g for 10 min to separate hydrophobic (chloroform) and hydrophilic 
(water) phases. The hydrophobic phase was transferred to a new glass tube, and was evaporated 
under a stream of nitrogen gas. Once all solvent was evaporated, 100 µL chloroform and 200 µL 
methanol were added to the tube, and the sample was vortexed to solubilise the compounds. The 
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sample was then stored at -80 °C prior to analysis. 
3.2.6. Silver Staining of PAGE gels 
This protocol was based on Blum silver staining protocol described in (Mortz et al., 2001). 
15 µL of protein and/or proteoliposome samples were mixed with 5 µL loading solution, and were 
run on SDS-PAGE (15 % acrylamide gel; 80 V, 1 h). The gel was then incubated in water at room 
temperature for 1 min, followed by incubation in fixer solution (40 % ethanol, 10 % acetic acid, and 
50 % water; v/v) at room temperature for 1 h. The gel was then incubated in water at room 
temperature for 6-8 h, replacing the water at least three times. 
The gel was incubated in 0.02 % Na2S2O3 solution for 1 min, and was washed with water at least 
three times for 20 s each. It was then incubated in staining solution (1 g/L AgNO3, and 0.2 g/L 
formaldehyde) on ice for 20 min. The gel was washed with water at least 3 times for 20 s each. The 
gel was then transferred to a new container, and was incubated in developing solution (30 g/L 
Na2CO3, 0.5 g/L formaldehyde) on ice until the stain had sufficiently developed. 
Once the stain had developed, the gel was washed with water, and incubated in 5 % acetic acid (v/v) 
for 5 min. 
3.3. Results and Discussion 
3.3.1. E. coli Phospholipids Natively Associating with MscL 
3.3.1.1. Thin-Layer Chromatography 
The main objective of this experiment was to identify any native E. coli lipids strongly associating 
with MscL. At the start of this project, it was hypothesised that MscL might exhibit a strong 
preference for particular lipids in the native environment. Different aggregation patterns and 
channel gating thresholds were observed for MscL reconstituted in phosphatidylcholine-only 
liposomes as opposed to mixed lipid liposomes. Hence, reasoning that the phospholipids 
preferentially interacting with MscL would also have high affinity to it and may potentially be of 
functional significance, experiments to identify them were carried out. 
In the first set of trials, thin-layer chromatography (TLC) was performed with an organic solvent 
extract of purified MscL alongside a number of detergent and lipid controls. The initial objective 
was to identify a suitable mobile phase (i.e. solvent) and sample loading. As it was not clear at this 
point if detergents and phospholipids would separate well, and if other lipids such as cholesterol and  
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lysophospholipid would be detected, a mobile phase developed by Dr. Eugene Zhang (IMB, 
Australia) which can screen for a broad range of organic molecules was used. This solvent 
contained toluene, acetone, methanol, and water (T:A:M:W, v/v), and the ratios were changed with 
each experiment to optimise the separation. 
In the initial experiment, (T:A:M:W = 6:7:1:1), detergents and phospholipids had similar levels of 
movement, making them hard to separate (Fig. 3.2). Most problematic was that β-DDM, the 
detergent used to purify MscL, and phosphatidylethanolamine (PE), the main lipid constituent of E. 
coli membranes, had similar migration profiles under these initial solvent conditions. However, this 
experiment still yielded some interesting results. Soy azolectin was found to contain a range of 
compounds instead of being largely phosphatidylcholine as suggested in the manufacturer’s 
description. Three constituents were detected in the purified MscL sample. The first component had 
a retention factor (Rf) of 0, likely residual MscL which remained in the acetone fraction. The second  
 
Figure 3.2. Thin layer chromatography of MscL and reference samples. The numbers next to arrows are Rf 
values. 
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component (Rf = 0.15), stained quite strongly, and given its location compared to the standards, was 
hypothesised to be β-DDM (Rf = 0.13). The third component (Rf = 0.18) was clearly visible only 
immediately after charring with H2SO4 and faded within minutes, but it appeared distinct from the 
much larger β-DDM band. While the chance of this band still being from β-DDM could not be 
discounted, there was also a possibility that this was a native E. coli membrane lipid (or lipids). Due 
to it running slightly higher than the β-DDM band, it was speculated that this could be PE (Rf = 
0.18). 
A more hydrophobic solvent (T:A:M:W = 7:9:0:1) was trialled in the second experiment, with the 
hypothesis that this could make phospholipids travel further on the TLC plate while having the 
opposite effect on detergents (Fig. 3.3A-D). Interestingly, the outcome was reversed relative to the 
expected effect, with detergents migrating further (Rf = 0.58) whereas DOPE standard remained 
much closer to the baseline (Rf = 0.06). Regardless, this solvent mixture was effective at 
significantly separating detergents and phospholipids, so the experiment was repeated for the TLC 
with MscL extract (Fig. 3.3E-H). 
 
Figure 3.3. TLC of MscL and various reference samples. The numbers next to arrows are Rf values. A) 
OG; B) β-DDM; C) Soy Azolectin (5 mg); D) DOPE; E) MscL (1 mg); F) β-DDM; G) Soy Azolectin (0.1 
mg); H) Soy Azolectin (0.5 mg) 
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Again, three components extracted from the purified MscL sample were able to be separated by 
TLC (Fig. 3.3E). One component again did not migrate up the plate at all (Rf = 0), and was 
hypothesised to be residual protein as in the earlier experiment. There was still the possibility that 
other organic molecules could also be present in this band, since most compounds in the soy 
azolectin sample remained on the baseline as well. 
The second component (Rf = 0.06) migrated a similar distance compared to DOPE standard (Rf = 
0.07), leading to further speculation that this could indeed be PE lipid. Interestingly, there was a 
band at the same location for the soy azolectin sample as well. PE is a major constituent of soy cell 
membranes (Erdahl et al., 1973). The third component (Rf = 0.50) closely matched the migration 
distance of β-DDM (Rf = 0.52), and also to a faint band in soy azolectin. Hence, while it was 
hypothesised to be β-DDM band, there was also a possibility of additional compounds being 
present. 
 
Figure 3.4. TLC of MscL and reference samples. The numbers next to arrows are Rf values of the bands. 
A) DOPC; B) Cardiolipin; C) DOPE; D) β-DDM; E) Acetone MscL extract (2 mg); F) Chloroform MscL 
extract (2 mg); G) E. coli lipid; H) Triton X-100. 
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In addition to the three bands corresponding with the MscL sample, a number of additional bands 
were seen in the reference lane for the soy azolectin sample (Fig. 3.4E, H). While those with lower 
Rf than detergents were likely minor phospholipids in soy azolectin, the two bands with high Rf 
values could have been compounds with significantly different structures such as sterols. As bands 
with such high Rf values were not detected in the MscL sample, it was assumed that compounds co-
purifying with MscL were mainly phospholipids. Hence, it was decided that the solvent for the next 
trial would be changed for better separation between different types of phospholipid. 
In the third experiment, a chloroform-based solvent system with the chloroform:methanol:water 
(C:M:W, v/v) ratio of 13:5:1 was used. This was based on a TLC solvent system chart published by 
Avanti®  Polar Lipids, Inc. (U.S.A.) (Avanti Polar Lipids), where the C:M:W ratio was simplified 
from 65:25:4. There were a total of five, well-separated bands for MscL samples (Fig. 3.4E). Apart 
from the lowest band (Rf = 0.01), which was likely residual protein, it was difficult to identify the 
stained compounds. However, the second lowest band (Rf = 0.05 – 0.23) was estimated to be β-
DDM as its smeared locus significantly overlapped with that detected for the chloroform-extraction 
sample (Rf = 0.09). 
The third band (Rf = 0.48) was speculated to be a phospholipid due to its position in the middle, but 
it neither matched PC nor PE. Interestingly, it did not match any major phospholipids in the E. coli 
lipid either, indicating that MscL might have an affinity for a less-abundant phospholipid in the 
native environment. Unfortunately, there was no stained band for cardiolipin sample – a minor 
constituent of E. coli cell membrane and also known to influence MscL channel gating (Andrew R. 
Battle et al., 2011) – to help with identification. 
The fourth and fifth bands (Rf = 0.85; 0.91) did not appear to be phospholipids due to their high Rf 
values. The high position suggested that they might be hydrophobic lipids such as triglycerides or 
products of degradation such as free fatty acids (Erdahl et al., 1973; Fuchs et al., 2011), however it 
was difficult to confirm this without reference samples. At this point, free fatty acid was not 
considered likely because there was no strongly-staining band which should have accounted for 
lysolipids (phospholipids with a fatty acid removed). It was also unlikely that there would be 
significant amount of triglyceride in E. coli membrane, or that triglycerides would have significant 
levels of interaction with MscL since it needs interaction with phospholipid bilayer for function. 
Due to the failure of some of the control lanes and the emergence of an additional two bands, the 
previous TLC experiment was repeated. This time stained bands were seen in all references samples 
(Fig. 3.5). There were six bands for the MscL sample in total, with the lowest one (Rf = 0.01) likely 
residual protein (Fig. 3.5C). The second lowest band (Rf = 0.12) matched with one of the bands 
from the DOPC sample (Rf = 0.12), suggesting that it could be lysolipids, one of the products of 
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phospholipid degradation during the MscL purification/extraction steps. Likewise, the bands at the 
top of the TLC plate (Rf = 0.84; 0.95) might be free fatty acids given the similar Rf value to a peak 
in the DOPC sample (Rf = 0.92). 
It was difficult to identify the compound responsible for the third band (Rf = 0.25 – 0.50) due to the 
smear. The band appeared overloaded, and its Rf range was broad enough to overlap with those of 
the main band of DOPC, one of the bands in the E. coli lipid reference sample (likely PG), 
cardiolipin, and β-DDM. While the large load suggested that most of it could be β-DDM, the 
probability of other compounds also being present could not be discounted. 
The fourth band of the MscL sample (Rf = 0.56) matched well with the DOPE sample band (Rf = 
0.57) and the upper band of E. coli lipid sample (Rf = 0.55). The presence of this compound, which 
is likely PE, correlates well with the results from the first and the second TLC experiments, where 
faint bands with matching Rf to PE were also detected. Interestingly, such a band was absent in the 
third trial. There are two possible explanations for this discrepancy: first, as this PE band was very  
 
Figure 3.5. TLC of MscL and reference samples. The numbers next to arrows are Rf values. A) DOPC; B) 
DOPE ; C) MscL (5 mg); D) E. coli lipid (1 mg on the left, 0.5 mg on the right); E) β-DDM ; F) 
Cardiolipin; G) Soy Azolectin (1 mg on the left, 0.5 mg on the right) 
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faint in all other experiments, sample load in the third TLC trial may have been too low to see the 
band with naked eye. The second explanation is that the third band in the third trial was actually PE 
which did not run to the same height as reference DOPE for an unidentified reason. In order to 
validate the two hypotheses, another TLC experiment was performed with a more hydrophilic 
mobile phase used to separate β-DDM from the phospholipids (C:M:W = 10:5:1, Fig. 3.6). 
Although the quality of the chromatogram was too poor for a definitive assessment, it seemed to 
validate the second hypothesis as the main band of MscL lane (Fig. 3.6A) had a similar Rf value 
(0.15) to the PE standard (0.18). 
3.3.1.2. Mass Spectrometry of Isolated Lipid 
As TLC had the limitation of not being able to provide clear identification of the observed band, 
extraction of compounds from the plate was attempted for reverse-phase high performance liquid 
chromatography (RP-HPLC) and mass spectrometry. In order to achieve this, a trial extraction of 
reference phospholipids was carried out. However, the rate of recovery was less than 10 % even for 
the most successful sample (Fig. 3.7) despite copious attempts, making it difficult for mass 
spectrometry to be carried out with the samples. 
In a collaboration with Prof. Stephen Blanksby (Queensland University of Technology, Australia),  
 
Figure 3.6. TLC of MscL and various reference samples. The numbers next to arrows are Rf values. A) 
MscL (3 mg); B) MscL (0.3 mg); C) DOPC; D) DOPE; E) POPG; F) DOPS; G) β-DDM 
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Figure 3.7. TLC of Reference Samples after a round of extraction with Bligh-Dyer method. A) DOPE 
extract; B) DOPC Extract; C) Cardiolipin extract; D) E. coli lipid; E) DOPE (100, 50, 20m and 10 
mg/mL); F) DPPC; G) Cardiolipin 
 
Figure 3.8. Mass spectrometry trace of silica containing MscL sample. A) Scanning mass spectrometry. 
Molecular weight (Mr) of 551 and 426 are too small to be phospholipids. B) Second ESI-MS of the peak 
with Mr of 551. 
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we sought to identify the lipids by mass spectrometry. One of Prof. Blanksby’s MS/MS mass 
spectrometers was set up so that compound extraction from silica matrix was automated and 
coupled to the mass spectrometer, bypassing the need for manual extraction which had not been 
successful. Therefore, mass spectrometry was performed on the fourth TLC band of the MscL 
sample (Rf = 0.56) in the fourth TLC experiment (Fig. 3.5C). A number of compounds were 
detected from the trial run (Fig. 3.8). There were two compounds with significant amount identified 
in the experiment, but their molecular weights were too small to be phospholipids. While 
phospholipids were not positively identified in this trial, it was shown from the abundance of peaks 
that automated compound extraction and mass spectrometry from silica gel was successful. An 
explanation for the failure of this run to conclusively identify a lipid species was the relatively low 
sample load and the age of the sample, which had been stored at -80 °C for eight months. 
3.3.1.3. Discussion 
While this project was not progressed further due to time constraints, it has provided valuable 
information on the relationship between MscL and phospholipids in the native membrane 
environment. First, the presence of native E. coli membrane compounds with strong affinity to 
MscL was confirmed from thin layer chromatography. At least one of them was suspected to be PE 
lipid with reasonable certainty. 
One of the outcomes of the TLC experiments was the confirmation of the hypothesis that some 
phospholipids in the native E. coli cell membrane have high enough affinity for MscL that they co-
purify with the protein. Moreover, it may have a net neutrally charged phosphatidylethanolamine 
(PE) head group, which is present in both E. coli and M. tuberculosis membranes. This is a 
significant difference to M. tuberculosis MscL, which interacts with net negatively charged 
phosphatidylinositol (PI) head group lipids (Zhong & Blount, 2013). M. tuberculosis MscL has an 
altered gating property in the presence of PI, one of the major phospholipid components in M. 
tuberculosis, showing that its MscL had functionally significant interaction with PI. As the E. coli 
equivalent to PI in M. tuberculosis is phosphatidylglycerol (PG), it was predicted that E. coli MscL 
might interact with PG. However, E. coli MscL’s apparent affinity for PE suggested that the two 
homologues may have significant differences in terms of their functional relationship with 
phospholipids. 
The apparent difference in phospholipid affinity between E. coli and M. tuberculosis MscL may be 
due to the sequence variation in the residues thought to interact with phospholipid head groups. The 
sequence is especially poorly conserved on the periplasmic side formed by the TM1/TM2 
interhelical loop between the two species (Fig. 1.10). E. coli MscL contains three aspartate residues 
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in this region, and the large number of negative charges may have resulted in the repulsion of 
negatively charged head groups (e.g. PG) in favour of neutral ones (e.g. PE). On the other hand, M. 
tuberculosis MscL has only one aspartate in the equivalent region, making it more receptive to 
negatively charged head groups (e.g. PI), although it would not necessarily lead to strong affinity 
for anionic lipids either (Elmore & Dougherty, 2003; Powl et al., 2003). 
The two MscL homologues’ differing phospholipid preference likely has a functional significance. 
Anionic lipids favour the open conformation and net neutral phospholipids have stabilising effect 
on the closed conformation of both E. coli and M. tuberculosis MscL (Powl et al., 2008a; Zhong & 
Blount, 2013). The TLC experiments in this section suggest that E. coli MscL has been evolved for 
increased affinity to PE, in which MscL has a higher gating threshold than even PC, another 
zwitterionic lipid (Powl et al., 2008a). This in turn suggests the preference for a higher gating 
threshold and reduced pore size in E. coli. On the other hand, M. tuberculosis MscL has evolved in 
an opposite direction to require PI for lowered channel gating threshold. 
While this appears to be divergent evolution at first glance, it can actually be explained as a case of 
convergent evolution. In a neutral phospholipid environment consisting mainly of PC and PE head 
groups, E. coli MscL’s pressure threshold is already well within a physiologically relevant range 
(i.e. low enough to be induced by hyposmotic environment) in neutral phospholipid environment 
(Zhong & Blount, 2013). Given the redundancy of protective channels for hyposmotic shock 
(Martinac et al., 2014), it would have been preferable for E. coli MscL to have higher gating 
threshold to reduce the collateral damage it can cause through the large channel pore, and this could 
have been facilitated by increased affinity for PE, the predominant a neutral phospholipid in the 
membrane. On the other hand, M. tuberculosis MscL has a pressure threshold that is too high to be 
useful as an osmotic emergency valve in neutral phospholipid environment. Hence, lowering the 
threshold to achieve a similar gating profile to E. coli MscL would have been necessary for M. 
tuberculosis MscL, and this could have been facilitated by increased affinity to PI (Zhong & 
Blount, 2013). 
E. coli MscL’s high affinity for PE is somewhat unusual from a structural perspective. Unlike 
MscS, which has phospholipid-sensing clefts between the transmembrane and cytoplasmic domains 
(Pliotas et al., 2015), MscL is a much smaller protein lacking pockets for high-affinity binding. 
However, E. coli MscL’s affinity for certain phospholipids, likely PE, has been observed in this 
study, and there is also an anecdotal observation of MscL resisting separation from β-DDM in mass 
spectrometry by Dr. Armagen Koçer (Konijnenberg et al., 2014). These indicate that MscL is 
capable of strong interaction with phospholipids and lipid-like molecules. 
One explanation for this is that MscL structure in the native phospholipid environment is more fluid 
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than is commonly accepted. Currently most structural studies (Corry et al., 2010; Deplazes et al., 
2012; Gullingsrud & Schulten, 2003; Meyer et al., 2006; Perozo, Cortes, et al., 2002; Sawada et al., 
2012) are based on the crystal structure of M. tuberculosis MscL (G. Chang et al., 1998), which has 
a compact and symmetric structure. However, MscL as a protein is dynamic enough that a 
significant proportion may exist as monomers in vivo (Hase, Minchin, et al., 1997), and S. aureus 
MscL has been shown to switch between tetrameric and pentameric states depending on the 
detergent used (Dorwart et al., 2010). Hence, unlike in crystal structures, MscL in a bilayer 
environment may exist in a more fluid state with an increased surface area available for stronger 
interaction with phospholipids. 
While this section of the chapter was not progressed further, this has provided enough results to 
suggest further investigation is warranted. More specifically, additional TLC experiments and mass 
spectrometry can be reasonably expected to yield sufficient data for a publication similar to Pliotas 
et al. (2015) that identifies native phospholipids co-purifying with MscL. The main challenges lie in 
obtaining enough high purity MscL (and hence associating phospholipids) and successfully 
extracting the phospholipids. It is likely that the inconclusive result from the mass spectrometry 
experiment in this section are due to the poor recovery of lipids from the TLC silica. One of the 
methods in discussion at the time of writing this thesis was to perform the extraction in situ on the 
mass spectrometry equipment. This would in theory bypass the loss of lipids from manual 
extraction and handling, not only increasing the efficiency of extraction but also resulting in more 
pure samples. With this thesis having provided exciting preliminary data and directions for future 
experiments, this strategy has the potential to more conclusively identify phospholipids interacting 
with MscL. 
3.3.2. MscL Behaviour in a Mixed Liposomal Environment 
The main objective of this experiment was to study the difference in function and other properties 
of MscL in various liposomal environments. This was based on the hypothesis that liposomes 
formed from a heterogeneous mix of phospholipids would be varied in both composition and size, 
which would provide a quick and affordable way to test a range of variables for their influence on 
MscL function and other properties. With the identification of membrane lipids preferentially 
associating with MscL (Section 3.3.1.), one of the aims of this experiments was to see if MscL 
would also show a preferential incorporation to certain liposomes/phospholipid membranes, and if 
MscL channel function would be affected by such environments.   
The proteoliposomes were produced from soy azolectin in this section for two reasons. First, a 
number of publications previously used soy azolectin to study the biophysical properties not only of 
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MscL (Chi et al., 2015; A. Foo et al., 2015; Kocer, 2015; Powl et al., 2008a; Yoshimura et al., 
2008; Zhong & Blount, 2013) but also of other mechanosensitive channels (Coste et al., 2012; Liao 
et al., 2013; Petrov et al., 2013). Therefore, using the same lipid environment would enable a more 
direct comparison of the data to previously published work. In addition, soy azolectin consists 
mostly of PC, which is the most commonly used phospholipid in MscL studies (Abdine et al., 2012; 
Grage et al., 2011; Iscla et al., 2013; Konijnenberg et al., 2014), and PE, which is suspected of 
associating with E. coli MscL (section 3.3.1.). The protocols for producing MscL/soy azolectin 
proteoliposomes and size-fractionation of the liposomes with sucrose gradient had already been 
largely established using soy azolectin by Dr. Alexander Foo (IMB) prior to the commencement of 
this project (Alexander Foo, 2014). Cost was also a consideration here since the costs of working 
with pure lipids was between 200 and 2,000 times more expensive, potentially reducing the scope 
and replicate of possible experiments that could be performed for a comparable cost. 
Size fractionation by sucrose gradient was used as the main method of separating the liposomes by 
a primary variable (liposome size), which would in turn encompass underlying variables such as 
membrane curvature and phospholipid composition. The effect of varying protein-to-lipid (P:L) 
ratio was also visualised with carboxyfluorescein reporter molecules in this step. Dynamic light 
scattering was used to measure size and size distribution of the liposomes, which were indirect 
markers for the membrane curvature (a major potential influence on MscL function), and the trend 
was confirmed with electron microscopy. MscL distribution within and between the 
proteoliposomes was visualised by electron microscopy, which provided insights to the channel 
aggregation pattern. Lipid mass spectrometry was carried out in collaboration with Prof. Stephen 
Blanksby (QUT, Australia) to analyse phospholipid composition in each fraction and to study its 
potential effect on MscL incorporation and behaviour, which was a continuation of the experiments 
in section 3.3.1. and 3.3.3. Fluorescence-based cargo release assay was also performed to study 
MscL channel gating properties in these environments, but they were not included in the result 
section as these were primarily performed by Dr. Alexander Foo as part of his thesis (Alexander 
Foo, 2014). The results are discussed in section 3.3.2.1. as part of a wider discussion on the 
influence of the studied variables on MscL function. 
3.3.2.1. Size-based Fractionation of MscL Proteoliposome by Sucrose Gradient 
 Sucrose gradients were performed on MscL/soy azolectin proteoliposome samples of P:L ratios of 
1:40 and 1:10 (Fig. 3.9), and two main differences emerged between them. Compared to the 
negative control (Fig. 3.9A), there were additional orange-coloured bands in proteoliposome 
samples (Fig. 3.9B, C). Carboxyfluorescein is a self-quenching fluorescent dye, with its absorption 
wavelength of 495 nm giving it an orange-colour at high concentration and its fluorescent emission 
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maximum at 517 nm wavelength giving it a yellow-green colour at low concentration. The faint 
orange colours of the bands indicated that carboxyfluorescein in the fractions was mostly contained 
within liposomes with little leakage. In the 1:10 (P:L) sample, however, there was a yellow smear 
across the entire gradient, indicating that some of the liposomes burst and released 
carboxyfluorescein as they travelled down the gradient. 
The migration pattern of bands within the sucrose gradient was influenced by the P:L reconstitution 
ratio. For example at a P:L ratio of 1:40 (Fig. 3.9B), the two main bands appeared in the upper half 
of the sucrose gradient, but all three bands were located in the bottom half of the 1:10 sample (Fig. 
3.9C). Generally, larger species migrate further down a sucrose gradient in experiments of this type, 
however, the migration patterns may have possibly been influenced by the higher MscL 
concentrations in the liposomes in the 1:10 sample. Since proteins are denser than lipids, increasing 
the amount of MscL in the liposomes would be expected to increase the overall density. Moreover, 
as the liposomes travelled down the gradient, fractionation over a wider range of sucrose gradient 
fractions would have made them better separated. This is probably responsible for the separation of 
two bands at fractions 10 and 12 in the 1:10 sample (Fig. 3.9C), which may not be adequately 
  
Figure 3.9. Fractionation of MscL/Soy azolectin proteoliposome. A) Control tube with only soy azolectin. 
There are two orange-coloured bands. B) Proteoliposome with P:L of 1:40. Three bands can be seen. C) 
Proteoliposome with P:L of 1:10. Four bands can be seen. Fractions were collected from this tube and 
labelled according to their fraction locations. 
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separated in the 1:40 sample. 
3.3.2.2. Electron Microscopy of Fractionated Liposomes 
Proteoliposomes in each fraction were analysed by negative stain electron microscopy to visually 
identify their characteristics (Fig. 3.10 – 3.13). Negative stain EM has several advantages over cryo-
EM in this experiment. First, much less optimisation is required for negative stain EM compared to 
cryo-EM. Second, negative stain EM allows screening larger area in shorter time than cryo-EM, 
which is beneficial not only for the high throughput required in semi-quantitative analysis but also 
for reducing sampling bias by viewing more liposomes than cryo-EM would allow. 
His-MscL was labelled with Ni-NTA-Nanogold prior to negative staining to aid with its 
visualisation. The top fraction (Fraction 1) mostly contained liposomes of varying sizes, many of 
them between 200 nm and 400 nm in diameter (Fig. 3.10). There were few Nanogold particles 
throughout the micrographs, indicating that these liposomes did not contain MscL. The appearance 
of these liposomes despite their relatively large size suggests that the change in density by the 
presence of either protein and/or lipid composition of the liposomes was having a greater influence 
on the liposome sedimentation than the size. 
Fractions 2, 3, and 4 were extracted from a region of the sucrose gradient that featured intense 
yellow colour. These contained a mix of small liposomes of less than 50 nm in size and lipid 
agglomerates of less than 10 nm in size (Fig. 3.10, 3.11). While most liposomes did not associate 
with Nanogold, the few which did had relatively large numbers of Nanogold particles bound. This 
suggests that MscL incorporated with high efficiency into some liposomes but not at all into others. 
The two possible explanations, not necessarily exclusive of each other, were that 1) the liposomes 
had high variability in their phospholipid composition, some of which MscL preferentially 
incorporated into; and that 2) MscL particles showed strong clustering patterns in the liposomes 
they incorporated into. As these particles were still significantly larger than the size of 
MscL/detergent micelles (approx. 10 nm), they were unlikely to be unincorporated MscL. 
Interestingly, fractions 2 and 4 contained both liposomes and small lipid globules, whereas only 
lipid aggregates were visible in fraction 3. In addition, the lipid globules could be seen throughout 
the micrographs in fractions 3 and 4, but their density was not as high in the micrographs of fraction 
2. This suggested that, on average, the sedimentation rate of the lipid globules was roughly equal to 
the sucrose concentration at fraction 3. Fraction 2 was likely at the transition interface between 
large liposomes (fraction 1) and small lipid agglomerates (fraction 3), hence featuring small 
liposomes. Likewise, fraction 4 would have been at the transition or overlap between lipid  
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Figure 3.10. Electron micrographs of proteoliposome fractions from sucrose gradient. The numbers in the 
top left corner represent the fraction number (Fig. 3.9). The black dots are Nanogold particles with His-tags, 
presumably bound to His-MscL. 
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Figure 3.11. Electron micrographs of proteoliposome fractions from sucrose gradient. The numbers in 
the top left corner represent the fraction number (Fig. 3.9) 
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Figure 3.12. Electron micrographs of proteoliposome fractions from sucrose gradient. The numbers in 
the top left corner represent the fraction number (Fig. 3.9) 
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agglomerates and small proteoliposomes. 
Although fractions 5, 6, 7, and 8 were all located in the part of the sucrose gradient with weak 
carboxyfluorescein intensity, the liposome profiles recorded by EM were considerably different 
(Fig. 3.11, 3.12). There was no visible lipid particle or Nanogold in fraction 5. In contrast, fractions 
6, 7, and 8 contained small liposomes of 50 nm to 100 nm in diameter. The average liposome size 
appeared to increase with increasing sucrose concentration (i.e. lower fractions in the gradient). 
While the majority of liposomes did not associate with Nanogold, a small but a significant 
proportion contained Nanogold clusters of 5 – 10 particles. While this was similar to fractions 2 and 
4, due to the larger liposome size, it could be clearly seen in these fractions that the Nanogold 
particles (by extension MscL molecules) were forming clusters instead of being randomly 
Figure 3.13. Electron micrographs of proteoliposome fractions from sucrose gradient. The numbers in 
the top left corner represent the fraction number (Fig. 3.9) 
84 
 
distributed throughout the liposome. 
Fraction 7 differed from 6 and 8 in that it was also populated by aggregated liposomes with highly 
variable sizes (100 nm to 500 nm). A few of them contained small Nanogold clusters, but most did 
not associate with any Nanogold despite the large surface area, indicating that MscL incorporation 
into them was poor. 
A faint orange band about two thirds of the way down the sucrose gradient was separated into the 
upper (fraction 9) and lower (fraction 10) portions (Fig. 3.12). Although the two fractions were 
from the same band, the liposome morphology was significantly different between them. Whereas 
intact liposomes populated fraction 9 micrographs, fraction 10 mostly featured flat phospholipid 
bilayers with irregular edges. However, the sizes of these structures were similar (200 nm – 500 
nm). In both fractions, Nanogold particles appeared largely randomly distributed, with only minor 
signs of clustering along the curved edge/grooves of the liposomes. These indicated that, despite the 
different appearance of the liposomes, they were still composed of similar species of phospholipid. 
In addition, the different MscL clustering pattern between fractions 6 – 8 and 9 – 10 suggested that 
the membrane environment for MscL was different between the two groups.  
In fractions 12 and 13, which accounted for the large opaque band in the bottom quarter of the 
gradient, both the liposome size and MscL clustering pattern were significantly different (Fig. 3.13). 
The liposomes were variable in size (200 – 500 nm), often formed aggregates, and were positively 
stained instead of negative stains. There was also little sign of MscL clustering, with singular 
Nanogold particles randomly distributed on the liposomes. The further shift away from the MscL’s 
propensity to aggregate indicated that the hypothesised cluster-inducing factor was further 
weakened in these liposomes. 
Fraction 14, which contained an opaque precipitate at the bottom of the tube, mostly featured a 
mixture of large unstructured lipid and liposomes of various sizes and shapes. This indicated that 
the precipitate consisted of phospholipids which did not form liposomes and those which are 
heavier than the highest density provided by this sucrose gradient. There were few Nanogold 
particles throughout the micrograph, which suggested that MscL would not incorporate into these 
non-bilayer-forming lipid masses. 
A semiquantitative analysis on the clustering pattern was carried out on fractions 1, 4, 6, and 13 to 
find if the observations made with the images could be quantified (Table 3.2).  The Nanogold 
particle distribution and liposome diameter were manually measured due to the gradient staining of 
liposomes making the automated method described in 3.2.3.3. inaccurate for images for fraction 13. 
From these experiments, two trends were observed. First, the average liposome size, especially 
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those with Nangold-tagged MscL, generally increased down the sucrose gradient, with the notable 
exception of Fraction 1. This suggests that the sucrose gradient successfully separated the  
proteoliposomes according to their sizes as expected. Dynamic light scattering was performed in a 
follow-up experiment to confirm this observed trend. 
Second, MscL’s propensity to form clusters gradually decreased down the gradient, with MscL in 
fractions 2 – 8 showing the highest level of clustering and those in fractions 12 – 13 being largely 
monodispersed. At this stage, this could be explained by either the membrane curvature or lipid 
composition of the liposomes in each fraction influencing the clustering of MscL. To test the two 
hypotheses, lipid mass spectrometry was carried out to study the lipid composition of each fraction. 
3.3.2.3. Liposome Size Measurement with Dynamic Light Scattering 
 The liposome samples were additionally assessed by dynamic light scattering with the assistance of 
Dr. Alexander Foo (Table 3.3) in order to quantitatively confirm the liposome size trend observed 
with electron microscopy. The overall trend in liposome size distribution throughout the gradient 
was consistent with what was observed by electron microscopy (Fig. 3.10 – 3.13). The liposome 
size decreased from fraction 1 to fraction 4, and then trended upward from fraction 4 to fraction 14. 
The aggregation observed in fractions by electron microscopy was consistent with the higher 
polydispersity index in this fraction, which was the highest of all fractions analysed by dynamic 
light scattering. 
Table 3.2. Average Liposome Size and MscL Clustering Size Estimated from Electron 
Microscopy Images 
Fraction 1 4 6 13 
Total Liposomes 21 17 17 18 
Mean Diameter (nm) 259 50 56 164 
Standard Deviation (nm) 36 21 18 78 
Standard Error (nm) 8 5 4 18 
Liposomes with Nanogold-tagged MscL 0 5 2 14 
Mean Diameter (nm) N/A 66 96 112 
Standard Deviation (nm) N/A 12 9 44 
Standard Error (nm) N/A 5 4 20 
Mean Nanogold-tagged MscL Cluster Size 0 9.8 5.0 1.4 
Standard Deviation N/A 7.4 5.7 0.9 
Standard Error  2.0 2.0 0.1 
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 The key difference between the light scattering data and the observations by negative-stained  
electron microscopy was that all fractions had average liposome sizes between 100 nm and 200 nm 
when measured by dynamic light scattering. This was in contrast with the electron microscopy 
where the average size varied from less than 50 nm in fraction 2 to over 300 nm in fraction 14. This 
discrepancy might be due to the interference with dynamic light scattering by carboxyfluorescein, 
which had been added to the liposome sample for band visualisation in sucrose gradient and 
potentially for follow-up experiments such as cargo release assay and total liposome volume 
analysis. Its emission spectrum ranges from approximately 450 nm to 650 nm, which overlaps with 
the wavelengths of the equipment’s both primary (633 nm) and secondary (532 nm) lasers. As it 
was not equipped with an optical filter to remove this interference, carboxyfluorescein could have 
been a significant source of background light level. While this would introduce a degree of 
inaccuracy to the data, it would not affect the observed trend as the same bias would be present 
across all samples.  
3.3.2.4.  Mass Spectrometry of Sucrose Gradient Fractionated Liposomes 
 Mass spectrometry was used to determine the phospholipid composition of the fractionated 
liposomes (Fig. 3.S1 – 3.S9; see section 3.6). Experiments were carried out in collaboration with 
Prof. Stephen Blanksby (QUT). Fractions 2 to 12 were scanned for the presence of 
phosphatidylcholines (PC), phosphatidylethanolamines (PE), and phosphatidylinositols (PI). 
Table 3.3. Average Liposome Diameter Measured by Dynamic Light Scattering Equipment  
Sample Number 
Average Diameter (nm) 
Polydispersity Index 
Mean Mode 
1 141 147 0.03 
2 114 124 0.09 
4 90 106 0.13 
6 102 120 0.14 
8 136 150 0.07 
10 140 147 0.03 
12 156 158 0.09 
14 188 191 0.19 
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Across all fractions, PC was the most abundant phospholipid, followed by PE and PI respectively 
(Fig. 3.14). This is not unexpected since PC and PE are the most abundant phospholipids in soy 
azolectin. Their roughly even ratios across the fractions suggested that the phospholipid head  
groups did not have significant influence on the liposome size. By extension, this also indicated that 
MscL clustering was not directly dependent on the phospholipid head groups. 
Unlike the head groups, there was a considerable variation in the tail group composition between 
fractions. In fractions 2 and 3, there were a wide range of fatty acid tail groups for all three 
phospholipids (Fig. 3.S1, 3.S4, 3.S7). There was a roughly even distribution of phospholipids with 
34 and 36 carbon atoms in the tail group, with significant amounts of PC and PI with 38 carbon 
atoms as well (Table 3.4). 
Phospholipid profiles of fractions 4 – 12 were similar for all three lipid head groups (Table 34). The 
tail groups were less heterogeneous than in fractions 2 and 3, with most containing 34 and 36 
carbons. With PE, there were roughly even ratios of 34 and 36-carbon tail groups; with PC, there 
were more 36-carbon tail groups than 34-carbon; and with PI, there were more 34-carbon tail 
groups than 36-carbon (Table 3.4). Given the significant difference in MscL clustering patterns of 
fractions 4 – 8, 9 – 10, and 12 – 13, it appeared that the tail groups of these phospholipids were not 
main determinants either. From these results, it was concluded that lipid composition were similar 
across fractions, making this variable unlikely to be responsible for differential MscL clustering 
observed between fractions. 
 
Figure 3.14. Relative abundance of phospholipid head groups estimated from mass spectrometry. Note 
that quantity estimation from mass spectrometry data has a large margin of error. 
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3.3.2.5. Discussion 
The main aim of this experiment was to investigate the potential influence of phospholipid bilayer 
environment on MscL function. This experiment was carried out in conjunction with a related  
project by Dr. Alexander Foo (IMB), where the relationship between liposome size and MscL 
channel gating properties was investigated. 
 While there was a clear relationship between the liposome size and MscL clustering pattern, 
phospholipid composition did not appear to be the underlying factor. Liposomes of all sizes 
consisted mainly of 34 and 36-carbon tail group phospholipids, and the ratios of PE, PC, and PI 
head groups were also similar. While fractions 2 and 3 were exceptions with the presence of 38-
carbon tail group phospholipids, it is likely that the long-chain phospholipids formed lipid globules 
seen in the electron micrograph rather than liposomes. These observations are unlikely to be 
artefacts of high protein to lipid ratio, since mass-to-mass protein-to-lipid ratio of 1:10 represents a 
molar ratio of approximately 1:1000. 
 Taken together, these observations have major implications for understanding MscL function in 
that membrane is a major influence on its channel gating properties and clustering pattern. The mass 
spectrometry results indicated that the phospholipid composition was similar across the fractions, 
leaving intrinsic membrane curvature as the main plausible explanation for differences observed in 
MscL clustering. There is a similar precedent with a voltage-gated potassium channel (KvAP),  
Table 3.4. The relative abundance of each phospholipid with 34-carbon hydrophobic tails 
compared to those with 36-carbon hydrophobic tails. The ratio for PI is less accurate than PC or 
PE because there were generally less of them in all fractions. 
Fraction 
Ratio of Tail Length Abundance (34/36) 
PC PE PI Total 
2 1.45 2.00 1.91 1.58 
3 1.26 2.53 1.31 1.45 
4 0.59 0.89 5.54 0.72 
5 0.61 1.01 2.73 0.79 
8 0.58 0.90 4.94 0.72 
9 0.55 0.97 4.24 0.72 
10 0.61 0.98 3.25 0.78 
11 0.58 1.07 2.55 0.80 
12 0.65 1.07 2.76 0.83 
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where global curvature of membrane was shown to directly induce protein clustering without 
secondary factors such as phospholipid composition (Aimon et al., 2014). 
The MscL channel gating function also appears affected by the liposome size (Fig. 3.15), hence 
potentially by membrane curvature. Recently, a cargo release assay was developed in which MscL’s  
sensitivity to the concentration of lysophosphatidylcholines (LPC), which induces membrane stress, 
could be used as an indirect measure of its channel gating threshold (A. Foo et al., 2015). 
Carboxyfluorescein efflux from small liposomes was generally higher than larger liposomes, which 
could be explained by the reduce channel gating threshold of MscL (Dr. Alexander Foo, 
unpublished) (Fig. 3.15). The mass spectrometry result confirms that this relationship is primarily 
due to the membrane curvature rather than phospholipid composition. It was predicted with 
molecular dynamics simulations that curvature at global level such as that of small liposomes could 
affect MscL channel gating threshold (Meyer et al., 2006), followed by more in-depth discussion 
with mathematical analyses and further simulations recently (Bavi, Cox, et al., 2016; Bavi et al., 
2014). However, due to the practical limitation of performing patch clamp experiments on small 
liposomes, it was difficult to experimentally confirm this. By measuring a different but related 
parameter (sensitivity to LPC) to patch clamp (physical pressure across the membrane), the cargo 
release assay provided an alternative way of confirming the hypothesis. 
This experiment to the best of my knowledge is the first to document the influence of membrane 
curvature on MscL clustering. It was shown from the electron microscopy experiments that MscL 
tends to cluster in smaller liposomes but not in larger ones (i.e. MscL’s clustering tendency and 
 
Figure 3.15. MscL channel activation sensitivity to LPC calculated by the percentage cargo release at 0.05 
mM LPC (12:0) divided by cargo release at 0.5 mM LPC (12:0). The P:L ratio of the proteoliposome 
sample used in this experiment was 1:100. 
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liposome size are inversely correlated). Since there is little variance in lipid composition between 
the fractions, it can be concluded that the clustering may be mediated by increased curvature of 
smaller liposomes. Previously, the effect of membrane curvature on MscL channel gating function 
was studied only in the context of the stress acting on singular channels (Meyer et al., 2006; Tang et 
al., 2008a; Zhu et al., 2016) although MscL gating threshold had been reported to be affected by 
clustering (Grage et al., 2011). A recent study investigated whether membrane curvature influences 
MscL aggregation in silico, but this was found to have a negligible effect (Bavi, Vossoughi, et al., 
2016). In contrast to this, the results presented here clearly indicate that clustering of MscL is 
dependent on liposome size, suggesting that intrinsic membrane curvature may indeed influence the 
propensity of MscL to aggregate. 
MscL clustering in the membranes of small liposomes may be the result of energetic factors. The 
lowered channel gating threshold postulated for MscL in small liposomes might reflect an 
energetically less stable system, which has been confirmed in molecular dynamics studies (Bavi, 
Cox, et al., 2016; Bavi et al., 2014). In such small liposomes, aggregation of MscL may become 
energetically favourable. Generally, protein aggregation can theoretically confer increased energetic 
stability in certain conditions (Patro & Przybycien, 1996). Combined molecular dynamics and patch 
clamp experiment have suggested that the clustering of MscL positively correlates with an 
increased channel gating threshold (Grage et al., 2011), confirming increased energetic stability in 
such environments. Therefore, the clustering of MscL particles might have partially compensated 
for the reduced energetic stability induced by membrane curvature. This phenomenon has also been 
experimentally observed with MscS, where MscL-induced clustering increased the membrane 
tension required for its activation, suggesting increased stability of the closed-state conformation 
(Nomura et al., 2012). 
A relationship between membrane protein function and membrane curvature has been documented 
with other proteins as well  (Davies et al., 2012; Draper & Liphardt, 2017; Hahn et al., 2016; Jiko et 
al., 2015; Pliotas et al., 2015). Some membrane proteins such as chemoreceptors tend to passively 
cluster on the curved edges of membranes due to the energetic favourability (Draper & Liphardt, 
2017) whereas in others such as MscS (Pliotas et al., 2015) and ATP synthases (Daum et al., 2013; 
Davies et al., 2012; Dudkina et al., 2005; Hahn et al., 2016) the proteins actively induce localised 
membrane curvature, which can then lead to higher global curvature and clustering in the case of 
the latter. Molecular dynamics simulations have shown MscL capable of inducing local curvature as 
well (Bavi, Vossoughi, et al., 2016), so an interesting area of future study would be to identify if 
MscL indeed has an active role in influencing membrane curvature and how this affects its 
clustering pattern and function.. 
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Experiments performed in this chapter could be improved with better statistical models. While the 
results clearly demonstrate curvature-induced clustering of MscL, the analysis was semi-
quantitative and there are uncontrolled variables which need to be measured in case they influenced 
the clustering behaviour. One such variables was phospholipid composition, which was studied by 
mass spectrometry in this chapter (section 3.3.2.4.) and confirmed not to be an influence, however 
there could still be other variables such as local protein-to-lipid ratio in liposomes with proteins 
only. While protein-to-lipid ratio is unlikely to be a factor as previously stated in this section, a 
measurement would have been helpful. Unfortunately, no experimental method was available at the 
time of writing that would allow MscL clustering to be quantitatively measured to the standard 
required for this thesis, although establishing a method to overcome this issue might be possible in 
the future. 
This property of membrane curvature-induced MscL clustering has implications in the development 
of MscL as a nanovalve for liposomal drug delivery system. Two of the challenges in this regard 
were that 1) the channel gating threshold of wild type MscL is too high to open the pore with 
external force only (Nakayama et al., 2015), and 2) liposomes for drug delivery systems need to be 
smaller than 200 nm to be able to filter through physiological barriers such as blood vessels (Sawant 
& Torchilin, 2012). Reducing the average size of liposomes will have the dual benefit of poising 
MscL channels to be more receptive to external triggers, improving its prospect as a nanovalve 
candidate. However, the propensity of MscL to self-associate in small liposomes prevents even 
incorporation of nanovalves across liposome surface, which would lead to mix populations of drug-
carrying liposomes with large numbers of clustered MscL and those without MscL. One potential 
solution to this is using phospholipids (or a mixture of phospholipids) which do not cause MscL 
clustering in liposome production. The influence of phospholipids on MscL clustering was 
investigated and detailed in the next section. 
3.3.3. MscL Distribution Pattern in Pure and Mixed Phospholipid Environments 
The main aim of this experiment was to study the relationship between MscL and phospholipids 
with respect to its clustering pattern. It was previously shown that MscL forms clusters in 
membranes consisting solely of DOPC (Grage et al., 2011) and even crystallises in this 
environment (Saint et al., 1998). However, there is limited information on the influence of 
phospholipids on MscL clustering beyond this. Therefore, this aspect of MscL channel function was 
explored by visualising the Nanogold-tagged proteins with electron microscopy. 
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3.3.3.1. Electron Microscopy of Negatively Stained Liposomes 
His-MscL was reconstituted into pure lipid liposomes using the protocol optimised for MscL 
crystallisation attempts described in section 4.3.1. In the first attempt, DOPC and E. coli lipid  
(heterogeneous phospholipid mixture) were used to replicate the result described by Grage et al. 
(Grage et al., 2011). 
 A large number of Nanogold-tagged MscL molecules in E. coli lipid liposomes contained large 
aggregates. While MscL did not form large clusters, they were not completely randomly distributed 
either. It appeared that the proteins would often localise to the curved edges of the liposomes. It is 
possible that this is a genuine feature of E. coli lipid liposomes, but it is more likely that this is an 
artefact of negative staining process. While liposomes are approximately spherical/ovoid in 
solution, the negative staining process flattens the liposomes and creates local curvature along the 
edges where the flattened liposome surfaces fold. Once the flat and curved interfaces form on the 
membrane, MscL would tend to form small clusters at the curved edges due to the effect discussed 
in section 3.3.2. On the other hand, monodisperse MscL particles have sufficient kinetic energy to 
diffuse away from the curved edges, hence leading to most Nanogold-tagged MscL particles still 
remaining on the flat surface. 
Along the liposomal edges, the proteins were partially clustered, with both small clusters and single 
particles present (Fig. 3.16). On the flattened area of the liposomal membrane, there were 
occasionally singular MscL particles, but clusters were not observed. This result was in conflict 
with Grage et al. (Grage et al., 2011), where MscL aggregation in E. coli spheroplasts was observed  
  
Figure 3.16. Electron micrographs (A, B) of Nanogold-tagged MscL in E. coli lipid liposome 
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by confocal fluorescence microscopy, but in agreement with another publication (Romantsov et al., 
2010) where MscL showed an even distribution across E. coli membrane in vivo. 
Additionally, it appeared that the rate of MscL incorporation was relatively high. Aggregated 
liposomes often had patches of very deeply-stained regions where very few features could be seen. 
The electron micrographs also became blurry when viewing these regions as if the focus had 
suddenly been lost. This is thought to be due to the large number of Ni-NTA-Nanogold particles 
bound to the membrane. Since the Nanogold particles carry Ni+ ions, having a very large number of 
them has the potential to distort the electron beam. As the liposome aggregates offered large 
membrane surface areas, MscL molecules, hence Ni-NTA-Nanogold particles, could be stacked in 
high enough concentration to significantly alter the course of incident electrons in random  
 directions and make the images appear unfocused. As this phenomenon was observed and 
replicated only with E. coli lipid samples, it was determined to be a qualitative confirmation of the 
influence of phospholipid on MscL incorporation observed by Grage et al. (Grage et al., 2011). 
 In contrast, MscL formed large clusters of up to hundreds of particles in DOPC liposomes (Fig. 
3.17). There were few single particles, and their levels were similar to the background. Similar to 
the E. coli lipid sample, the clusters were usually located at the edges or aggregating surfaces of 
liposomes, further confirming this localisation as an artefact of negative staining. This also 
confirmed the MscL clustering in DOPC liposomes reported by Grage et al. (Grage et al., 2011). 
Since MscL molecules showed a very distinct pattern of clustering in DOPC and did not pose the 
challenge with electron microscopy which it did in E. coli lipid. MscL/DOPC proteoliposome  
  
Figure 3.17. Electron micrographs (A, B) of Nanogold-tagged MscL in DOPC liposome 
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samples were prepared in all subsequent experiments as reference samples to check if the results 
were consistent between trials. 
 In the second trial, a wider range of phospholipids were screened for MscL clustering, mainly with 
respect to the head groups. MscL formed large clusters in DOPC samples, and were roughly 
randomly distributed with minor clustering along the liposomal edges in E. coli lipid samples (Fig. 
3.18). Both of these observations are identical to the results in the first trial. 
As pure DOPE does not form liposomes, its influence on MscL clustering pattern was studied via 
mixed DOPC/DOPE liposomes. In samples with the DOPC:DOPE ratios of 3:1 and 1:1, Nanogold-
tagged MscL appeared to cluster in a similar pattern to pure DOPC liposomes (Fig. 3.19A-D). In 
samples with the DOPC:DOPE ratio of 1:3 and pure DOPE lipid, liposomes did not form and no  
 
Figure 3.18. Electron micrographs of Nanogold-tagged MscL in DOPC (A, B) and E. coli lipid (C, D) 
liposomes. 
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   Figure 3.19. Electron micrographs of Nanogold-tagged MscL in mixed DOPC/DOPE liposomes at 
ratios of 3:1 (A, B) and 1:1 (C, D), and DOPC/cardiolipin liposomes at the ratio of 1:1 (E, F). 
96 
 
image could be taken. There were two explanations for the MscL clustering in the DOPC/DOPE  
mixed liposome. First, DOPE might have little influence on MscL aggregation or even have a 
positive influence (hence reinforcing MscL’s tendency to cluster in DOPC). The latter was possible 
since MscL appeared to form even larger clusters in liposomes with the DOPC:DOPE ratio of 1:1 
than in 3:1. The second explanation was that the pro-clustering influence of DOPC could be 
overwhelming DOPE’s negative influence. This hypothesis could not be experimentally tested in 
this trial because pure DOPE liposomes could not be produced. 
Likewise, cardiolipin (18:1) appeared to have little influence on MscL clustering, as the large 
clusters similar to those in pure DOPC liposomes were seen in the sample with the 
DOPC:cardiolipin ratio of 1:1 (Fig. 3.19E-F). For an unknown reason, the sample with 
DOPC:cardiolipin ratio of 3:1 did not produce liposomes. 
MscL proteoliposome formation was attempted with DOPC/DPPC mixed lipids in order to test if 
hydrophobic tails had any influence on MscL clustering. However, liposomes did not form, likely 
due to the high transition temperature of DPPC, which has saturated fatty acid tails. The transition 
of DPPC’s state from gel (i.e. solid) phase to liquid crystalline (i.e. fluid) phase occurs at the 
temperature range of 42 – 52 °C, and significant changes to its ability to form phospholipid bilayers 
occurs in this range (Leonenko et al., 2004). However, the liposomes were prepared at room 
temperature (22 °C), which would have kept DPPC firmly in the gel phase and prevent liposome 
formation. Since it was practically impossible to repeat this experiment at 55 °C, which would not 
only introduce temperature as a major confounding factor but also risk heat denaturation of MscL, 
this condition was not further pursued in the subsequent trials. 
Figure 3.20. Electron micrographs of Nanogold-tagged MscL in DOPC (A) and E. coli lipid (B) liposomes. 
High level of background Nanogold can be seen in the bottom corners of both images. 
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Figure 3.21. Electron micrographs of Nanogold-tagged MscL in pure POPC liposomes (A), DMPC  
liposomes (B),  mixed DOPC/DMPC liposomes at ratios of 2:1 (C) and 1:1 (D), and DOPC/POPC liposomes 
at the ratios of 2:1 (E) and 1:1 (F). 
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Figure 3.22. Left – Electron micrographs of Nanogold-tagged MscL in mixed DOPC/E. coli liposomes 
at the ratios of 1:3 (A), 1:1 (C), and 3:1 (E). Right – Electron micrographs of Nanogold only (B), 
Nanogold and MscL (D), and Nanogold and bovine serum albumin (F). 
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In the third trial, a range of phospholipid tail groups were screened for MscL clustering. 
Unfortunately, using a new batch of Nanogold led to a very high background level of Nanogold, 
making it difficult to properly analyse the micrographs (Fig. 3.20). As a result, MscL clustering 
pattern could not be identified in DOPC/DOPE mixed liposomes. However, the sample conditions 
were still good enough for analysis in other samples. 
MscL did not incorporate into pure POPC and DMPC liposomes, suggesting that the saturation of 
both fatty acid chains might be important in MscL incorporation efficiency (Fig. 3.21A-B). Unlike 
DPPC, DMPC formed liposomes in this trial, which indicated that either 1) phase transition might 
not have been the sole explanation for the failure of DPPC to form liposomes, or 2) the room 
temperature environment (22 °C) in which these experiments were carried out was sufficiently close 
to DMPC’s transition temperature (23 °C) to allow liposome formation. In mixed DOPC/POPC and 
DOPC/DMPC samples, however, MscL aggregation could be observed, confirming that 
hydrophobic tail did not have a significant influence on MscL clustering (Fig. 3.21C-F). 
MscL’s tendency to cluster appeared to weaken in mixed DOPC/E. coli lipid liposomes with 
increasing levels of DOPC (Fig. 3.22A, C, E). Although the high background Nanogold made it 
difficult to make a definitive observation, MscL seemed to form only small clusters of 
approximately ten particles in 1:1 DOPC/E. coli lipid mixture. In contrast, MscL formed much 
larger clusters in the sample with 3:1 ratio. While this showed that some of the phospholipids in E. 
coli lipid samples negatively influenced MscL clustering, these phospholipids could not be 
identified with this experiment alone. 
Since the high background Nanogold level interfered with electron microscopy, troubleshooting 
experiments were performed (Fig. 3.22B, D, F). The grid incubated with only Ni-NTA-Nanogold 
appeared largely featureless (Fig. 3.22B). Another with Ni-NTA-Nanogold and bovine serum 
albumin (BSA) did not show significant load of Nanogold either (Fig. 3.22F). On the other hand, 
Nanogold particles were observed throughout the grid incubated with MscL (in β-DDM) and 
Nanogold (Fig. 3.22D). From these, it was deduced that the background Nanogold level seen in the 
third trial was not due to nonspecific binding, and likely because there was a significant amount of 
MscL which did not incorporate into liposomes. A possible explanation was that MscL and β-DDM 
interacted strongly enough to resist detergent adsorption by Biobeads, which had previously been 
reported (Konijnenberg et al., 2014). 
With the source of the problem identified, additional experiments with modified protocols were set 
up in which phospholipid head groups were screened. The protein-to-lipid ratio was lowered from 
1:1 to 1:10, and this successfully reduced the level of unincorporated MscL, which in turn led to  
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Figure 3.23. Electron micrographs of Nanogold-tagged MscL in mixed DOPC/POPG liposomes at 
ratios of 3:1 (A, B) and 1:1 (C, D), and DOPE/POPG liposomes at 3:1 ratio (E, F). 
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Figure 3.24. Electron micrographs of Nanogold-tagged MscL in mixed DOPC/DOPE liposomes at 
ratios of 3:1 (A, B) and 1:1 (C, D), and DOPC/POPC liposomes at 3:1 ratio (E, F). 
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lower background Nanogold level (Fig. 3.23 – 3.24). Liposomes did not form in mixed 
DOPC/DOPS samples at both 3:1 and 1:1 ratios. 
Both MscL aggregation and incorporation appeared to be negatively influenced by the presence of 
POPG (Fig. 3.23A-D). In the sample with DOPC/POPG at the 3:1 ratio, the dominant species 
appeared to be singular MscL in equilibrium with small linear clusters. In addition, it looked as if 
the particles were surrounded by a raft of phospholipids on the membrane. Most of these singular 
MscL particles were located in flat membranes, and those in liposomes formed large clusters in a 
similar pattern to pure DOPC lipid (Fig. 3.23C, D). In the sample with DOPC/POPG ratio of 1:1, 
there were fewer Nanogold particles in general, indicating that MscL did not incorporate well into 
membrane with high proportion of PG lipid. However, similar to the ones with 3:1 ratio, some of 
the liposomes featured well-clustered MscL particles. 
MscL particles were mostly monodisperse in the 3:1 DOPE/POPG phospholipid sample (Fig. 
3.23E-F). Similarly to the 3:1 DOPC/POPG sample, most of the membrane formed flat surfaces 
rather than liposomes. Most of the Nanogold-MscL particles were co-located with what looked like 
curved protrusions from the flat surface. Interestingly, large MscL clusters could not be found in 
this sample, which suggested that MscL clustering seen in other samples may have been largely 
driven by the phosphatidylcholine (PC) head group. 
DOPC/DOPE and DOPC/POPC phospholipid conditions were also tested in this trial to check for 
the reproducibility of the observations made in the previous trials (Fig. 3.24A-F). The outcome was 
similar to the past experiments, with Nanogold-MscL particles forming large clusters in the 
liposomes in DOPC/DOPE and DOPC/POPC phospholipids. With the 3:1 DOPC/POPC mixture 
sample, however, there were occasionally areas with singular MscL particles (Fig. 3.24E, F), 
indicating that POPC might be less likely to produce clusters than DOPC.  
3.3.3.2. Semi-quantitative Analysis of MscL Clustering Pattern 
 In this experiment, a semi-quantitative analysis was carried out on the electron microscopy images 
to assess if correct observations were made with the relationship between MscL  clustering and 
phospholipids. Two approaches were developed to test the hypothesis that MscL formed clusters in 
some samples but not in others. 
First, a Gaussian distribution cluster analysis was carried out on the Nanogold-MscL particle 
images using the Matlab program to test whether this approach could identify MscL clusters and 
segregate them from singular species. The function identified large clusters in DOPC samples, 
which was in agreement with the visual observation. Similarly, it failed to reach convergence in E. 
coli lipid samples, indicating that MscL did not form clusters (Fig. 3.25). However, it could not  
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segregate scattered (i.e. singular) MscL particles from clustered ones, often placing them in the 
same group (Fig. 3.25C, D). This was likely due to the nature of the Gaussian function, which 
would only form oval-shaped contours in two-dimensional space. On the other hand, the MscL 
clusters often formed arcs around the edges of the liposomes, making this approach incompatible. 
As a result, this method was ultimately determined unsuitable for cluster analysis. 
The second approach estimated the size of clusters by measuring their areas. This was based on the 
assumption that the Nanogold particles were similar in size, and that Nanogold particles would not 
stack on top of each other due to the flattening effect of the negative staining process. By  
  
Figure 3.25. Gaussian distribution cluster analysis of Fig. 3.18C (MscL/E. coli lipids) with Matlab. Two 
runs were performed on the same micrograph. In the first step (A, B), potential clusters were identified 
with the Gaussian function. Two identical runs reaching different conclusions can be seen. In the second 
step (C, D), particles were assigned to each cluster. While some of the actual MscL clusters along the edge 
of the liposomes (light blue, black, purple, and orange) could be reliably classed, it was common for other 
clusters (red and green in C, green in D) to contain both clustered and scattered particles. In both 
instances, Matlab failed to reach convergence after 50 iterations, indicating that Matlab could not assign 
particles into cluster groups with high level of confidence. 
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Figure 3.26. Proportion of particles in each cluster grouped by the number of particles. All ratios are w/w. 
A) DOPC/E. coli lipid liposome; B) DOPC/POPC Liposome; C)  DOPC/DOPE liposome; D) 
DOPC/DMPC Liposome; E)  DOPC/POPG liposome. F) 1 – DOPC liposome; 2 – 1:1 DOPC/DOPE 
liposome; 3 – 1:1 DOPC/cardiolipin lipid liposome; 4 – 1:1 DOPC/POPG liposome; 5 – 3:1 DOPE/POPG 
liposome; 6 – E. coli lipid liposome. Grey – large clusters; Blue – medium-sized clusters; Green/yellow – 
small clusters; Red – monodisperse particles. 
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performing statistical analysis on the sizes of the clusters, it could be quantitatively measured if the 
MscL particles were randomly distributed or preferred cluster formation. 
This analysis confirmed many of the observations made in the previous section, and revealed 
additional details on the clustering pattern. First, hydrophobic tails had a minor influence on MscL 
clustering pattern (Fig. 3.26B, D). Clusters larger than 20 particles were the dominant species in 
samples with DOPC, DOPC/POPC, and DOPC/DMPC phospholipids. However, clusters were the 
largest on average in the pure DOPC sample, and smaller clusters of 20 – 500 particles became 
more dominant with decreasing DOPC levels. 
The influence of phospholipid head groups on MscL clustering pattern was more pronounced. 
Whereas MscL formed large clusters in DOPC liposomes, it remained largely singular in mixed  
DOPE/POPG lipid (Fig. 3.26F-5). In 3:1 DOPC/POPG mixed liposomes, there was an even 
distribution of cluster sizes, suggesting that POPG’s strong anti-clustering influence was balancing 
DOPC’s pro-clustering force (Fig. 3.26E). Although the proportion of large clusters increased in the 
1:1 DOPC/POPG sample, this was likely explained by the poor incorporation of MscL into flat 
membranes which were speculated to have a relatively higher proportion of POPG. 
On the other hand, DOPE and cardiolipin did not appear to have an active role in MscL clustering 
(Fig. 3.26C, F-3). In mixed DOPC/DOPE and DOPC/cardiolipin samples, smaller cluster size 
seemed to be preferred but the proportion of singular MscL particles remained small. This indicated 
that, while both phospholipids were not strongly cluster-inducing, they had much smaller influence 
than DOPC. A similar pattern was observed with MscL in DOPC/E. coli mixed environment, which 
was an expected result, since PE is the most abundant head group in E. coli lipid. 
3.3.3.3. Discussion 
The influence of phospholipid on MscL aggregation was investigated in this section, and a 
causative relationship was clearly established. The phospholipid head group was found to be the 
main influence on MscL clustering: PC head groups strongly favoured MscL aggregation, PE and 
cardiolipin head groups did not have significant involvement in MscL clustering, and PG head 
groups strongly favoured dissociation of MscL clusters (Fig. 3.26). This was an interesting result 
since this indicated that, while the head groups of phospholipids were important in MscL clustering, 
this was not due to their net charge. Both PC and PE head groups are net neutral, with the only 
difference being the amine group (PC has a quaternary amine, whereas PE has a primary one). 
However, PC was strongly cluster-inducing whereas PE was not, suggesting that this was driven by 
very specific interaction involving the amine group. In contrast, both PG and cardiolipin are net 
negatively charged head groups – cardiolipin effectively consists of two PG molecules linked by a 
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glycerol group (this is in fact how bacteria synthesise cardiolipin from PG and glycerol (Guo & 
Tropp, 2000)). That PG actively prevented MscL from clustering while cardiolipin did not indicates 
the possibility of another specific interaction with the protein which may be distinct from that of 
PC. 
It is difficult to speculate on the MscL residues involved in the clustering – and by extension, 
interaction with phospholipids – or even the nature of the interactions from this experiment alone, 
especially with the discovery that charges of their head groups are not the main factor. In general, 
proteins can be induced to aggregate if their interaction with the environment is less favourable than 
interaction between the proteins themselves. While this can be a possible explanation for MscL 
clustering in the presence of PC head groups, this is contradicted by a mass spectrometry result 
showing MscL’s increased structural stability in the presence of PC (Kocer, 2015). However, 
another common pathway where the strong affinity for intermediary molecules cause proteins to 
aggregate around them is unlikely in this case. PC molecules outnumbered MscL by a factor of 20 
in the experiments even if 100 % incorporation rate at 1:1 P:L ratio (w/w) were assumed, so there 
would have been no relative shortage of PC head groups required for aggregation to occur. 
Moreover, MscL formed small clusters when the proportion of PC lipid in the membrane was 
reduced, contradicting this hypothesis. 
Likewise, it is difficult to identify the interaction between PG and MscL responsible for interfering 
with the latter’s cluster formation. This is possible if MscL has high affinity to PG, effectively 
“coating” itself with PG. However, the thin layer chromatography experiment carried out in section 
3.3.1. showed that PG did not have high enough affinity to co-purify with MscL, whereas PE did. 
Moreover, MscL appeared to have a reduced rate of incorporation into membrane containing PG, 
which would be very unusual if they had high affinity for each other. 
MscL’s resistance to cluster formation in the presence of PG and the lack of influence by PE or 
cardiolipin may have functional significance in vivo. In an environment with little PG, MscL forms 
co-clusters with MscS and raises the gating threshold of the latter (Nomura et al., 2012). However, 
unlike MscS, which usually localises to cardiolipin-rich regions, MscL is generally evenly 
distributed across E. coli membranes, suggesting that there is a counteracting factor to prevent 
MscL from co-clustering with MscS in vivo. The results described in this Chapter suggest that PG, 
which account for approximately five percent of E. coli membranes (Oliver et al., 2014), might be 
this counteracting factor. Moreover, it is possible that E. coli might use the level of PG in the 
membrane to control the gating threshold of MscS by facilitating co-clustering with MscL in low-
PG environment. The PG level in E. coli membranes can fluctuate between 4 – 7 % in routine cell 
cycle alone (Furse et al., 2015), and E. coli is known to alter phospholipid composition to influence 
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membrane protein function (Vitrac et al., 2015), giving further credence to this hypothesis. In 
addition, the lack of preference for either clustered or singular state of MscL by PE lipids, which it 
has a high affinity for (section 3.3.1.), will possibly moderate the transition between the two states 
to avoid inducing an unwanted physiological shock to the bacteria. 
One of the potential confounding factors was the curvature of the membrane indirectly influencing 
the clustering of MscL. MscL tends to form clusters in small liposomes (section 3.3.2.), likely due 
to the increased curvature. In the experiments in this section, however, liposomes generally had 
sizes larger than 500 nm in diameter, hence making the effect of global curvature on MscL 
clustering negligible. 
Phospholipid-mediated clustering properties of MscL can be used for nanovalve development as 
well. As discussed in section 3.3.2, MscL cluster formation in small liposomes can present a unique 
challenge for its use in a liposomal drug delivery system. A potential solution to this problem is 
adding small amounts of PG to the liposome preparation so that clustering can be minimised to 
allow for more even MscL incorporation across small liposomes. 
In the near term, the findings from this section will aid with the design and analysis of other 
experiments on MscL. For example, phospholipid composition in patch clamp experiments could be 
designed to control the level of MscL clustering, which is a major confounding factor in analysing 
the channel gating function (Grage et al., 2011; Nomura et al., 2012). Additionally, molecular 
dynamics simulation can be designed to analyse the clustering effect of the phospholipids used, and 
assist with the investigation of the interaction between MscL and phospholipids. Pure 
phospholipids, especially those with PC head groups, are commonly used in such studies (Bavi, 
Vossoughi, et al., 2016; Rui et al., 2011; Sawada et al., 2012; Zhu et al., 2016). Results from this 
section can therefore be used to improve the experimental design such as using multiple MscL 
particles in the simulation instead of single particles suspended in the membrane, which has been 
put forward as necessary to properly study MscL channel function (Phillips et al., 2009). 
3.4. Summary 
In this chapter, various aspects of the relationship between MscL and phospholipids were 
investigated. The general strategy was to identify variables which affect the MscL channel gating 
and clustering and to understand the results in the context of MscL’s affinity to certain lipids. From 
thin layer chromatography experiments, phosphatidylethanolamine (PE) was identified as 
potentially having high enough affinity to co-purify with MscL. There have been experiments 
pointing to PE as an active participant in MscL channel function instead of being just a bulk lipid, 
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such as marked increase in MscL channel gating threshold when used to replace PC (Powl et al., 
2008b), and this result is the direct confirmation of such observations. 
Sucrose gradient fractionation experiment has identified membrane curvature as a major variable 
affecting MscL function. While it was initially suspected that phospholipid composition was the 
underlying factor behind the observed dependence of channel gating properties and aggregation on 
liposome size, this was disproven by mass spectrometry, which showed similar phospholipid 
composition across liposome size. This has two implications in understanding the dynamics of 
MscL function in liposomes. First, small liposomes have enough membrane curvature to affect 
MscL channel gating and aggregation. Second, MscL passively incorporates into liposomes rather 
than actively “shaping” their properties during or after incorporation. This has both positive and 
negative implications for the evaluation of MscL as a nanovalve candidate for liposomal drug 
delivery system, which generally requires small liposomal size for improved penetration to target 
tissues (van den Hoven et al., 2011). 
Lastly, MscL distribution in various pure phospholipid liposomes was visualised with electron 
microscopy and analysed to conclusively establish the causative relationship between the two 
variables. It was determined from these experiments that phospholipid head groups are the main 
determinants of MscL aggregation, with tail groups potentially having minor influence (Fig. 3.26). 
The anti-clustering properties of phosphatidylglycerols (PG) may be used to address the MscL 
clustering problem in small liposomes. The findings from this study can also be used for better 
molecular dynamics simulation design, improved analysis of patch clamp experiments, and 
potentially structural studies of MscL in membranes, which are discussed in Chapter 4. 
3.5. Future Directions 
A worthwhile experiment in the near term would be the completion of follow up experiments to 
confirm the identity of the phospholipid natively associating with MscL by mass spectrometry. 
While thin layer chromatography is useful for quick identification of lipids, it is limited in not being 
conclusive evidence for phospholipid identification and specifically its inability to identify the tail 
group. Mass spectrometry, while being a more complicated process, will be able to provide these 
data, which will greatly improve the understanding of MscL channel function in the native 
environment. This is also a more cost-effective way of identifying phospholipid head groups than 
comparing MscL’s TLC trace to reference lipids. Preliminary mass spectrometry experiments have 
already been performed, albeit unsuccessfully, so the main challenge will be in optimising the 
protocol. In addition, reconstituting MscL into liposomes with various pure lipid composition and 
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re-extracting the protein will yield a much more direct evidence of MscL’s relative affinity to 
specific lipids. 
It will be interesting to see if the sucrose gradient result can be replicated with E. coli lipids as well. 
Although soy azolectin is a commonly used phospholipid mixture, it is rich in PC and other lipids 
(such as phytosterols) which are not native to E. coli. Moreover, it was found from the pure 
phospholipid studies that the MscL clustering pattern is significantly different between PE (main 
head group of E. coli lipid) and PC (main head group of soy azolectin). As such, it is likely that 
MscL will have a different clustering and channel gating threshold in E. coli lipid, and it will be 
interesting to study the effect of membrane curvature on such properties in the context of a more 
native phospholipid environment. 
Lastly, future work should include the repetition of some of the studies on the clustering of MscL 
pure phospholipids. The results for the DOPC/cardiolipin condition were time-consuming to 
reproduce, and there was only one attempt at producing DOPC/DOPS liposomes. Both cardiolipin 
and DOPS are minor constituents of E. coli lipid, and they are also negatively charged 
phospholipids, so observing their influence on MscL clustering pattern will help with better 
understanding the anti-clustering influence of PG lipid. 
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3.6. Supplementary Information 
3.6.1. Mass Spectrometry of Size-fractionated MscL Proteoliposome 
  
Figure 3.S1. Mass spectrometry of PE lipid region of MscL/Soy azolectin proteoliposomes size-
fractionated by sucrose gradient. Numbers in the top left corner represents the fraction number (Fig. 
3.9). Blue numbers in the trace indicate the estimated molecular mass of the peak compounds, and 
black numbers indicate the likely tail group configurations of the phospholipids. 
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Figure 3.S2. Mass spectrometry of PE lipid region of MscL/Soy azolectin proteoliposomes size-
fractionated by sucrose gradient. Numbers in the top left corner represents the fraction number (Fig. 
3.9). Blue numbers in the trace indicate the estimated molecular mass of the peak compounds, and 
black numbers indicate the likely tail group configurations of the phospholipids. 
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Figure 3.S3. Mass spectrometry of PE lipid region of MscL/Soy azolectin proteoliposomes size-
fractionated by sucrose gradient. Numbers in the top left corner represents the fraction number (Fig. 
3.9). Blue numbers in the trace indicate the estimated molecular mass of the peak compounds, and 
black numbers indicate the likely tail group configurations of the phospholipids. 
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Figure 3.S4. Mass spectrometry of PC lipid region of MscL/Soy azolectin proteoliposomes size-
fractionated by sucrose gradient. Numbers in the top left corner represents the fraction number (Fig. 
3.9). Blue numbers in the trace indicate the estimated molecular mass of the peak compounds, and 
black numbers indicate the likely tail group configurations of the phospholipids. 
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Figure 3.S5. Mass spectrometry of PC lipid region of MscL/Soy azolectin proteoliposomes size-
fractionated by sucrose gradient. Numbers in the top left corner represents the fraction number (Fig. 
3.9). Blue numbers in the trace indicate the estimated molecular mass of the peak compounds, and 
black numbers indicate the likely tail group configurations of the phospholipids. 
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Figure 3.S6. Mass spectrometry of PC lipid region of MscL/Soy azolectin proteoliposomes size-
fractionated by sucrose gradient. Numbers in the top left corner represents the fraction number (Fig. 
3.9). Blue numbers in the trace indicate the estimated molecular mass of the peak compounds, and 
black numbers indicate the likely tail group configurations of the phospholipids. 
116 
 
  
Figure 3.S7. Mass spectrometry of PI lipid region of MscL/Soy azolectin proteoliposomes size-
fractionated by sucrose gradient. Numbers in the top left corner represents the fraction number (Fig. 
3.9). Blue numbers in the trace indicate the estimated molecular mass of the peak compounds, and 
black numbers indicate the likely tail group configurations of the phospholipids. 
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Figure 3.S8. Mass spectrometry of PI lipid region of MscL/Soy azolectin proteoliposomes size-
fractionated by sucrose gradient. Numbers in the top left corner represents the fraction number (Fig. 
3.9). Blue numbers in the trace indicate the estimated molecular mass of the peak compounds, and 
black numbers indicate the likely tail group configurations of the phospholipids. 
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Figure 3.S9. Mass spectrometry of PI lipid region of MscL/Soy azolectin proteoliposomes size-
fractionated by sucrose gradient. Numbers in the top left corner represents the fraction number (Fig. 
3.9). Blue numbers in the trace indicate the estimated molecular mass of the peak compounds, and 
black numbers indicate the likely tail group configurations of the phospholipids. 
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3.6.2. Matlab Plot for the Electron Microscopy of MscL reconstituted in DOPC/DOPE (3:1) 
membrane 
clear all 
close all 
clc  
 
%% Import image  
I = imread('bd.jpg'); % imports your file 
imshow(I);  % shows image in a figure 
title('Gammas original dot image') 
 
%% 
% Create a binary matrix - this assigns all non-white pixels as black; 
idx_a  = I <45; 
idx = flipdim(idx_a,1); 
 
figure 
contour (idx)  % produces a contour plot of the index values 
 
% Finds the centre of your 'dots' to assign x,y coordinates 
B = zeros(length(I(:,1)),length(idx)-6); 
C = length(B(:,1))-1; 
D = length(B)-1; 
for i = 1:C 
    for j = 1:D 
    B(i,j) = (idx(i,j)+idx(i,j+1)+idx(i,j+2)+idx(i,j+3)+idx(i,j+4)+idx(i,j+5)); 
    end 
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end 
 
% This part tries to pick out the centre of your protein based on a 6x6 dot 
BB = transpose(B); 
BBB = zeros(size(BB)); 
CC = length(BBB); 
DD = length(BBB(1,:))-8; 
for i = 1:CC 
    for j = 1:DD 
    BBB(i,j) = (BB(i,j)+BB(i,j+1)+BB(i,j+2)+BB(i,j+3)+BB(i,j+4)+BB(i,j+5)); 
    end 
end 
 
idx2 = BBB > 20, BBB < 30;  % Logical index, finds summed binary values of 32, which is pixel 
size of your dots 
idx2 = transpose(idx2); 
 
[x, y] = find(idx2==1); 
xy = [x, y]; 
 
 
 
%% 
 
%feature extraction - size distribution (area, pixels) 
NG = regionprops(idx); 
AA = [NG.Area]; 
121 
 
AK = transpose(AA); 
figure 
hist(AA) 
xlabel('Area (pixels)') 
ylabel Popularity 
title('Size Distribution') 
 
%statistical measurements 
mean(AA) 
mode(AA) 
std(AA) 
median(AA) 
 
3.6.3. Excel workflow and commands used for data processing 
Conversion of area (imported from Matlab) to the number of Nanogold particles 
 =IF(C12>10,ROUNDDOWN(C12,-1)/10,"") 
Table 3.S1. (Next page) Number and proportion of Nanogold-MscL particles in each cluster 
grouped by the number of particles in reconstituted pure phospholipid-MscL membrane 
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Number E. coli DOPC DOPC/DOPE 
1:1 
DOPC/DOPE 
2:1 
DOPC/POPC 
1:1 
DOPC/POPC 
3:1 
DOPC/Card 
1:1 
DOPC/DMPC 
2:1 
DOPC/DMPC 
1:1 
DOPC/Eco 
3:1 
DOPC/POPG 
3:1 
DOPC/POPG 
1:1 
DOPE/POPG 
3:1 
1 28 5 106 53 5 42 49 18 8 16 266 11 92 
2-4 67 0 160 55 26 136 153 14 5 44 495 42 34 
5-19 116 32 217 71 85 182 271 92 47 71 440 57 21 
20-99 260 158 23 117 357 366 466 202 352 267 268 75 0 
100-499 185 743 1362 224 384 2330 804 199 320 0 0 1018 0 
500-1999 0 1430 559 2037 0 0 1583 1424 0 751 560 0 0 
2000-10000 0 4416 0 0 0 0 0 0 0 0 0 0 0 
              
Total 656 6784 2427 2557 857 3056 3326 1949 732 1149 2029 1203 147 
              
Proportion E. coli DOPC DOPC/DOPE 
1:1 
DOPC/DOPE 
2:1 
DOPC/POPC 
1:1 
DOPC/POPC 
3:1 
DOPC/Card 
1:1 
DOPC/DMPC 
2:1 
DOPC/DMPC 
1:1 
DOPC/Eco 
3:1 
DOPC/POPG 
3:1 
DOPC/POPG 
1:1 
DOPE/POPG 
3:1 
1 0.04 0.00 0.04 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.13 0.01 0.63 
2-4 0.10 0.00 0.07 0.02 0.03 0.04 0.05 0.01 0.01 0.04 0.24 0.03 0.23 
5-19 0.18 0.00 0.09 0.03 0.10 0.06 0.08 0.05 0.06 0.06 0.22 0.05 0.14 
20-99 0.40 0.02 0.01 0.05 0.42 0.12 0.14 0.10 0.48 0.23 0.13 0.06 0.00 
100-499 0.28 0.11 0.56 0.09 0.45 0.76 0.24 0.10 0.44 0.00 0.00 0.85 0.00 
500-1999 0.00 0.21 0.23 0.80 0.00 0.00 0.48 0.73 0.00 0.65 0.28 0.00 0.00 
2000-10000 0.00 0.65 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
              
Total 1 1 1 1 1 1 1 1 1 1 1 1 1 
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Table 3.S2. Statistics of the Nanogold-MscL particle negative stain electron microscopy for reconstituted pure phospholipid-MscL membrane 
 E. coli DOPC DOPC/DOPE 
1:1 
DOPC/DOPE 
2:1 
DOPC/POPC 
1:1 
DOPC/POPC 
3:1 
DOPC/Card 
1:1 
DOPC/DMPC 
2:1 
DOPC/DMPC 
1:1 
DOPC/Eco 
3:1 
DOPC/POPG 
3:1 
DOPC/POPG 
1:1 
DOPE/POPG 
3:1 
Mean cluster 
size 
8.6 357.1 12.1 27.5 28.6 23.2 22.6 51.3 29.3 25.0 4.0 30.1 1.4 
Median 
cluster size 
2 22 1 1 9.5 3 3 2 8 3 1 2 1 
Total number 
of clusters 
76 19 201 93 30 132 147 38 25 46 510 40 105 
Total number 
of particles 
656 6784 2427 2557 857 3056 3326 1949 732 1149 2029 1203 147 
Standard 
deviation 
23 1009 58 150 42 70 104 231 45 110 25 92 1 
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4. Structural Characterisation of E. coli MscL 
4.1. Introduction 
One of the main objectives of this thesis was to obtain crystals of E. coli MscL with a view to 
determining its 3D structure. The structures of M. tuberculosis MscL, S. aureus, and M. acetivorans 
MscL have all provided significant insight into MscL function (J. Li et al., 2015; Liu et al., 2009; 
Steinbacher et al., 2007). However, no structure currently exists for E. coli which is the best 
characterised MscL channel biophysically. There are significant differences between E. coli MscL 
and M. tuberculosis MscL in sequence (36 % identity and 50 % similarity between them; pBLAST) 
and in the gating function in different phospholipid environments (Zhong & Blount, 2013), so 
extrapolation of results between the two has often been difficult. Finally, no experimentally 
determined open channel structure of MscL exists. This chapter describes the work conducted to 
progress MscL crystal production using both 2D and 3D crystallisation approaches. 
4.1.1. 2D crystallisation Experiments of MscL 
The first strategy taken was to develop 2D crystallisation protocols for MscL to enable structure 
determination in a lipid bilayer environment. 2D crystallisation is a method of membrane protein 
crystallisation in which the protein is induced to form ordered 2D crystalline arrays following 
reconstitution into a phospholipid bilayer. It has the advantage of membrane proteins being studied 
in a near-native phospholipid environment rather than in detergent micelles (common for 3D 
membrane protein crystallisation), which can force the protein into an unnatural conformation 
(Dorwart et al., 2010). Notably, 3D crystals of S. aureus MscL were reported to have an 
unexpected, tetrameric conformation rather than the native pentamer (Liu et al., 2009), which was 
subsequently shown to be a result of the detergent conditions employed for crystallisation (Dorwart 
et al., 2010). 2D crystallisation was therefore trialled to avoid this problem. 
Previous attempts to obtain a structure of E. coli MscL using 2D methods have been reported (Saint 
et al., 1998), further suggesting that this was a reasonable strategy to pursue. These early attempts 
yielded a 2D projection map erroneously determined as a hexamer, likely due to the incorrect 
imposition of a six-fold pseudosymmetry resulting from a hexagonal close packing arrangement of  
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the proteins rather than a true 2D crystal lattice. This necessitated identifying an improved 
crystallisation condition with reduced freedom for MscL in the crystal lattice. 
In addition to protein and protein concentration, it is well established that a range of variables 
influence the propensity of membrane proteins to form 2D crystals. 
Lipids: The type of lipid is a major factor in 2D crystallisation as it can determine the morphology 
of the bilayer (Lasala et al., 2015). Depending on the relative cross-sectional areas of the lipid head 
and tail groups, the lipid molecules can induce the membrane to be either curved or flat, with the 
former potentially triggering tube and/or liposome formation (Fig. 4.1) (Alberts et al., 2003). Lipids 
can also influence protein crystallisation via direct interaction with protein molecules. While there 
is no consensus on the principle behind this, it is believed to involve the general shift in the 
energetic favourability of the protein molecules toward the crystallised state. In certain cases, 
specific interactions between proteins and annular lipids might aid with crystallisation by increasing 
the protein’s stability. 
In general, 2D crystallisation has been most successful with phosphatidylcholines (PC) such as 
DMPC, POPC, and DOPC, and E. coli lipids, which together accounted for 85 % of published 
successful 2D crystallisation conditions (Lasala et al., 2015; Schmidt-Krey, 2007). MscL was 
reported to crystallise in E. coli lipids as well (Saint et al., 1998). Therefore, 2D crystallisation 
experiments outlined in this thesis focused on these lipids. 
 
Figure 4.1. Schematic representation of lipid packing mediated by phospholipid geometry. Individual 
lipid molecules and their geometry are represented on the left, and the resulting membrane geometry are 
presented on the right. A) Positive curvature-inducing phospholipids. B) Curvature-neutral phospholipids. 
C) Negative curvature-inducing phospholipids. 
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Protein-to-Lipid ratio: In 3D crystallisation, the solubility of proteins is predominantly controlled 
using a range of precipitants and precipitant concentrations (Lasala et al., 2015). Precipitants draw 
water away from the proteins and force them to associate either into crystals or non-crystalline 
aggregates. An analogous approach in 2D crystallography is to screen a range of protein-to-lipid 
(P:L) ratios. At higher P:L ratios, there is less lipid bilayer available per protein to maintain its 
solubility, forcing proteins to pack more closely together, either into 2D arrays or non-crystalline 
aggregates. 
Detergent: Stability of the target protein in the detergent used for extraction/purification is an 
important consideration in 2D crystallography, although ideally this would be optimised before a 
project advances to the stage of attempting to obtain protein crystals. Detergents can, however, have 
significant impact in the early phases of 2D crystallisation, as the interaction with proteins and 
phospholipids can affect the way protein molecules incorporate into the membrane (Lasala et al., 
2015). Nonionic glucoside detergents such as β-DDM as well as Triton X-100 are among the most 
commonly used detergents in 2D crystallisation. 
MscL is reported to be relatively stable in both β-DDM and Triton X-100 (Price et al., 2011; 
Yilmaz et al., 2015). It has been suggested that β-DDM associates tightly with MscL (Konijnenberg 
et al., 2014), making it potentially undesirable for 2D crystallisation since it might make complete 
detergent removal difficult. Furthermore, MscL was found to adopt non-native conformations in the 
presence of LDAO (Dorwart et al., 2010), while in the early stages of this work it was observed that 
MscL solubility is negatively affected when stored in octylglucoside (data not shown) meaning that 
the choice of detergent had to be made carefully in these studies. In addition, the rate and extent of 
detergent removal can affect the morphology of reconstituted bilayers (Schmidt-Krey, 2007). 
Detergent chelators like Biobeads and cyclodextrins are most commonly used with microdialysis 
providing an alternative approach, albeit one that is limited by the long times required to completely 
remove detergents with low critical micelle concentration (Brent L. Nannenga et al., 2013). 
Anions and cations: As for 3D crystallisation, the type and concentration of inorganic salts can 
also affect 2D crystallisation. At high concentrations, solutes (which include ions) can “compete” 
with proteins for water molecules in solution to the point where a crystalline state is energetically 
favoured by the proteins (Majeed et al., 2003; McPherson, 2004). An additional consideration for 
2D crystallography is that ions can facilitate the fusion of lipid bilayers either by attracting 
liposomes which would otherwise electrostatically repel each other (Akashi et al., 1998; Bentz & 
Duzgunes, 1985; Ruso et al., 2003), or through Hofmeister ion effects where ions of inorganic salts 
indirectly influence the solubility of organic molecules (primarily proteins but also applicable to 
phospholipids) via weak interactions with bulk water molecules (Baldwin, 1996; Salis & Ninham, 
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2014; Z. Yang, 2009). Therefore, 2D crystallisation conditions were screened for various salt 
concentrations in this study. 
A substantial amount of work in this chapter is focused on screening the influence of these 
parameters. Other variables which were screened in this study were pH, and freeze-thaw process. In 
particular, the freeze-thaw process can increase both the size of liposomes (Castile & Taylor, 1999), 
reduce the proportion of multilamellar vesicles (Traikia et al., 2000), and incorporation of protein 
into the bilayer (Katzen et al., 2009) through physical disruption of the membrane. It should be 
noted that automated screening methods that are commonplace in 3D crystallisation laboratories are 
not well-suited to 2D crystals and so the process is far more labour-intensive (Schmidt-Krey, 2007). 
Consequently a broad spectrum approach was initially taken to identify conditions of interest within 
this complex multi-dimensional space matrix. 
4.1.1.1. Alternative crystallisation approaches 
In this project, both the traditional 2D bilayer crystallography method introduced above and an 
approach that incorporated a phospholipid monolayer template were trialled in parallel. In the latter 
method, a mixture of phospholipids with and without affinity tags such as Ni-NTA was used to 
arrange the protein molecules in a specific orientation and to concentrate them at the water-template 
interface, both of which can promote crystallisation. This strategy is especially useful for membrane 
proteins, since proteins can be reconstituted into membranes in two orientations without such 
guidance. 
One requirement of the monolayer-based method is that the protein’s affinity tag should not to be 
cleaved off during purification to facilitate interaction with the template. Since additional linker 
residues or tags interfere with crystallisation (as these tend to have higher levels of freedom – i.e. 
are more flexible) this can be problematic. In the case of MscL, an important consideration is that 
the N-terminal peptide might be buried in the hydrophobic layer of micelles/membranes (see 
section 2.4.1.1.). Technically, this could be circumvented by the use of C-terminal hexahistidine 
tags. However, existing MscL constructs with C-terminal affinity tags had significantly different 
gating thresholds to both the wild-type MscL and the construct used in this study (Prof. Boris 
Martinac, personal communication), suggesting significant interference of the channel function and 
structure by the affinity tags, which in turn made its use in the crystallisation experiments 
undesirable. 
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4.1.2. 3D Crystallisation Experiments of MscL 
In parallel, 3D crystallisation of MscL in the presence of detergents was attempted. X-ray 
diffraction from 3D crystals is the most common method of protein structure determination, and has 
been successfully used to determine the structures of M. tuberculosis, S. aureus, and M. acetivorans 
MscL (G. Chang et al., 1998; J. Li et al., 2015; Liu et al., 2009). While this has the disadvantage of 
not being able to study MscL in the lipid bilayer environment, which is especially significant given 
its tight association with phosphatidylethanolamines (section 3.3.1.), the ability to perform high-
throughput screening for a large number of crystallisation conditions and the less labour-intensive 
process have made this an approach worth exploring in this study. 
An MscL construct with the N-terminal fusion tag uncleaved was intentionally used despite a 
potential drawback. It was hypothesised from publication records and personal communications that 
the difficulty with crystallising E. coli MscL could be in its native structure. Not only has the E. coli 
MscL structure remained undetermined despite its status as the most intensively studied species of 
MscL, there have been at least two unsuccessful attempts at crystallising E. coli MscL (Prof. Boris 
Martinac, personal communication). These suggested that using conventional methods of 3D 
crystallisation, one of which was using near-wild-type MscL in the experiments, would have a low 
chance of success. 
Therefore, the N-terminal affinity tag was left uncleaved from MscL during the purification process 
to increase the solvent-facing surface of the protein. While there was a risk of the fusion tag 
interfering with crystallisation due to its high degree of freedom (as previously discussed), it was 
hypothesised that this might be outweighed by significantly increasing the solvent-facing surface of 
the protein, which generally has a positive effect on membrane protein crystallisation. Similar 
strategy was adopted to determine the structure of M. acetivorans MscL, where the pentameric 
riboflavin synthase is thought to have aided with crystallisation by creating a large solvent-facing 
surface for the fusion protein (J. Li et al., 2015). Using a hexahistidine fusion-tag (His-tag) to aid 
with crystallisation also has precedents (Tajika et al., 2004), and in some cases this is thought to be 
partly due to the interaction between histidine residues and organic buffer molecules such as 
HEPES (Majorek et al., 2014). 
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4.2. Methods 
4.2.1. 2D Crystallisation 
4.2.1.1. 2D Crystallisation of MscL with Traditional Method 
6 µL of 5 mg/mL liposome solution, 1.5 µL, 3µL or 7.5 µL of either PD1 buffer (PBS pH 7.4, 1 
mM β-DDM), 200 mM MgCl2 or 200 mM MgSO4, and either 3 µL, 6 µL, 7.5 µL, or 12 µL  of 10 
mg/mL MscL were combined in a tube to yield protein-to-lipid ratios (w/w) of 1:1.5, 1:1, 1.5:1, 2:1, 
3:1, and 5:1 respectively. PD1 buffer (pH 7.4 or 7.0) was added to a final volume of 30 µL. The 
solution was incubated on a rocker at room temperature for 30 min. The solution was then 
transferred to a new tube containing either 1 or 1.5 mg of Biobeads, and incubated on a rocker at 
room temperature for 1 h. The solution was then transferred to another tube containing another 1.5 
mg of Biobeads, and further incubated on a rocker at room temperature for 3 h. For solutions 
undergoing freeze-thaw cycles, these were transferred to new tubes and flash-frozen in liquid 
nitrogen, followed by thawing at room temperature, and repeating three times. The samples were 
incubated for 12 h to facilitate crystallisation. 
The samples were negatively stained on a mesh grid as described in section 3.2.3.2., and was 
analysed using a JEOL 1011 coupled to Morada CCD imaging system or Tecnai-12 (FEI, U.S.A.) 
coupled to FEI Eagle 4K x 4K CCD Imaging System (FEI). Images were recorded at a high-tension 
voltage of 100 keV and at magnifications of 5,000x, 25,000x, 50,000x, 80,000x and 100,000x. 
4.2.1.2. 2D Crystallisation Assisted by Ni-NTA-coupled Phospholipid 
This method was based on the protocol by Hussein et al. (2009) and Lévy et al. (1999). 
40 µL of PBS (phosphate buffered saline) was placed in each well of a 12-well Teflon plate. 0.5 µL 
of chloroform solution containing 0.1 mg/mL Ni-NTA-DLPC and 4.9 mg/mL DOPC, or 1 mg/mL 
Ni-NTA-DLPC and 4 mg/mL DOPC were mixed and added to the top of the aqueous buffer 
reservoir. The chloroform was then left to evaporate at room temperature for 2 h. 5 µL of a 5 
mg/mL liposome solution and 5 µL of 5 mg/mL MscL were combined and then added to the 
solution via a side port so as not to disturb the monolayer. The plate was incubated at room 
temperature for 30 min. 5 mg of Biobeads were added to the solution via the side port for each well 
for detergent removal, and the plate was further incubated at room temperature for 6 h to facilitate 
detergent depletion. 
A glow-discharged 400-mesh copper grid (Electron Microscopy Sciences) was gently placed onto 
the solution, and then taken out after 15 s. It was blotted and negatively stained as described in 
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section 3.2.3.2., and analysed with JEOL 1011 coupled to Morada CCD imaging system. Images 
were recorded at high-tension voltage of 100 keV and at magnifications of 5,000x, 25,000x, 
50,000x, and 100,000x. 
4.2.2. 3D Crystallisation 
4.2.2.1. Initial (Broad) Screen of MscL Crystallisation Conditions 
Five commercial crystallisation screens were selected based on the properties of MscL (i.e. it being 
a membrane protein with a pI of 6.1). Specifically PEGRx1, PEGRx2, PEG/Ion, and PEG/Ion2 
screens from Hampton Research (U.S.A.), and Clear StrategyTM, Clear Strategy2TM, MemGold2TM, 
and MemSysTM screens from Molecular Dimensions (United Kingdom) were used. 
A 96-well flat-bottom vapour diffusion plate (Hampton Research) containing the precipitants, a 
Viewdrop 96-well plate seal (TTP Labtech, United Kingdom), and 10 µL of 10 mg/mL His-MscLL-
7Y in PBS with 0.5 mM β-DDM were placed on a Mosquito®  Crystal (TTP Labtech) system, and 
the crystallisation set up was performed with the hanging drops containing protein sample and 
precipitant at 1:1 (v/v) ratio. The sealed plated was placed in a Rock Imager (Formulatrix, U.S.A.) 
for a six-hour period of monitoring for eight days at 16 °C. 
Crystallisation progress was checked every day, and wells which appeared to contain crystals or 
relatively well-defined spherulites were identified and the crystallisation conditions recorded for 
further investigation. 
4.2.2.2. Optimisation of MscL Crystallisation Conditions 
2x stock solutions of the precipitant were placed into 200 µL aliquots. To change the pH of the 
precipitants, 2 M HCl, 2 M NaOH or 2 M KOH was added to the aliquots to create a range of pH 
screens with 0.2 increment. Precipitant concentration was controlled by diluting the aliquots with 
different volumes of water for 10% increment. 
For the hanging drop method, 200 µL of the prepared precipitant solutions were placed in each 
reservoir well of 24-well hanging drop plate (Hampton Research). 2 µL of 10 mg/mL His-MscLL-7Y 
was placed on one side of cover slip and 1 µL of the protein solution was placed on the other side, 
and 1 µL of the precipitant solution was added to each drop. The cover slips were quickly inverted 
and sealed onto the wells matching the precipitant solutions. The plates were stored at 4 °C until 
there was visible crystal growth or up to a maximum of two weeks. 
For the sitting drop method, the protocol for the hanging drop method was largely repeated but 
using a 24-well sitting drop plate (Hampton Research). However, in this case 2 µL of protein 
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solutions were placed on the upper well instead of onto the cover slip. 10 µL of silicon oil was also 
added to some of the wells to control the rate of vapour diffusion. 
For the microbatch method, 200 µL of either paraffin oil, Al’s oil or a 1:1 (v/v) mix of both was 
added to each well of 96-well PCR plate (Thermo-Fisher). 2µL of 10 mg/mL His-MscLL-7Y was 
mixed with either 1 µL or 2 µL of precipitant solution, and it was carefully placed at the bottom of 
each well (Chayen et al., 1992). The plate was left on the bench for 10 min for the drop to adhere to 
the bottom of the well, and moved to a crystallisation bay for incubation at either 4 °C or room 
temperature until there was visible crystal growth, or up to two weeks. 
20 µL of precipitant was gently added to the drop containing crystals. The solution was gently 
aspirated with a pipette. For this, the tip was cut to increase the diameter of the entrance and to 
minimise damage to the crystals. The solution was then mixed with 20 µL of precipitant and 
incubated for 10 s. Crystals were picked mount onto CryoLoopsTM (Hampton Research) and 
transferred to 20 µL of precipitant containing 10 % ethylene glycol as cryoprotectant, and incubated 
for 1 min. The crystals were mounted on CryoLoops again and were flash-frozen in liquid nitrogen. 
The crystals were analysed with the FR-E Superbright X-ray generator (Rigaku, Japan) coupled to 
Saturn 944 CCD area detector (Rigaku). 
4.2.2.3. Preparation of Crystals for SDS-PAGE 
Two frozen crystals were thawed and placed in 3 µL of water. 12 µL of 8M urea was added to the 
crystal solution to solubilise the crystals. This was followed by the addition of 5 µL of protein 
loading dye (50 mM Tris pH 6.8, 200 mM NaCl, 50 mM EDTA, 1 % SDS, 30 % glycerol (v/v)). 
The sample was run on SDS-PAGE and silver staining was performed as described in section 3.2.6. 
4.3. Results/Discussion 
4.3.1.  2D Crystallisation 
For crystal screening of MscL, a broad incomplete factorial screen was conducted to cover a wide 
range of variables including phospholipid types, protein-to-lipid (P:L) ratio, rate of detergent 
removal, freeze-thaw process, pH, and the crystallisation method. This incomplete factorial-based 
approach (Fig. 4.2) was designed to identify promising ranges of conditions for more detailed 
investigation using a full factorial design (Page et al., 2003). This is a favoured experimental design 
for 2D crystallisation than the more comprehensive, full factorial analysis, or a shotgun screen 
approach (Page et al., 2003), while sacrificing minimal sampling space. 
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Such a multi-dimensional factorial screen relies on the use of one condition for evaluating multiple 
variables simultaneously. For example, one sample (MscL/E. coli lipid, 2:1 P:L ratio; 0 mM 
inorganic salt; 3 mg Biobeads used; no freeze-thaw; pH 7.5) was used to study the influence of both 
the rate of detergent removal and inorganic salt concentration (Fig. 4.6C, 4.7A). While this is 
advantageous for 2D crystallisation screens, which are often resource-intensive, it also means some 
micrographs had to be featured multiple times in this chapter. 
4.3.1.1. The Influence of Phospholipid Types on 2D Crystallisation 
The significance of phospholipids on MscL incorporation into lipid bilayers and potentially 
crystallisation was explored in this experiment first. Specifically, MscL and each of four 
phospholipids commonly used in 2D crystallography (POPC, DMPC, DOPC, and E. coli lipid) 
were mixed at the ratio (P:L ratio) of 1:1 (w/w) and the resultant proteoliposomes were compared to 
negative phospholipid controls. All four phospholipids changed morphologies with the addition of 
MscL, suggesting efficient MscL incorporation (Fig. 4.3). However, there were differences between 
them in detail. 
 
Figure 4.2. Schematic diagram of sparse/incomplete factorial approach to screen 2D crystallisation of 
MscL. Three of the screened factors (phospholipids, P:L ratio, and inorganic salt concentration) are 
featured. The quality of screened conditions, represented as spheres on the matrix, can be ranked (black – 
poor quality; red – high quality) to identify the best crystallisation environment (red arrow). 
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Figure 4.3. Electron micrographs of 2D crystallisation trials of MscL. Left column – lipid-only control 
samples; Right column – MscL/lipid samples (P:L = 1:1, 0 mM inorganic salt, 3 mg Biobeads, no freeze-
thaw, pH 7.5). B) orange arrow – curved edge of the membrane; E) blue arrow – POPC vesicle; F) red 
arrow – small flat membrane with curved edge; G) black arrow – lysed DOPC vesicle; H) purple arrow – 
small flat membrane; green arrow – small flat membrane with curved edge 
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The negative controls for DMPC (PC 14:0/14:0) and E. coli lipid are shown in Figures 4.3A and 
4.3C. Typically in these sample the vesicles had highly variable diameters of 20 nm to over 500 nm. 
On the other hand, in the negative control for POPC (PC 16:0/18:1, Fig. 4.3E), the vesicles were 
generally smaller and more consistent with diameters of 50 – 200 nm, and in the case of DOPC (PC 
18:1/18:1, Fig. 4.3G), most vesicles were ~50 nm in diameter although a few vesicles with 
approximately 200 nm diameters could be seen. The larger liposome size of DMPC compared to 
smaller sizes for POPC and DOPC might be related to their lipid packing properties (Alberts et al., 
2003; Lasala et al., 2015), where DMPC is a “cylindrical” phospholipid (i.e. curvature-neutral) 
preferring flatter membrane geometry, while DOPC and POPC have “inverted cone” shapes (i.e. 
negatively curvature-inducing) favouring curvature in general (Shearman et al., 2006; Shinoda & 
Klein Michael, 2014; Vanni et al., 2014). 
With the addition of MscL, the MscL/DMPC samples formed sheet-like structures with high levels 
of curvature along the edges (Fig. 4.3B, orange arrow). MscL/E. coli lipid and MscL/DOPC 
membranes formed flatter bilayers with highly variable diameters from ~100 nm to over a few µm 
(Fig. 4.3D, H). This was in contrast to the intrinsic lipid packing properties of the phospholipids. 
This suggests that the transmembrane domain of MscL was counteracting DOPC’s negative 
curvature-inducing properties, possibly by accommodating the unsaturated fatty acyl chains (Bavi, 
Vossoughi, et al., 2016), whereas hydrophobic mismatch between MscL and DMPC (Bavi, 
Vossoughi, et al., 2016) and curvature-inducing properties of the protein itself would have led to the 
membrane favouring curvature at certain points. 
Since E. coli lipid (Fig. 4.3D) and DOPC (Fig. 4.3H) formed reasonably flat membranes upon 
incorporation of MscL, they were considered a sensible starting point for 2D crystallisation. While 
there were flat membrane structures present in the MscL/POPC sample as well (Fig. 4.3F), their low 
prevalence suggested relatively poor rates of incorporation. This is consistent with the result in 
section 3.3.3. (Fig. 3.21), where MscL (visualised by Ni-NTA-Nanogold) did not appear to 
incorporate well into POPC liposomes. The heterogeneous membrane morphology conditions (flat 
and highly curved areas) of MscL/DMPC membrane also made 2D crystallisation less possible in 
such a phospholipid bilayer. In addition to this experiment, it was reported that the majority of 2D 
crystallisation of alpha-helical membrane proteins – which MscL also belongs to – were successful 
with DOPC, POPC, and E. coli lipids (DMPC was favoured by beta-barrel proteins, which MscL 
does not belong to), making DOPC and E. coli lipid ideal phospholipids of choice for subsequent 
experiments. 
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4.3.1.2. The Influence of Protein to Lipid Ratio on 2D Crystallisation 
With both MscL/DOPC and MscL/POPC samples, there was an approximate inverse correlation 
between the P:L ratio and the size of membrane structures. Samples with a higher P:L tended to 
exhibit smaller structures. This was especially noticeable in the MscL/POPC samples, for which 
P:L ratios of 10:1, 4:1, 2:1, 1:1, and 1:1.5 were trialled (Fig. 4.4A-D). The 10:1 and 4:1 samples 
appeared to contain fragments of sheets/vesicles with exposed edges which suggested insufficient  
  
Figure 4.4. Electron micrographs of 2D crystallisation trials of MscL in POPC membrane with various 
P:L ratios (0 mM inorganic salt, 3 mg Biobeads, no freeze-thaw, pH 7.5). A/B) black arrow – small 
membranes with rough edges typically indicate insufficient phospholipids for continuous membrane 
formation; C) blue arrow – membrane in liposomal morphology; D) red arrow – membrane in flat surface 
morphology 
136 
 
phospholipid to form continuous membrane (Fig. 4.4A, B). Although this can also be caused by 
incomplete detergent removal, it was noted that lower P:L ratios yielded complete vesicles, 
suggesting detergent removal was likely complete. At the 2:1 (P:L) ratio, both small protein packed 
vesicles (Fig. 4.4C) and flat bilayer regions similar to those in the higher P:L ratio samples but 
larger in size (Fig. 4.4D) were observed. This suggested that there was enough phospholipid to form  
continuous membranes but not so much that all membranes would form vesicles. At lower P:L 
ratios of 1:1 and 1:1.5, most membranes formed vesicles (Fig. 4.4E, F). 
 
Figure 4.5. Electron micrographs of MscL reconstituted with DOPC (A-D) and E. coli lipid (E, F) lipids. 
The denoted P:L ratios were used in the presence of [3 mg Biobeads, no freeze-thaw, PBS pH 7.5].         
A) blue indicates vesicular membranes; the red arrow – MscL aggregate; B) green arrow – flat sheet; C/D) 
– purple arrow – vesicular membrane, black arrow – small flat surface membrane with partially curved 
edges; E/F) orange arrow – flat surface membrane with partially curved edges 
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A similar trend was observed for MscL/DOPC samples (Fig. 4.5A-D), but with a key difference to 
the MscL/POPC trials. At the P:L ratio of 3:1 (Fig. 4.5A), liposomes with smooth surfaces and 
protein aggregates were observed, suggesting that MscL did not incorporate into the membrane. In 
the sample with 2:1 (P:L) ratio, flat membranes larger than 200 nm in width were regularly 
observed, often aggregated and/or folded (Fig. 4.5B). At lower P:L ratios of 1:1 and 1:1.5, vesicles 
dominated the samples, although there were still significant fractions  
of flat membranes of approximately 100 nm in size (Fig. 4.5C, D). From these results, it was 
decided that 2:1 was the highest P:L ratio that could be used without negatively affecting the 
membrane morphology. This was also supported by the previous experiments of Saint et al., who 
reported MscL crystals obtained in the 2:1 MscL:DOPC ratio environment (Saint et al., 1998). 
A narrower range of P:L ratios was trialled for MscL/E. coli lipid samples, and a slightly different 
pattern was observed. Both flat membranes and liposomes were observed in both 2:1 and 1:1 (P:L) 
samples (Fig. 4.5E, F). This suggested that a higher P:L ratio could be used with MscL/E. coli lipid,  
however for consistency most MscL/E. coli lipid samples were prepared with 2:1 P:L ratio. 
4.3.1.3. The Influence of Detergent Types and Rate of Removal on 2D Crystallisation 
Both the type of detergent and its rate of removal can significantly affect MscL stability and its 
reconstitution into a lipid bilayer, as well as crystallisation kinetics and potentially crystal size and 
morphology. To analyse the role of detergents in these respects, β-DDM and Triton X-100 were 
chosen as the detergents. The starting concentrations were 0.3 mM for β-DDM and 0.7 mM for 
Triton X-100, which were approximately 2.5-3 times their critical micellar concentrations (~0.12 
mM for β-DDM and ~0.24 mM for Triton X-100). To induce crystallisation, the Biobeads were 
added to the MscL/phospholipid samples to induce detergent removal. As detergent adsorption by 
Biobeads is proportional to the total surface area of the Biobeads, the rate of detergent removal 
from the solution can be decreased simply by reducing the amount of Biobeads added from 2 x 1.5 
mg to 2 x 1.0 mg (Lambert et al., 1998). Since Biobeads have 7 % adsorption capacity (i.e. 1 mg 
Biobeads can adsorb 0.07 mg detergent), 2 mg of Biobeads are theoretically able to remove up to 
0.14 mg of β-DDM, which was far in excess of the nominal β-DDM mass in each solution (0.005 
mg). 
As expected given that Biobeads were added in excess, little noticeable difference between the two 
treatments was observed in the case of the MscL/E. coli samples (Fig. 4.6C, D). In contrast, in the 
case of MscL/DOPC samples, lowering the amount of added Biobeads had a significant effect on 
the membrane morphology (Fig. 4.6B). Large flat sheets of several µm in diameter were dominant 
in the sample treated with 2 mg Biobeads, and the fusion of small liposomes with flat membranes  
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was observed. There were also lightly-stained patches of 20 – 100 nm in size in the membrane (Fig. 
4.6B-2), which might be MscL complexes aggregating in the membrane. These results were 
encouraging as the starting point for 2D crystallisation of MscL. However, the MscL density in the 
membrane (based on the relative area of the light-staining patches in the membrane) appeared to be 
too low to induce crystal formation, suggesting that, for this condition in particular, the P:L ratio 
could be increased (i.e. less phospholipid in sample). In addition, the membranes often had lightly 
stained round edges, which could be either a band of MscL along the peripheries of the membrane 
or residual β-DDM stabilising the edge. 
Two starting β-DDM concentrations were trialled to investigate its effect on membrane formation. 
General destabilisation of the lipid bilayer with detergent has the potential to increase the rate of 
MscL incorporation into the membrane (A. Foo et al., 2015; Kocer et al., 2007; van den Bogaart et 
al., 2007), making it a potentially important factor in 2D crystallisation. Therefore, an experiment 
was conducted in which the starting β-DDM concentration of the solution prior to Biobead addition 
 
Figure 4.6. Electron micrographs of 2D crystallisation trials of MscL in DOPC (A, B) and E. coli lipid (C, 
D) membranes with variations in the amount of Biobeads added (2:1 P:L ratio, 0 mM inorganic salt, no 
freeze-thaw, pH 7.5). A) blue arrow – flat surface membrane, green arrow – vesicular membrane; B) red 
arrow – small liposomes fusing to large flat surface membrane, black arrow – round edge of the flat 
surface membrane; B-2) further 2x magnification of a section of the micrograph. Purple arrow – light-
staining patch hypothesised to be MscL aggregating in membrane 
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 was around twice (0.7 mM) that of the standard protocol (0.3 mM). Interestingly, this had a 
negative effect on the membrane formation instead, with the lipid and MscL aggregating separately 
(Fig. 4.7B). This was unlikely to be due to solubilisation of the phospholipids, since 0.7 mM β-
DDM is still lower than the concentrations commonly used in biophysics studies (A. Foo et al., 
2015; Kocer et al., 2007). A likely explanation is that the interaction between MscL and the 
phospholipid components is dependent on their molecular ratio. P:L ratios used in biophysics 
experiments generally do not exceed 1:100 (Anishkin et al., 2005; A. R. Battle et al., 2009; A. Foo 
et al., 2015; Grage et al., 2011; Kocer et al., 2007; Yilmaz et al., 2015), so MscL reconstitution 
would occur as MscL/detergent micelles incorporating into already formed large lipid bilayers (A. 
R. Battle et al., 2009). In the 2D crystallisation trials, however, the mechanism of membrane 
formation is likely different due to the high concentration of MscL relative to lipids, as was 
observed in the P:L screen in section 4.3.1.2. (Fig. 4.4, 4.5). Therefore, it is possible that a higher 
detergent concentration would have interfered with membrane formation instead of assisting with it. 
Replacing β-DDM with Triton X-100 as the detergent for MscL purification and 2D crystallisation 
did not lead to significant changes in the membrane morphology (Fig. 4.7C). This indicated that at 
least in the case of these two detergents their exchange had little influence on the size or shape of 
the MscL/lipid membranes formed under the conditions tested. 
4.3.1.4.  The Influence of Inorganic Ions on 2D Crystallisation 
Counterions have a very significant effect both on the incorporation of membrane proteins into lipid 
bilayers and the formation of ordered 2D crystals. Consequently the influence of ion type and 
concentration on the size of the proteoliposomes was analysed next. To initiate this process  
 
Figure 4.7. Electron micrographs of 2D crystallisation trials of MscL/E. coli lipid (2:1 P:L ratio, 3 mg 
Biobeads, no freeze-thaw, PBS pH 7.5). A) Reference sample where the starting β-DDM concentration 
was 0.3 mM, which was removed with Biobeads. B) The starting β-DDM concentration was 0.7 mM, 
which was removed with Biobeads. Blue arrow – large lipid aggregate, red arrow – MscL aggregate; C) 
0.7 mM Triton X-100 was used throughout MscL purification instead of β-DDM. 
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 MscL/E. coli lipid samples were supplemented with MgCl2 (0 mM, 10 mM, and 20 mM) during 
reconstitution to measure the effect of divalent cations. No significant difference was observed, 
with the size and shape of the membrane remaining similar (Fig. 4.8A-C). In contrast, 10 mM 
MgSO4 addition yielded larger MscL/E. coli lipid membranes (Fig. 4.8D), as well as aggregated 
lipid structures of over 500 nm in diameter with 50 mM MgSO4 (Fig. 4.8E). The effect of MgSO4 
on MscL/DOPC was even more pronounced, with the 10 mM MgSO4 treatment leading to large flat 
membrane formation (Fig. 4.9B) and 20 mM MgSO4 inducing general lipid aggregation (Fig. 4.9C). 
 These results indicate that the fusion of membranes in this trial was largely induced by the anions 
(SO42- in particular) (Baldwin, 1996; Z. Yang, 2009) rather than by cation-mediated electrostatic 
attraction (Mg2+) (Akashi et al., 1998; Bentz & Duzgunes, 1985; Ruso et al., 2003). In general, 
divalent cations are believed to assist with 2D crystallisation by attracting net negatively charged 
surface of membranes and/or proteins, which would otherwise repel each other due to the 
electrostatic repulsion (Akashi et al., 1998; Bentz & Duzgunes, 1985; Ruso et al., 2003). This 
attraction could in turn induce the membrane fusion, which is favourable for large 2D crystal 
 
Figure 4.8. Electron micrographs of 2D crystallisation trials of MscL in E. coli lipid membrane with 
variations in the type and concentration of added inorganic salt in solution (2:1 P:L ratio, no freeze-thaw, 
pH 7.5). A/B/C) small flat membrane with partially curved edges; D) black arrow – larger membrane with 
better defined edges; E) black arrow – large lipid aggregate 
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 formation (Brent L. Nannenga et al., 2013). However, many experiments studying this effect used 
net anionic phospholipids such as phosphatidylserine and phosphatidylglycerol rather than 
zwitterionic phospholipids used in this experiment (phosphatidylcholine and E. coli lipid, which is 
largely phosphatidylethanolamine) (Akashi et al., 1998; Bentz & Duzgunes, 1985; Ruso et al., 
2003). Hence, for this experiment, it is probable that Mg2+ did not have significant influence on the 
membrane morphology. 
 In contrast, the differential effects of the anions Cl- and SO42- suggest that the observed changes 
may be driven by Hofmeister effect, where anions generally have stronger influence than cations (Z. 
Yang, 2009), on proteins. The position of ions in the Hofmeister series affects the 
solubility/aggregation of both proteins (Baldwin, 1996; Salis & Ninham, 2014) and phospholipids 
(Clarke & Lupfert, 1999; Petrache et al., 2006; Z. Yang, 2009), but the effect of individual ions is 
more complicated. SO42- has a higher ionic strength than Cl- with respect to proteins (Baldwin, 
1996; Salis & Ninham, 2014), but it has a weaker strength than Cl- with respect to liposomes 
(Clarke & Lupfert, 1999; Petrache et al., 2006). In this trial, SO42- was shown to induce larger 
membrane formation (Fig. 4.8D), whereas Cl- had little influence on the membrane morphology 
(Fig. 4.8B). This indicates that this was largely driven by the anions affecting MscL. This result is a 
positive outcome for MscL 2D crystallisation efforts, because 1) it suggests that MscL density in 
the membrane is high enough to overcome the opposing influence of phospholipids with respect to 
Hofmeister effect, and 2) this same effect is also thought to be the main driver for inorganic ion-
mediated protein crystallisation in general (Majeed et al., 2003). Therefore, 10 mM MgSO4 was 
determined to be the optimal inorganic salt type and concentration for MscL 2D crystallisation   
  
Figure 4.9. Electron micrographs of 2D crystallisation trials of MscL in DOPC membrane with variations 
in the concentration of added MgSO4 in solution (2:1 P:L ratio, 3 mg Biobeads, no freeze-thaw, pH 7.5). 
A) green arrow – vesicular membrane, blue arrow – flat surface membrane; B) red arrows – large flat 
surface membrane, the elongated shape of the lower membrane suggests that the membrane’s edge is 
stable; C) black arrow – large lipid aggregate 
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experiments, with potential for finer factorial screening around this ion concentration once other 
conditions have been further optimised. 
4.3.1.5. The Influence of Freeze-Thaw Process on 2D Crystallisation 
It is reported that, in some instances, the use of freeze-thaw cycles can increase the size of 
proteoliposomes/membranes, which can in turn assist with 2D crystallisation (Lasala et al., 2015). 
The freeze-thaw process did not have significant effect on the MscL/E. coli lipid membrane 
morphology (Fig. 4.10). Although the sheet-like structures appeared to aggregate more often in 
freeze-thawed samples, there was no significant change in the size of the structures.  
4.3.1.6. The Influence of pH on 2D Crystallisation 
pH appeared to have little influence on the MscL/lipid membrane morphology and crystallisation 
(Fig. 4.11), although this might be due to the limited range tested (pH 7.0, 7.5). With the exception 
of synthetic lipids, net neutral phospholipids are generally not sensitive to such a small pH change 
(Phayre et al., 2002), so it was expected that this would not significantly change the membrane 
formation. However, MscL has a pI of 6.1, so this experiment aimed to test whether lowering the 
pH to 7.0 from 7.5 would help induce MscL aggregation in the membrane without precipitating it in 
solution (observed at pH 6.0). While this parameter does not seem to be a major factor in promoting 
MscL aggregation/crystallisation, it may still be important in improving crystal quality once an 
otherwise optimal condition for MscL 2D crystallisation is identified. 
 
Figure 4.10. Electron micrographs of 2D crystallisation trials of MscL in E. coli lipid membrane 
plus/minus the use of freeze-thaw cycles (2:1 P:L ratio, 10 mM MgSO4, 3 mg Biobeads, pH 7.5). A/B) 
Red arrow – flat membrane with curved edge 
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4.3.1.7. Monolayer-assisted MscL 2D Crystallisation 
 2D crystallisation using phospholipid monolayer scaffolds is another method of 2D protein 
crystallisation related to the traditional method detailed in the previous sections. As it was learned 
from the previous trials that MscL and phospholipids could form large sheet-like structures, it was 
hypothesised that repeating this experiment in the presence of a monolayer scaffold might help with 
achieving high MscL density in the membrane, and that this coupled with aligning MscL molecules 
in the same orientation would assist with its crystallisation. Since the MscL/DOPC mixture could 
form large flat membranes with the least membrane curvature in the previous trials, DOPC was 
selected as the bilayer-forming phospholipid component in this experiment. 
Small granular structures of approximately 10 nm in size could be seen in the MscL/β-DDM 
samples of both high (20 %) and low (2 %) Ni-NTA-DLPC densities in the monolayer (Fig. 4.12A, 
B). These were unlikely to be nonspecifically bound detergent micelles, since the negative control 
with only 1 mM β-DDM did not contain similar features (Fig. 4.12F). Instead, they are likely 
MscL/β-DDM micelles specifically bound to the Ni-NTA head groups of the lipid monolayer. In 
both samples, darkly stained MscL aggregates of 50 – 100 nm in size could also be seen (Fig. 4.12, 
 
Figure 4.11. Electron micrographs of 2D crystallisation trials of MscL in DOPC (A, B) and E. coli lipid 
(C, D) membranes with variations in the pH of the solution (2:1 P:L ratio, 10 mM MgSO4, 3 mg Biobeads, 
no freeze-thaw). A/B) Red arrow – flat membrane with sharp edge, blue arrow – vesicular membrane; 
C/D) green arrow – flat membrane with curved edge 
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blue arrow), but these could simply be random aggregation of the protein on the scaffold rather than 
specific clustering of the protein. Additionally for the 2 % Ni-NTA-DLPC sample, the micelles 
appeared to merge to form larger continuous lightly stained areas throughout the grid (Fig. 4.12A). 
While such structures were occasionally present in the 20 % Ni-NTA-DLPC sample as well, they  
 
Figure 4.12. Electron micrographs of monolayer-assisted 2D crystallisation trials of MscL. Monolayer 
containing 2 % Ni-NTA-DLPC (w/w) was used for samples in the left column (A, C, E), and monolayer 
containing 20 % Ni-NTA-DLCP (w/w) was used for samples in the right column (B, D, F). A/B) MscL in 
1 mM β-DDM, C/D) MscL in 1 mM β-DDM mixed with DOPC at the P:L ratio of 2:1. E) MscL in 1 mM 
β-DDM mixed with DOPC at the P:L ratio of 2:1, with the further addition of 3 mg Biobeads to each well. 
Red arrow – Fused MscL/β-DDM micelles; Blue arrow – MscL aggregate; Green arrow – string-like 
MscL/β-DDM/DOPC membrane. F) Negative control with only 1 mM β-DDM in solution. 
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were relatively rare in comparison and not present in the micrograph presented in this thesis (Fig. 
4.12B). The high density of MscL/β-DDM micelles in the 2 % Ni-NTA-DLPC sample (Fig. 4.12A)  
was somewhat unexpected, since the lower density of Ni-NTA head group should have led to fewer 
particles binding to the monolayer. This could have been due to 2 % Ni-NTA-DLPC still being a 
high enough concentration to saturate the monolayer scaffold with MscL, but subsequent 
experiments showed significant differences between 2 % and 20 % samples, disproving this 
hypothesis. 
The addition of DOPC to the MscL/β-DDM solution had different results for 2 % and 20 % Ni-
NTA-DLPC samples. The density of the granular structures decreased, the lightly stained fused 
membrane/micellar structures became better defined (but not necessarily larger), and MscL 
aggregates became much less common in the 2 % Ni-NTA-DLPC sample (Fig. 4.12C). In contrast, 
string-like features largely replaced the granular structures in the 20 % Ni-NTA-DLPC sample (Fig. 
4.12D). These might be one-dimensional aggregates (as opposed to 2D arrays) which can represent 
intermediates of curvature-inducing detergent-solubilised complexes and sheet-forming protein 
bilayers (Fig. 4.12C, D). These 1D aggregates appear flexible and this may explain MscL’s 
orientation and the degree of freedom on the monolayer surface. MscL aggregates were also 
commonly present in this sample (Fig. 4.12D, blue arrow), but they were relatively small in size (50 
– 100 nm), suggesting that these were random aggregates as well. Such differences in the two 
samples were in line with expectations, since they reflected the difference in the affinity tag density 
on the monolayer between them. 
  
Figure 4.13. Electron micrographs of monolayer-assisted 2D crystallisation trials of MscL in 1 mM β-
DDM mixed with DOPC at the P:L ratio of 2:1, with the further addition of 3 mg Biobeads to each well. 
The monolayer contained 20 % Ni-NTA-DLPC. A) Low-magnification image of the sample. The 
rectangular dark-staining structure (red arrow) is a large MscL aggregate. A section of the aggregate (red 
square) was further magnified in B), which shows unstructured MscL complexes (black arrow). C) is the 
light-staining region (blue square) of (A). Green arrow – fused string-like MscL/DOPC membrane 
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Removal of β-DDM from the solution with Biobeads had a significant impact on both samples (Fig. 
4.12E, Fig. 4.13). String-like MscL/DOPC membranes also appeared in the 2 % Ni-NTA-DLPC 
sample (Fig. 4.12E), which was similar to the 20 % Ni-NTA-DLPC sample before detergent 
removal (Fig. 4.12D). This observed change suggests that the removal of detergent promoted partial 
organisation of MscL/DOPC membranes. In addition, large MscL aggregates up to a few µm in size 
could be seen (Fig. 4.12E, blue arrow). Given the relative lack of small aggregates, this could have 
been caused by the cluster-inducing effect of DOPC on MscL, which has been documented in 
Grage et al. (2011) as well as in section 3.3.3. of this thesis. 
Detergent removal from the 20 % Ni-NTA-DLPC sample led to the formation of very large two-
dimensional MscL aggregates (Fig. 4.13A, red arrow). Unlike smaller aggregates, they were well-
defined at the global level and remained largely on the two-dimensional plane of the monolayer 
instead of forming a three-dimensional aggregate, suggesting some sort of order at the global level. 
However, at the local level, the MscL complexes were randomly oriented and did not form lattice 
structures (Fig. 4.13B, black arrow), indicating that they were still aggregates, not crystals. Light-
staining “holes” were occasionally present in the sheet of MscL aggregate (Fig. 4.13B), indicating 
the presence of residual detergent (Ujwal & Bowie, 2011). Outside the large aggregate region, the 
sample was mostly dominated by string-like MscL/DOPC membranes which often fused to form 
slightly more continuous sheet-like structures (Fig. 4.13C). The failure of the membrane to form 
proper continuous sheets indicated that there was still a significant concentration of β-DDM in the 
solution, promoting 1D aggregate morphology and stabilising edges of the membrane. Hence, a 
strategy to more completely remove the detergent at a slower rate would likely help better 
organisation of both the MscL complex and the membrane. 
4.3.1.8. Discussion 
While further progress was hindered by time constraints, the results presented here identify a 
number of leads for further improvement of 2D crystallisation conditions. MscL/DOPC and 
MscL/E. coli lipid systems with P:L ratio of 2:1 were identified as producing planar membranes 
most conducive to 2D crystal formation. The addition of 10 mM MgSO4 and slower detergent 
removal with Biobeads were factors also found to aid with the formation of larger, sheet-like 
membranes required for 2D crystallography. The experiments also identified factors which might 
not be critical for crystal formation at this stage of optimisation, such as the use of freeze-thaw 
cycles, pH, and the type of detergent used. It was also shown from the monolayer-assisted 
crystallisation trials that MscL was capable of forming nondenaturing 2D aggregates on the 
membrane, which are often precursors to crystallisation. Consequently these experiments have 
defined a region of interest within the complex multi-dimensional space analysed, which would 
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assist future crystallisation experiments. 
However, the experiments have also revealed areas requiring further analysis. First, in larger planar 
membranes the edges were often smooth, suggesting that they were stabilised by the presence of 
residual detergents. Furthermore this was likely under relatively low local P:L ratio of the 
membrane as the membranes did not appear protein-packed. While the former possibility can be 
addressed by the inclusion of an extra Biobead addition step, it is more difficult to solve the latter 
problem since higher global P:L ratio of the solution would simply lead to reduction in membrane 
size as shown in Fig. 4.4 and Fig. 4.5. One potential way to overcome this might be through a 
stepwise addition of the protein component (i.e. MscL solution) so that the extra MscL added in 
later steps could incorporate into the preformed large membranes, raising its local P:L ratio. P:L 
ratio is recognised as one of the most important factors in 2D crystallisation (Kuang et al., 2015; 
Lasala et al., 2015; Lévy et al., 1999; Brent L. Nannenga et al., 2013; Stuart et al., 2004), but 
strategies to control it, including the stepwise method proposed, are surprisingly sparse in the 
literature. 
Another major challenge is controlling MscL aggregation in a way that will promote crystallisation 
instead of unstructured clustering as shown in the monolayer studies (Fig. 4.13). The MscL 
aggregation was likely mediated in two ways: a local over-concentration of MscL to the monolayer 
interface, and by the fact that it is energetically favourable for MscL to aggregate in DOPC 
membranes (see section 3.3.3.).  The difference in the size of MscL aggregates observed on the 2 % 
and 20 % Ni-NTA-DLPC monolayers (Fig. 4.12E, 4.13B) suggests the importance of crowding 
factor, and MscL aggregation in DOPC is well-documented in Grage et al. (2011) and in section 
3.3.3. While both factors can promote crystallisation under the right conditions (Majeed et al., 
2003; McPherson, 2004; Wiener, 2004), the aggregation needs to occur in an orderly progression 
for MscL to crystallise. One potential solution is to lower the rate of detergent removal, either by 
reducing the amount of Biobeads added per step (e.g. 6 x 0.5 mg Biobead addition instead of 2 x 1.5 
mg) or by removing detergents by microdialysis instead. The reduced prevalence of MscL 
aggregates in the [MscL/β-DDM/DOPC; 2 % Ni-NTA-DOPC] sample suggests that detergents have 
a negative effect on MscL clustering. Hence, slower detergent removal may also make MscL 
aggregation occur at a slower pace, potentially leading to crystallisation. 
Alternatively, DOPC-mediated MscL aggregation may be able to be controlled through the addition 
of other lipids and detergents. Section 3.3.3. showed phosphatidylglycerols (PG) to have a negative 
influence on MscL aggregation. While high concentrations of PG in the membrane might fully 
inhibit MscL aggregation (hence crystallisation), at lower concentrations, it may be a useful tool to 
control the energetic favourability of MscL to aggregate. While PG is by itself not a commonly  
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 used phospholipid for 2D crystallisation, it is one of two major components of E. coli lipid (Oursel  
et al., 2007), a mixture which is commonly used (Lasala et al., 2015), giving credence to this 
strategy. 
Especially with MscL/E. coli lipid systems, membrane curvature may need to be controlled for a 
successful 2D crystallisation. Much of the membranes formed flat sheets, but there were also curved 
regions especially near the rim of the membranes. While this is apparently not critical to 
crystallisation since some 2D crystal structures were determined with tubular and vesicular 
membranes, flat membranes are still preferred this since it tends to yield higher-resolution structures 
(Lasala et al., 2015). Solutions to this include adding small amounts of detergents such as HTG, 
which had success improving the quality of 3D Photosystem II crystals (Piano et al., 2010), or 
phospholipids with specific lipid packing properties. 
While the 2D crystallisation experiments are still a work in progress, the trials so far have produced 
significant results for studying the biophysical relationship between MscL and phospholipids. The 
most significant was the direct observation of MscL aggregation in DOPC membranes (Fig. 4.12, 
4.13B). Section 3.3.3. indirectly visualised MscL clustering on membranes via Ni-NTA-Nanogold, 
and this experiment confirms the finding by showing MscL aggregation on the 2D plane. The 
resolution appears to be similar to that visualised by atomic force microscopy (AFM) in Grage et. 
al. (2011), which reinforces the findings of the study as well. 
 
Figure 4.14. Schematic representation of MscL-induced membrane curvature. In MscL/DMPC membrane 
(A1, A2), curved membrane (A2) will be favoured to flat membrane (A1) due to the smaller void region 
(shaded in blue). In MscL/DOPC membrane (B), however, the negative curvature-inducing effect of 
DOPC will cancel out the positive curvature-inducing effect of MscL, leading to flat membrane. 
149 
 
The second major finding is that MscL can directly influence the membrane curvature and/or 
stability. DMPC is generally a non-curvature-inducing phospholipid, whereas POPC and DOPC are 
negatively curvature-inducing phospholipids due to their molecular packing properties. However, in 
this trial MscL/DMPC membranes showed the highest level of curvature; MscL/POPC membranes 
had an intermediate level of curvature; and MscL/DOPC membranes showed the least. One of the 
major differences between DMPC and DOPC which could have affected membrane curvature in the 
presence of MscL is the hydrophobic mismatch. The length of the fatty acyl chains of DMPC is 
much shorter (14 carbons) than that of DOPC (18 carbons). This would have led to different levels 
of hydrophobic mismatch with the hydrophobic interface of MscL’s transmembrane domain. The 
influence of hydrophobic mismatch on MscL channel function has been documented both 
experimentally and by molecular dynamics simulations (Bavi et al., 2014; A. Foo et al., 2015; 
Perozo, Kloda, et al., 2002) and it has been correlated with local membrane curvature as well (Bavi, 
Vossoughi, et al., 2016; Perozo, Kloda, et al., 2002; Phillips et al., 2009), giving further credence to 
the idea that the hydrophobic mismatch between MscL and the phospholipids could be affecting the 
observed membrane curvature. 
Another difference between DMPC and DOPC which could affect the curvature of MscL/lipid 
membrane is the packing shape of both MscL and the phospholipids in the membrane. In this 
explanation, MscL has a positive curvature-inducing effect which can be negated by the negative 
curvature-inducing effects of DOPC but not by DMPC (which has a neutral curvature-inducing 
effect) (Fig. 4.14). Both this explanation and hydrophobic mismatch show that MscL can be an 
active factor influencing membrane curvature rather than merely being affected by it. 
This result potentially has the significance of being an experimental observation of a 
mechanosensitive channel directly influencing membrane curvature. It has been hypothesised based 
on molecular dynamics studies that MscS can induce local curvature on the membrane (Phillips et 
al., 2009; Pliotas et al., 2015), but this has not been experimentally verified. Likewise, MscL and 
membrane curvature are hypothesised to influence each other (Phillips et al., 2009), but most 
studies have generally focused on only one side of the relationship (i.e. curvature affecting MscL 
function) (Bavi, Cox, et al., 2016; Bavi et al., 2014; Bavi, Vossoughi, et al., 2016; Tang et al., 
2008b). Despite its clear importance in both membrane protein biophysics and 2D crystallography, 
the relationship between the intrinsic shape of membrane proteins and membrane curvature is 
relatively little studied (McMahon & Boucrot, 2015; Svetina, 2015) apart from the observation of 
yeast and bovine ATPases inducing membrane curvature both in vivo (Davies et al., 2012) and in 
attempted 2D crystallisation experiments (Jiko et al., 2015). The experiments performed in this 
section have shown membrane proteins to be a potentially significant factor in membrane curvature, 
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and therefore presents an interesting starting point for further investigation into this relationship. 
Lastly, the results from this section were also helpful for the design and interpretation of 
experiments in section 3.3.3. For example, early preparatory trials such as the suitable time for 
phospholipid sonication performed for this section were largely carried over to those in section 
3.3.3., saving considerable time in this regard. One of the potential confounding factors in section 
3.3.3. was liposome size influencing MscL clustering (instead of phospholipid composition). This 
could be addressed by adding 10 mM MgSO4 to the samples (to make the liposomes larger in 
general), which are findings from this section. In addition, the observation of MscL clusters in the 
monolayer studies was a confirmation of the MscL clustering observed in DOPC liposomes seen in 
section 3.3.3., and it also supported the explanation that MscL clusters localising to the edges of 
liposomes was an artefact of the negative staining process (as opposed to being of biophysical 
relevance). Conversely, the improved understanding of MscL/phospholipid relationship from 
studies in section 3.3.3. will also be useful in guiding the future optimisation trials for 2D 
crystallography of MscL. 
4.3.2. 3D Crystallisation 
3D protein crystallisation is the most commonly used method to determine protein structure, and 
has been used to determine the structures of M. tuberculosis, S. aureus, and M. acetivorans MscL. 
While this had not been successful with E. coli MscL at the start of this project, it was considered as 
a potential approach to use in this thesis. 
With the failure to cleave the linker region of MscLTEVc construct with both TEV protease and 
thrombin, it seemed likely that the linker region formed a structure partially embedded in the 
solubilising detergent micelle instead of being an unstructured strand located in solution. It was 
hypothesised from this observation that the linker region could aid with 3D crystallisation by 1) 
providing a more rigid and consistent structure to the micelles, which often sterically hinder 
crystallisation (Ghosh et al., 2015); and 2) the soluble component of the linker region increasing the 
overall size of solution-facing surface. Increasing the soluble domain to aid with membrane protein 
crystallisation is commonly practiced with GPCR (Ghosh et al., 2015). It has also been used to 
produce crystals of M. acetivorans MscL/riboflavin synthase fusion protein, where the latter is 
thought to have enabled crystallisation by significantly increasing the hydrophilic surface of the 
protein (J. Li et al., 2015). Therefore, a crystallisation strategy where the full MscL construct with 
the linker region not cleaved was adopted. 
Commercial broad screen conditions were chosen with the assistance of Dr. Suzanne Norwood  
151 
 
 
Figure 4.15. Crystallisation well of MscL in [0.1 M Tris pH 8.5, 1.8 M Li2SO4]. There were no crystals at 
the time of set up (A) However, crystal-like features appeared in Day 1 (B), and became larger in Day 5 
(C). In Day 8 (D; magnified view), short rod-like precipitation can be seen. 
 
 
Figure 4.16. Crystallisation wells of MscL in [0.1 M Tris 8.5, 0.1 M MgCl2, 0.1 M NaCl, 12 % PEG 
4000] (A-B) and [0.2 M MgCl2, 20 % PEG 3350] (C-D). With the first condition, large rod-like crystals 
showed up as soon as the well was set up (A), indicating that they could be inorganic salt crystals. With 
the second condition, there were only cloudy precipitates until Day 1 (C), but needle-like crystals started 
growing in Day 2 and reached peak size by Day 5 (D). 
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 (IMB) to identify promising regions for refined investigation. The rationale for the selections were 
as follows: 
 PEGRx sets screen for the polyethylene glycol’s (PEG) length; PEG/Ion sets screen for a range  
 of inorganic ions while keeping the PEG size constant; 
 Clear Strategy sets have generally produced protein crystals in Dr. Brett Collins’ group (oral 
communication; IMB); 
 MemGold and MemSys sets are screens designed for the crystallisation of membrane proteins. 
In addition, to reduce the possibility of detergent phase separation and detergent crystal formation, 
the buffer for MscL solution was exchanged to one with lower β-DDM concentration (0.5 mM) 
before the crystallisation experiments. 
Once the broad screen was set up, the wells were checked every day for the next eight days and 
conditions ranked according to the morphology of the precipitate and/or crystals observed. X-
shaped rod-like crystals appeared in two conditions (Condition 1 and 2; Fig. 4.16A/B, 4.17A) 
within 24 h. In addition, amorphous but still mildly defined clear precipitate appeared in five 
conditions between 12 h and 3 days, one of which produced a radiating bundle of needle-like 
crystals after three days (Condition 3, Fig. 4.16C/D). There were also a number of wells which  
Figure 4.17. Crystallisation wells of MscL. A) Day 8, [0.1 M CAPSO pH 6.5, 0.1 M MgCl2, 0.1 M 
NaCl, 12 % PEG 4000]; B) Day 8, [0.2 M CaCl2, 0.2 M CoCl2, 0.2 M CoCl2, 10 % PEG 3350]; C) Day 
8, [0.1 M MES pH 6.5, 0.1 M NaCl, 0.1 M Li2SO4, 30 % PEG 400]; D) Day 8, [0.1 M MOPS pH 7.0, 
0.1 M NaCl, 30 % PEG 400;]. Crystal-like features appeared in Day 0 in the first two conditions (A, B). 
Cloudy precipitates appeared in Day 0 in the latter two conditions (C, D), and they progressively became 
more organised over the next three days. 
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Table 4.1. MscL 3D crystallisation optimisation trials using hanging drop method. Appearance 
of crystallisation drops were labelled with colour shading. Light purple – clear; Light blue – 
amorphous precipitate (spherulite); Light orange – X-shaped crystals; Pink – phase separation; 
Yellow – needle-like crystals on spherulite; Light green – cloudy precipitate 
 Tray 1 
 1-1 1-2 1-3 1-4 1-5 1-6 
A 
0.05 M Tris pH 8.5; 
0.9 M Li2SO4 
0.06 M Tris pH 8.5; 
1.1 M Li2SO4 
0.007 M Tris pH 8.5; 
1.3 M Li2SO4 
0.08 M Tris pH 8.5; 
1.4 M Li2SO4 
0.09 M Tris pH 8.5; 
1.6 M Li2SO4 
0.1 M Tris pH 8.5; 
1.8 M Li2SO4 
B 
0.05 M MES pH 6.5; 
0.05 M NaCl; 
0.05 M Li2SO4; 
15 % PEG 400 
0.06 M MES pH 6.5; 
0.06 M NaCl; 
0.06 M Li2SO4; 
18 % PEG 400 
0.07 M MES pH 6.5; 
0.07 M NaCl; 
0.07 M Li2SO4; 
21 % PEG 400 
0.08 M MES pH 6.5; 
0.08 M NaCl; 
0.08 M Li2SO4; 
24 % PEG 400 
0.09 M MES pH 6.5; 
0.09 M NaCl; 
0.09 M Li2SO4; 
27 % PEG 400 
0.1 M MES pH 6.5; 
0.1 M NaCl; 
0.1 M Li2SO4; 
30 % PEG 400 
C 
0.05 M MOPS 
pH 7.0; 
0.05 M NaCl; 
15 % PEG 400; 
0.06 M MOPS 
pH 7.0; 
0.06 M NaCl; 
18 % PEG 400; 
0.07 M MOPS 
pH 7.0; 
0.07 M NaCl; 
21 % PEG 400; 
0.08 M MOPS 
pH 7.0; 
0.08 M NaCl; 
24 % PEG 400; 
0.09 M MOPS 
pH 7.0; 
0.09 M NaCl; 
27 % PEG 400; 
0.1 M MOPS pH 7.0; 
0.1 M NaCl; 
30 % PEG 400; 
D 
0.05 M Tris pH 8.5; 
0.05 M MgCl2; 
0.05 M NaCl; 
6 % PEG 4000 
0.06 M Tris pH 8.5; 
0.06 M MgCl2; 
0.06 M NaCl; 
7 % PEG 4000 
0.07 M Tris pH 8.5; 
0.07 M MgCl2; 
0.07 M NaCl; 
8 % PEG 4000 
0.08 M Tris pH 8.5; 
0.08 M MgCl2; 
0.08 M NaCl; 
10 % PEG 4000 
0.09 M Tris pH 8.5; 
0.09 M MgCl2; 
0.09 M NaCl; 
11 % PEG 4000 
0.1 M Tris pH 8.5; 
0.1 M MgCl2; 
0.1 M NaCl; 
12 % PEG 4000 
 Tray 2 
 2-1 2-2 2-3 2-4 2-5 2-6 
A 
0.05 M CAPSO 
pH 6.5; 
0.05 M MgCl2; 
0.05 M NaCl; 
6 % PEG 4000 
0.06 M CAPSO 
pH 6.5; 
0.06 M MgCl2; 
0.06 M NaCl; 
7 % PEG 4000 
0.07 M CAPSO 
pH 6.5; 
0.07 M MgCl2; 
0.07 M NaCl; 
8 % PEG 4000 
0.08 M CAPSO 
pH 6.5; 
0.08 M MgCl2; 
0.08 M NaCl; 
10 % PEG 4000 
0.09 M CAPSO 
pH 6.5; 
0.09 M MgCl2; 
0.09 M NaCl; 
11 % PEG 4000 
0.1 M CAPSO 
pH 6.5; 
0.1 M MgCl2; 
0.1 M NaCl; 
12 % PEG 4000 
B 
0.1 M MgCl2; 
10 % PEG 3350 
0.12 M MgCl2; 
11 % PEG 3350 
0.14 M MgCl2; 
14 % PEG 3350 
0.16 M MgCl2; 
16 % PEG 3350 
0.18 M MgCl2; 
18 % PEG 3350 
0.2 M MgCl2; 
20 % PEG 3350 
C 
0.1 M CaCl2; 
0.1 M CoCl2; 
0.1 M CdCl2; 
10 % PEG 3350 
0.12 M CaCl2; 
0.12 M CoCl2; 
0.12 M CoCl2; 
11 % PEG 3350 
0.14 M CaCl2; 
0.14 M CoCl2; 
0.14 M CoCl2; 
14 % PEG 3350 
0.16 M CaCl2; 
0.16 M CoCl2; 
0.16 M CoCl2; 
16 % PEG 3350 
0.18 M CaCl2; 
0.18 M CoCl2; 
0.18 M CoCl2; 
18 % PEG 3350 
0.2 M CaCl2; 
0.2 M CoCl2; 
0.2 M CoCl2; 
10 % PEG 3350 
D 
Negative Control 
(1-6B) 
Negative Control 
(1-6C) 
Negative Control 
(1-6D) 
Negative Control 
(2-6A) 
Negative Control 
(2-6B) 
Negative Control 
(2-6C) 
 
      
Table 4.2. MscL 3D crystallisation optimisation trials using microbatch method. Appearance of 
crystallisation drops were labelled with colour shading. Light blue – amorphous precipitate 
(spherulite); Yellow – needle-like crystals on spherulite; Light green – cloudy precipitate 
 
Tray 4 
 4-1 4-2 4-3 4-4 4-5 4-6 
A 
0.1 M MgCl2; 
10 % PEG 3350; 
pH 6.0; 
Paraffin oil 
0.12 M MgCl2; 
11 % PEG 3350; 
pH 6.0; 
Paraffin oil 
0.14 M MgCl2; 
14 % PEG 3350; 
pH 6.0; 
Paraffin oil 
0.16 M MgCl2; 
16 % PEG 3350; 
pH 6.0; 
Paraffin oil 
0.18 M MgCl2; 
18 % PEG 3350; 
pH 6.0; 
Paraffin oil 
0.2 M MgCl2; 
20 % PEG 3350; 
pH 6.0; 
Paraffin oil 
B 
0.1 M MgCl2; 
10 % PEG 3350; 
pH 7.5; 
Paraffin oil 
0.12 M MgCl2; 
11 % PEG 3350; 
pH 7.5; 
Paraffin oil 
0.14 M MgCl2; 
14 % PEG 3350; 
pH 7.5; 
Paraffin oil 
0.16 M MgCl2; 
16 % PEG 3350; 
pH 7.5; 
Paraffin oil 
0.18 M MgCl2; 
18 % PEG 3350; 
pH 7.5; 
Paraffin oil 
0.2 M MgCl2; 
20 % PEG 3350; 
pH 7.5; 
Paraffin oil 
C 
0.1 M MgCl2; 
10 % PEG 3350; 
pH 6.0; 
Al’s oil 
0.12 M MgCl2; 
11 % PEG 3350; 
pH 6.0; 
Al’s oil 
0.14 M MgCl2; 
14 % PEG 3350; 
pH 6.0; 
Al’s oil 
0.16 M MgCl2; 
16 % PEG 3350; 
pH 6.0; 
Al’s oil 
0.18 M MgCl2; 
18 % PEG 3350; 
pH 6.0; 
Al’s oil 
0.2 M MgCl2; 
20 % PEG 3350; 
pH 6.0; 
Al’s oil 
D 
0.1 M MgCl2; 
10 % PEG 3350; 
pH 7.5; 
Al’s oil 
0.12 M MgCl2; 
11 % PEG 3350; 
pH 7.5; 
Al’s oil 
0.14 M MgCl2; 
14 % PEG 3350; 
pH 7.5; 
Al’s oil 
0.16 M MgCl2; 
16 % PEG 3350; 
pH 7.5; 
Al’s oil 
0.18 M MgCl2; 
18 % PEG 3350; 
pH 7.5; 
Al’s oil 
0.2 M MgCl2; 
20 % PEG 3350; 
pH 7.5; 
Al’s oil 
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produced poorly defined spherulites and/or clear precipitate, which were discarded as the chances of 
them being crystals were deemed too small. 
Crystallisation conditions were then refined around the 8 selected conditions (Fig. 4.15, 4.16, 4.17), 
where precipitant concentration was varied for each condition (Table 4.1). Long rod-like crystals 
(>500 µm in length) with branches formed in both the control group (which did not contain MscL) 
and drops with MscL within 5 min in Conditions 1 and 2, which suggested that they were salt 
crystals. This was further confirmed by a quick experiment where the crystals were briefly treated  
with heat, which would destroy protein crystals but not salt crystals (Raghunathan et al., 2010). The 
other five conditions (conditions 4 – 8) only produced spherulites and/or cloudy precipitate, which 
Table 4.3. MscL 3D crystallisation optimisation trials using microbatch method. Appearance of 
crystallisation drops were labelled with colour shading. Light blue – amorphous precipitate 
(spherulite); Yellow – needle-like crystals on spherulite; Dark green – Hexagonal 3D crystals 
 Tray 5 
 5-1 5-2 5-3 5-4 5-5 5-6 
A 
0.12 M MgCl2; 
14 % PEG 3350; 
PBS pH 7.5; 
Paraffin oil; 
2 µL precipitant 
0.16 M MgCl2; 
16 % PEG 3350; 
PBS pH 7.5; 
Paraffin oil; 
2 µL precipitant 
0.2 M MgCl2; 
20 % PEG 3350; 
PBS pH 7.5; 
Paraffin oil; 
2 µL precipitant 
0.12 M MgCl2; 
14 % PEG 3350; 
PBS pH 7.5; 
Paraffin oil; 
1 µL precipitant 
0.16 M MgCl2; 
16 % PEG 3350; 
PBS pH 7.5; 
Paraffin oil; 
1 µL precipitant 
0.2 M MgCl2; 
20 % PEG 3350; 
PBS pH 7.5; 
Paraffin oil; 
1 µL precipitant 
B 
0.12 M MgCl2; 
14 % PEG 3350; 
PBS pH 6.0; 
Paraffin oil; 
2 µL precipitant 
0.16 M MgCl2; 
16 % PEG 3350; 
PBS pH 6.0; 
Paraffin oil; 
2 µL precipitant 
0.2 M MgCl2; 
20 % PEG 3350; 
PBS pH 6.0; 
Paraffin oil; 
2 µL precipitant 
0.12 M MgCl2; 
14 % PEG 3350; 
PBS pH 6.0; 
Paraffin oil; 
1 µL precipitant 
0.16 M MgCl2; 
16 % PEG 3350; 
PBS pH 6.0; 
Paraffin oil; 
1 µL precipitant 
0.2 M MgCl2; 
20 % PEG 3350; 
PBS pH 6.0; 
Paraffin oil; 
1 µL precipitant 
C 
0.12 M MgCl2; 
14 % PEG 3350; 
PBS pH 7.5; 
Al’s oil; 
2 µL precipitant 
0.16 M MgCl2; 
16 % PEG 3350; 
PBS pH 7.5; 
Al’s oil; 
2 µL precipitant 
0.2 M MgCl2; 
20 % PEG 3350; 
PBS pH 7.5; 
Al’s oil; 
2 µL precipitant 
0.12 M MgCl2; 
14 % PEG 3350; 
PBS pH 7.5; 
Al’s oil; 
1 µL precipitant 
0.16 M MgCl2; 
16 % PEG 3350; 
PBS pH 7.5; 
Al’s oil; 
1 µL precipitant 
0.2 M MgCl2; 
20 % PEG 3350; 
PBS pH 7.5; 
Al’s oil; 
1 µL precipitant 
D 
0.12 M MgCl2; 
14 % PEG 3350; 
PBS pH 6.0; 
Al’s oil; 
2 µL precipitant 
0.16 M MgCl2; 
16 % PEG 3350; 
PBS pH 6.0; 
Al’s oil; 
2 µL precipitant 
0.2 M MgCl2; 
20 % PEG 3350; 
PBS pH 6.0; 
Al’s oil; 
2 µL precipitant 
0.12 M MgCl2; 
14 % PEG 3350; 
PBS pH 6.0; 
Al’s oil; 
1 µL precipitant 
0.16 M MgCl2; 
16 % PEG 3350; 
PBS pH 6.0; 
Al’s oil; 
1 µL precipitant 
0.2 M MgCl2; 
20 % PEG 3350; 
PBS pH 6.0; 
Al’s oil; 
1 µL precipitant 
 Tray 6 
 6-1 6-2 6-3 6-4 6-5 6-6 
A 
0.12 M MgCl2; 
14 % PEG 3350; 
HEPES pH 7.5; 
Paraffin oil; 
2 µL precipitant 
0.16 M MgCl2; 
16 % PEG 3350; 
HEPES pH 7.5; 
Paraffin oil; 
2 µL precipitant 
0.2 M MgCl2; 
20 % PEG 3350; 
HEPES pH 7.5; 
Paraffin oil; 
2 µL precipitant 
0.12 M MgCl2; 
14 % PEG 3350; 
HEPES pH 7.5; 
Paraffin oil; 
1 µL precipitant 
0.16 M MgCl2; 
16 % PEG 3350; 
HEPES pH 7.5; 
Paraffin oil; 
1 µL precipitant 
0.2 M MgCl2; 
20 % PEG 3350; 
HEPES pH 7.5; 
Paraffin oil; 
1 µL precipitant 
B 
0.12 M MgCl2; 
14 % PEG 3350; 
HEPES pH 7.5; 
Al’s oil; 
2 µL precipitant 
0.16 M MgCl2; 
16 % PEG 3350; 
HEPES pH 7.5; 
Al’s oil; 
2 µL precipitant 
0.2 M MgCl2; 
20 % PEG 3350; 
HEPES pH 7.5; 
Al’s oil; 
2 µL precipitant 
0.12 M MgCl2; 
14 % PEG 3350; 
HEPES pH 7.5; 
Al’s oil; 
1 µL precipitant 
0.16 M MgCl2; 
16 % PEG 3350; 
HEPES pH 7.5; 
Al’s oil; 
1 µL precipitant 
0.2 M MgCl2; 
20 % PEG 3350; 
HEPES pH 7.5; 
Al’s oil; 
1 µL precipitant 
C 
      
D 
 0.12 M MgCl2; 
14 % PEG 3350; 
HEPES pH 7.5; 
Al’s oil+ Paraffin oil; 
1 µL precipitant 
0.16 M MgCl2; 
16 % PEG 3350; 
HEPES pH 7.5; 
Al’s oil+ Paraffin oil; 
1 µL precipitant 
0.2 M MgCl2; 
20 % PEG 3350; 
HEPES pH 7.5; 
Al’s oil+ Paraffin oil; 
1 µL precipitant 
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indicated that they were not suitable environments for MscL crystal growth. In two (60% and 80% 
precipitant concentrations) of the six conditions screened around condition 3 (Table 4.1, wells 2-3B, 
2-4B), however, discrete needle-like crystals (too small for measurement) formed around well-
defined spherulite-like mass after the fifth day, which made it a likely condition for MscL crystal 
growth.  
In the second round of optimisation, both sitting drop and microbatch methods were trialled instead 
of the hanging drop method. The pH (6.0, 7.5), precipitant concentration (50 – 100 %), and in the 
case of microbatch plate, type of oil used (Paraffin oil, Al’s oil) were varied (Table 4.2). Although 
only amorphous precipitates formed in the sitting drop plate, small discrete needles formed around 
such amorphous precipitates in the microbatch plate in eight conditions. However, the needle-like 
crystals were still too small for structural analysis and required further optimisation. 
In a third round of optimisation, only the microbatch method was repeated. MscL buffer (PBS, 0.02 
M HEPES), pH (6.0, 7.5), precipitant concentration (50 – 100 %), oil used (Paraffin oil, Al’s oil, 
1:1 mixture of Paraffin oil and Al’s oil), and protein-to-precipitant ratio (2:1, 1:1) were varied 
(Table 4.3). The protein buffer was also varied as this precipitant condition did not contain its own 
buffer. Most conditions produced amorphous precipitates with tiny needles as before; however, one 
condition (20 mM HEPES pH 7.5; precipitant pH 6.0; 100 % precipitant; 1:1 paraffin oil and Al’s 
oil mix; 2µL 10 mg/mL MscL; 1 µL precipitant) produced well-defined three-dimensional crystals 
of approximately 200 – 400 µm in diameter between the second and the third day (Fig. 4.18A). The 
crystals were harvested on the sixth day. 
The crystals diffracted X-rays very poorly when tested at the UQ ROCX facility. While very poor 
diffraction patterns were seen around the beam stop and attempts at indexing with the Refmac 
program were unsuccessful. An important observation was that there was no strongly-diffracting 
spot in the high-resolution area of the detection plate, suggesting that the crystals were unlikely to 
be salt crystals. 
There are two possibilities for the poor diffraction observed. First, protein molecules in the crystals 
might have been too poorly ordered to yield high resolution diffraction data. Second, the crystals 
might have been a β-DDM detergent-rich phase or detergent crystals, which are known to form 
crystals of various shapes. While the theoretical β-DDM concentration of the solution was too low 
for crystal formation and crystals of such large quantity, its actual concentration might have been 
higher due to its affinity for MscL. Given that 90 kDa His-MscLL-7Y molecules are in β-DDM 
micelles (which are normally 50 – 55 kDa in mass), it is reasonable to assume that the actual 
concentration of β-DDM in 10 mg/mL MscL solution could have been as high as 6 mg/mL. 
Although the solubility of β-DDM in water is over 200 mg/mL, the PEG-rich environment could 
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have facilitated its crystallisation in this scenario.  
In order to test the two possibilities, two frozen crystals were solubilised in 8M urea, and analysed 
using silver stained SDS-PAGE (Fig. 4.18B). The single band matching the size of MscL suggest 
that the crystals either contained significant amounts of MscL or were MscL protein crystals. In 
addition, the crystals did not dissolve in water but dissolved in 8M urea, suggesting that the crystals 
were largely made of protein rather than detergent. The hypothesis that these are protein crystals is 
supported by the fact that MscL should precipitate if significant amounts of β-DDM had 
crystallised, since the nominal concentration of the detergent was close to the critical micelle 
concentration. However, little precipitation was observed in this condition, indicating that MscL 
crystallised with the detergent micelles.  
This leaves the second possibility of poor crystal quality as the likely cause of the diffraction 
problem. At least part of this could be attributed to the simple operational issues with the 
experiment such as not being able to quickly harvest the crystals due to equipment problems at the 
 
Figure 4.18. A) Crystals obtained in the well 6-4D, and B) Silver-stained SDS-PAGE of the crystals. The 
resolubilised crystal solution was loaded in the far left lane, where a band matching the size of His-MscL 
(19 kDa) can be seen. 
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time. Therefore, a repeat of the crystallisation trial with less damage to the crystals might increase 
the diffraction quality. There are also a number of techniques which can be used to improve the 
crystal quality. In addition to conventional optimisations such as finer screening for pH (only two 
pH conditions were trialled in this study) to find a condition for crystals with higher-resolution 
diffraction, microseeding and macroseeding techniques (Bergfors, 2003) can be used to produce 
better-ordered crystals. Since at least needle-like crystals can be reliably produced, microED, which 
is suitable for small 3D crystals, could also be trialled in the future studies (Rodriguez & Gonen, 
2016). 
4.4. Conclusion and Future Directions 
I have detailed in this chapter my work conducted to crystallise E. coli MscL using 2D and 3D 
crystallography methods. The 2D crystallography experiments allowed me to identify conditions 
yielding sheet-like lipid bilayers containing MscL (Fig. 4.9B, 4.11A), which provide a solid basis 
for further refinement. Both optimised conditions and morphology of the MscL/phospholipid 
membrane were similar to that reported by Saint et al. (1998), but with several key improvements 
such as the addition of MgSO4 and slower detergent removal with Biobeads leading to larger 
membrane formation, and the identification of DOPC as a potentially suitable lipid environment for 
crystallisation in addition to E. coli lipids. Additionally, monolayer-assisted 2D crystallisation 
allowed the direct visualisation of MscL complexes and aggregates in the native (i.e. not denatured) 
state in the presence of DOPC (Fig. 4.12, 4.13). These results indicate that it is possible for MscL to 
be crystallised in 2D lattice for future structure determination. 
2D crystallisation experiments also provided valuable information for MscL aggregation 
experiments in Chapter 3 (section 3.3.3.). As the methods for these two projects were similar, the 
optimisation experiments carried out in this chapter could be applied to section 3.3.3. Moreover, the 
visualisation of MscL aggregation in the monolayer experiment confirmed the observation made in 
section 3.3.3. 
3D crystallisation experiments also produced mixed but promising results. A suitable condition for 
3D crystal formation was identified, and the observed quality was improved from spherulites and 
needle-like crystals to large discrete crystals through rationally designed optimisations. However, 
there still remains the challenge of improving the quality of diffraction, which was very poor to 
nearly absent when tested with an in-house X-ray source. As some of the identified problems such 
as late crystal harvesting can be easily rectified, there is a significant likelihood of improvement in 
crystal quality with further trials. Therefore, it will be worthwhile to continue this strategy for the 
determination of E. coli MscL structure. 
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An interesting alternative to conventional X-ray diffraction is an electron diffraction technique 
called MicroED (Brent L. Nannenga et al., 2013; B. L. Nannenga et al., 2014). The main advantage 
of this technique is that it requires the use of small protein crystals. Hence MicroED may allow 
bypassing one of the major bottlenecks in 3D crystallography, growing large crystals while 
maintaining crystallinity, for this project. In the 3D crystallisation trials of MscL, only one 
condition produced large crystals but small needle-like crystals were reproduced multiple times 
over a range of conditions (Tables 4.1, 4.2, 4.3). It is possible that the protein molecules are better 
ordered with these crystals, or at least that these crystals have larger windows for optimisation. An 
F30 electron microscope (FEI, USA) with a K2 direct electron detector camera (Gatan, USA), 
which is capable of MicroED, became operational at UQ at the time of writing this thesis, so this is 
an option with high potential for structure determination in the near future. 
Although not described elsewhere in this chapter due to the lack of relevant data presented, single 
particle analysis is another potentially viable route to determine MscL structure. While this is 
theoretically limited by the small molecular weight of MscL (80 kDa), it could be overcome by 
either producing a fusion protein similar to that used by Li et al. (2015), or by using monoclonal 
antibodies (approx. 45 kDa). As MscL is a homopentamer, up to five antibodies will bind to MscL 
and bring the total molecular weight to ~300 kDa, which is large enough for single particle analysis 
if cryo-electron microscopy is employed. Moreover, these antibodies will bind to the cytoplasmic 
domain, which will further help with single particle analysis by reducing the relative influence of 
detergent micelles (heterogeneous in size and shape). This strategy was similarly employed for 
GPCRs to facilitate 3D crystallisation (Ghosh et al., 2015), so it may also be applicable to 
technically challenging proteins such as MscL in order to determine their structures with electron 
microscopy. 
Limited exploratory trials using anti-His monoclonal antibodies typically used in Western blots 
were carried out, however this could not be properly tested due to the formation of crystalline ice 
throughout the electron microscopy grids. Due to time and resource constraints, and to prevent 
distraction from more productive projects of the thesis, no further work was carried out as of the 
time of writing of the thesis. However, this still remains an interesting alternative method to 
determine MscL structure, albeit with less priority than crystallography approach due to technical 
and resource challenges. 
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5. Conclusion and Future Directions 
5.1. Conclusion 
Nanoparticle-based targeted drug delivery systems are rapidly being developed as therapeutic drug 
delivery systems with the potential to improve the safety and efficacy of both existing drugs and 
drug candidates by targeting these specific sites (Egusquiaguirre et al., 2012; Torchilin, 2006). In 
the nanoparticle family, liposomes hold particular promise because they represent a proven 
technology already used in cosmetics and for medical applications, because it can be further 
improved for active targeting of the liposomal drugs to specific cells and tissues, and because 
externally controlled drug release mechanisms can be incorporated (Fan & Zhang, 2013; Levchenko 
et al., 2012). To improve controlled drug release, a focused electromagnetic force can be used to 
open the nanovalves containing magnetic tags to release cargo molecules from liposomes in a site-
specific manner (Nakayama et al., 2015). Using this strategy, side effects resulting from non-
specific drug release into healthy tissues could be greatly reduced. Drug doses could also be 
reduced to improve safety and cost. Nanovalves are therefore being actively researched, and 
successful proof-of-concept studies both in vitro and in vivo have been reported (Hughes et al., 
2008; Iscla et al., 2013; Nakayama et al., 2015). 
The mechanosensitive channel of large conductance (MscL) in Escherichia coli is one of the best 
studied mechanosensitive channels both as a prototype for this class of protein channels and as a 
nanovalve candidate for liposomal drug delivery systems. The structures of its homologues in 
Mycobacterium tuberculosis, Staphylococcus aureus, and Methanosarcina acetivorans have been 
determined by protein 3D crystallography (G. Chang et al., 1998; Liu et al., 2009; Zhu et al., 2016), 
and a wide range of biophysical studies to characterise the mechanism of channel gating have been 
reported (A. Foo et al., 2015; Grage et al., 2011; Petrov et al., 2011; Y. Wang et al., 2014; Yilmaz 
et al., 2015; Zhu et al., 2016). Despite this, a key point to be addressed in order to fully understand 
the mechanism of channel triggering and gating is to solve the channel structure in its open state in 
near native conditions. Therefore, this project commenced with the two main aims of biophysical 
characterisation of MscL in the membrane environment and its structural characterisation using 
crystallographic methods. 
Chapter 2 focused on the development of new constructs for homogeneous MscL expression and 
improved quantification. The original MscL construct, used in a number of publications by several 
groups (Doerner et al., 2012; Grage et al., 2011; Hase, Le Dain, et al., 1997; Kloda et al., 2006; S. 
I. Sukharev et al., 1994; Yoshimura et al., 2001), had the problems of yielding two protein species 
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and inaccurate quantification due to the lack of tryptophan and tyrosine. To produce pure MscL 
which is also more readily detectable, a series of MscL constructs were designed and characterised, 
which eventually yielded the MscLL-7Y construct (Chi et al., 2015). 
In Chapter 3, MscL’s relationship with the membrane environment was studied using various 
approaches. First, co-purifying lipids were analysed using thin layer chromatography to determine 
whether specific lipid constituents of E. coli membranes were tightly associated with the purified 
MscL complex. Phosphatidylethanolamine (PE), one of the main phospholipids of E. coli 
membrane, was identified as a molecule which associated with MscL with high enough affinity to 
co-purify. 
In a separate set of experiments, MscL/soy azolectin proteoliposomes were size-fractionated by 
sucrose density gradient centrifugation to study if there were variables which could influence MscL 
function. It was found from this experiment that membrane curvature of liposomes can affect MscL 
channel gating and aggregation pattern even without changes in underlying factors such as 
phospholipid composition. This was a confirmation of the hypothesis that global membrane 
curvature is a significant influence on MscL function, and it has implications in the development of 
MscL for nanovalve since this factor will need to be considered when designing liposomal drug 
delivery system that incorporate MscL. 
In the last set of experiments in this chapter, MscL’s aggregation pattern in various phospholipid 
environments was studied to understand its relationship with phospholipids in the resting state. 
Phosphatidylcholine (PC) was found to have a positive influence on MscL clustering, whereas 
phosphatidylglycerol (PG) had a negative influence (Fig. 3.26). Interestingly, PE, which was found 
to have a relatively high affinity for MscL based on thin-layer chromatography analyses, did not 
appear to have a significant role in MscL clustering. The dependence of MscL aggregation on 
phospholipid composition provides another factor to consider in the design of liposomal drug 
delivery systems, since the phospholipid composition can significantly affect MscL distribution 
between liposomes. In summary, the key findings of Chapter 3 were that phospholipid type 
(especially its head groups) and membrane curvature influence MscL distribution in the membrane 
and its channel gating function, and that MscL clustering is influenced by phospholipids which do 
not associate with high affinity in the native E. coli membrane environment. 
In Chapter 4, 2D and 3D crystallisation experiments were conducted with the objective of refining 
E. coli MscL crystallisation conditions. The 2D crystallisation experiments identified conditions 
yielding reasonably large sheet-like membrane structures which appear to be on the right rack in 
terms of 2D crystal formation. With monolayer-assisted crystallisation experiments, large two-
dimensional MscL aggregates in the presence of DOPC were obtained, which was another 
161 
 
promising sign for 2D crystallisation. These experiments also yielded valuable information on the 
biophysical relationship between MscL and phospholipids, including the potential influence of 
MscL on membrane curvature and direct confirmation of MscL clustering in DOPC membranes. 3D 
crystallisation experiments also led to the identification of conditions for formation of 3D MscL 
crystals in detergent environment. Silver-stained SDS-PAGE confirmed these crystals to consist of 
MscL. 
Collectively this project has made significant contributions both towards the biophysical 
understanding of MscL and to its development for nanovalve-based liposomal drug delivery 
systems. MscL’s interaction with phospholipids, membrane curvature, and its aggregation state 
have been proposed as factors influencing its channel gating properties (Grage et al., 2011; Meyer 
et al., 2006; Pliotas et al., 2015; Tang et al., 2008b). This project has not only experimentally 
confirmed these speculations but also shown the factors to be correlated. This new information can 
be applied in the analysis of patch clamp data, improving the accuracy of fluorescence-based 
studies, and in the design of molecular dynamics simulations, hence helping with the biophysical 
characterisation of MscL in general. It is also a valuable finding of its own as it shows that the 
engineering of MscL into a protein-based nanovalve needs to be considered in the wider context of 
liposomal drug delivery system development to produce a nanovalve with desired channel gating 
properties and distribution. 
5.2. Considerations for Advanced Nanovalve Design in the Context of 
Liposomal Drug Delivery Systems 
Liposomal drug delivery systems, currently used in cosmetics and in medical therapies (particularly 
anticancer therapies), can be significantly improved for targeted drug delivery, which is part of the 
longer aim of developing MscL as nanovalves. A number of solutions for such improvement have 
been proposed, including antibody-mediated active targeting and externally triggered drug release at 
the target tissue. It is likely that a successful liposomal drug delivery system will incorporate many 
of these proposed features as there are both benefits and risks to most of them. For example, while 
antibodies provide highly specific targeting to the desired cells (Basile et al., 2012), they also carry 
the risk of becoming ineffective e.g. if cancer cells have mutations which reduce their affinity for 
the receptors, as well as the documented safety concerns (Gabizon, 2001; Torchilin, 2006). 
Nanovalve-based liposomal drug delivery systems can circumvent these problems, but they are also 
limited by not enhancing deposition of the liposomes (which will likely be injected in very low 
concentrations) on their own. A successful approach will need to include both site-specific targeting 
and nanovalve-mediated drug release. 
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Figure 5.1 describes one such liposomal drug delivery system utilising the multiple strategies. 
Ideally, the liposomes will be small in size (less than 100 nm in diameter) to allow liposomes to 
pass through physiological barriers such as blood vessels and skin tissues (Egusquiaguirre et al., 
2012; Fan & Zhang, 2013; Tahover et al., 2015). Accessory molecules on the liposomes such as 
polyethylene glycol and oligosaccharides will not only help with the immune system evasion by the 
liposomes but also actively target certain diseased tissues/cells with moderate specificity, allowing 
  
Figure 5.1. Schematic representation of a conceptual liposomal drug delivery system with externally 
activated nanovalves. 1 – Smaller liposomes ( less than 100 nm in diameter) are generally preferred due to 
the permeability to physiological barriers such as the walls of blood vessels; 2,3 – The liposomal drug will 
need to contain glycolipids (2) or PEGylated lipids (3) to evade the immune system and for active 
targeting to targeted tissues; 4 – Magnetic nanoparticles attached to the nanovalves will provide the 
necessary mechanical force to open the channel pore – hence releasing the drug molecules (brown 
particles) from the liposomes – in the presence of focused electromagnetic field (yellow shading); 5 – If 
desired, the channel pore size can be controlled via the modification of the cytoplasmic domain of the 
nanovalve. A) In this thesis, the curvature of small liposomes was found to be significant enough to lower 
the channel gating threshold of MscL. Can be used to poise nanovalves close to their trigger point and to 
engineer them for modified gating threshold. B) Additionally, the curvature of small liposomes and lipid 
composition can trigger the clustering of MscL, which may in turn lead to the uneven distribution of 
MscL/nanovalves in the liposomal membranes. This can potentially be addressed by adding small amount 
of phospholipids with PG head group (lipids with green head group). 
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liposome deposition at the targeted site (H. I. Chang & Yeh, 2012; Immordino et al., 2006; 
Slingerland et al., 2012). The issue of depositing at non-target tissues can be circumvented by the 
use of site-specific triggering of nanovalve-based drug release system, which will ensure that the 
liposome-encapsulated drugs are released only at the target tissues and not in healthy ones. A 
promising strategy to facilitate the nanovalve opening is to engineer nanovalves to activate on the 
application of external triggers such as light or electromagnetic fields (Kocer et al., 2005; 
Nakayama et al., 2015). 
In this thesis, a protocol was developed to isolate a range of size-fractionated liposomes from 50 nm 
to over 200 nm. The phospholipid composition of the liposome fractions were defined, and based 
on this and the electron micrographs of MscL proteoliposomes, lipid effects on MscL clustering and 
potentially gating threshold were identified. In order to engineer MscL into an externally triggered 
protein-based nanovalve, its gating threshold has to be controlled. This thesis has presented the 
experimental evidence that MscL channel gating threshold is sensitive to the membrane curvature 
of liposomes, providing an important factor to consider in the adjustment of the threshold (Fig. 5.1). 
From this thesis it was also learned that MscL can form self-associating clusters in curved 
membranes and in membranes with phosphatidylcholine head groups, currently the most commonly 
used lipid in liposomal drug formulations (H. I. Chang & Yeh, 2012; Fan & Zhang, 2013). Hence to 
ensure more even distribution of the MscL nanovalve in the liposomal populations, lipids with 
negative influence on the clustering such as phosphatidylglycerols also identified in this thesis will 
also need to be part of the liposomal formulations. The improved formulation of liposomes with 
nanovalves will therefore aid with the development of a novel liposomal drug delivery system with 
targeted drug delivery. 
5.3. Future Directions 
While this PhD project has significantly advanced the understanding of MscL function, there are 
still aspects which require further study. In the near term, some of the experiments which could not 
be performed due to time constraints will need to be carried out to confirm the discoveries made in 
this project. 
First, the phospholipid found to have high affinity to MscL will need to be conclusively identified 
with mass spectrometry. This is currently in progress in collaboration with Prof. Stephen Blanksby 
(Queensland University of Technology). The protocol for this experiment is described in this thesis, 
and a similar experiment on MscS was recently performed by Pliotas et al. (2015), making it a 
project with high potential to yield results for publication. 
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Second, the crystallisation experiments using MscL will need to be continued for the structural 
characterisation of E. coli MscL. Significant progress has already been made in 2D crystallisation, 
and crystallisation conditions were found and optimised for 3D crystallography as well, so it is 
reasonable to expect the structure to be determined with further work. In particular, 3D 
crystallisation experiments look promising since the crystals obtained in this thesis was confirmed 
to be of protein and not of detergent or inorganic salt. However, it should be cautioned that it is 
common for membrane protein crystals to have poor diffraction, making this a still challenging 
project in general. Single particle analysis of cryo-electron microscopy of MscL may also be a 
viable route to determine its structure if the issue with protein size can be addressed.  
Third, crystallisation trials with MscLG22C will be interesting experiments to carry out. MscLG22C 
can be locked in the open state with the addition of MTSET (L. M. Yang & Blount, 2011). Since 
MscL in the open state has a significantly different conformation to the closed state (Deplazes et al., 
2012), it will likely have a unique crystallising condition. While this was not carried out in this 
thesis as doing so would have spread the focus of the project even further, it will be a worthwhile 
project since this is probably a structural biology experiment with highest impact regarding MscL. 
The aim for the structural biology experiments is not necessarily to obtain high-resolution structure. 
There are already a number of low-resolution structural information from FRET and EPR 
experiments (Corry et al., 2010; Y. Wang et al., 2014; Yilmaz et al., 2015) as well as molecular 
dynamics simulations (Chen et al., 2008; Corry et al., 2010; Corry et al., 2005; Deplazes et al., 
2012; Pliotas et al., 2015; Rui et al., 2011). These and the crystal structure of M. tuberculosis MscL 
will enable building an accurate atomic level structural model of E. coli MscL from a relatively 
low-resolution crystal or EM structure. Hence, while obtaining a high-resolution structure of this 
membrane protein may still be challenging, a publishable outcome is still a possibility with further 
experiments. 
Fourth, additional quantitative analysis of the experiments discussed in sections 3.3.2. and 3.3.3. 
needs to be carried out. While the analyses described in this thesis successfully demonstrated the 
significance of membrane curvature and phospholipids in MscL clustering behaviour, there may be 
a better and more rigorous statistical method to validate this observation. This will likely bring the 
result of the section to the publishable quality without additional experiments. 
In the medium term, the biophysical studies on MscL need to be expanded to include phospholipids 
as the main subject both to understand MscL channel function and for the development of 
nanovalve-assisted liposomal drug delivery systems. Prior to the start of this PhD project, most 
studies on MscL focused on the protein aspect of biophysics while comparatively little attention 
was paid to phospholipids. For example, most molecular dynamics studies use a model in which a 
165 
 
single MscL complex “floats” in a membrane consisting of a single species of phospholipid, which 
is more often than not phosphatidylcholine (which is not native to E. coli membrane) (Bavi, 
Vossoughi, et al., 2016; Deplazes et al., 2012; Meyer et al., 2006; Sawada et al., 2012). This project 
provides evidence that the relationship between MscL and phospholipids needs to be studied in the 
context of multiple proteins influencing the biophysics of phospholipid. These studies will 
contribute to our understanding of the mechanisms of the discoveries made in this project at the 
molecular level. Molecular dynamics simulation performed in this context not only will help to 
identify the protein residues and atoms in the phospholipids responsible for the aggregation and 
change in channel gating function, but also will be able to model the lipid and MscL structures more 
accurately and facilitate structure-guided nanovalve design. 
A long term biotechnological goal of MscL studies is to develop these channels for use as protein-
based nanovalves for new drug delivery systems. For example, there are already significant efforts 
to engineer MscL into light and magnetically activated nanovalves (Kocer et al., 2005; Nakayama 
et al., 2015), and this work will have to continue in tandem with liposome development to fast track 
the development of next generation liposomal drug delivery system. Significant work remains, but 
the work described here, together with conclusions from past experiments and future efforts, could 
collectively contribute to a new drug delivery system with improved safety, efficacy, and cost, 
which are among the main challenges facing modern medicine. 
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